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ABSTRACT 
 
Salmonella spp. are facultative intracellular pathogens, which cause gastrointestinal and 
systemic diseases in a broad range of hosts including animals and humans. In addition to 
virulence genes clustered within pathogenicity islands, numerous additional genes scattered 
throughout the genome are also involved in various aspects of Salmoenlla virulence and 
pathogenesis. In this study, I identified a Salmonella putative transcriptional regulator 
encoded by a previously uncharacterized open reading frame designated STM0029. Deletion 
of STM0029 altered the expression of genes involved in both the resistance to host 
bactericidal challenges, and bacterial cell wall biosynthesis in S. Tyhpimurium. 
The ΔSTM0029 strain showed a defect in the resistance to host antimicrobial peptides, 
including α-defensin-1, β-defensin-1, β-defensin-2, LL-37, and polymyxin B as well as serum 
challenges compared to the wildtype. Unexpectedly, expression of STM0029 was found to be 
repressed by the PmrA/B two component system, but appeared to be independent of the 
PhoP/Q two component system, both of which are well-known regulatory systems involved in 
the regulation of expression of genes involved in Salmonella intracellular survival. Notably, 
the expression of a set of genes involved in bacterial LPS O-antigen and peptidoglycan 
biosyntheses and modifications showed decreases in the absence of STM0029. These 
experimental results indicate that the STM0029 gene product in S. Typhimurium contributes 
to resistance against host cell defense mechanisms, likely through regulation of genes 
involved in LPS O-antigen and peptidoglycan biosynthesis and modifications. 
 
 
Key words  
Salmonella/Antimicrobial peptide/PmrA/B and PhoP/Q two component system/LPS O-
antigen 
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ZUSAMMENFASSUNG 
 
 
Salmonella spp. sind fakultative intrazelluläre Pathogene, die gastrointestinale und 
systemische Erkrankungen in einem umfassenden Wirtsbereich, einschließlich Tier und 
Mensch, hervorrufen. Salmonella benötigt verschiedene Virulenzgene für die Infektion 
welche auf sogenannten Salmonella Pathogenitäts-Inseln (SPI) kodiert sind. Hinzu kommt, 
dass auch zahlreiche im Salmonella Genom verstreuten Gene an verschiedenen Aspekten von 
Virulenz und Pathogenese beteiligt sind. In der vorliegenden Studie wurde die Funktion eines 
zuvor nicht beschriebenen putativen transkriptionellen Regulators (STM0029) charakterisiert 
und definiert. Dieser scheint für die Abwehr von zellulären bakterizid wirkenden 
Verbindungen und das Überleben des Bakteriums innerhalb einer intrazellulären Nische von 
entscheidender Bedeutung zu sein. 
Die STM0029-deletierte Mutante wies eine gesteigerte Sensitivität gegenüber 
antimikrobiellen Peptiden und bakteriziden Verbindungen auf. Dazu zählten α-Defensin-1, β-
Defensin-1, β-Defensin-2, LL-37 und Polymyxin B sowie Komponenten des 
Komplementsystems. Unerwartet war die Beobachtung, dass die Expression von STM0029 
durch das PmrA/B Zwei Komponenten System reprimiert vorlag, während das PhoP/Q Zwei 
Komponenten System keinen Einfluss auf die Expression von STM0029 zu scheinen hat. 
Beide Komponent Systeme spielen bekanntlich eine entscheidende Rolle bei der 
Expressionsregulation von Genen die für das intrazelluläre Überleben von Salmonella wichtig 
sind. Bemerkenswert ist, dass ein Set von Genen welche an der Biosynthese und/oder der 
Modifikation für das LPS O-Antigen sowie des Peptidoglykans in der bakteriellen Zellwand 
beteiligt ist, im STM0029 Deletionshintergrund herab reguliert vorlag. Dieses Ergebnis deutet 
darauf hin, dass das STM0029 Genprodukt die Persistenz des Pathogen in Wirtszellen 
beeinflusst. Möglicherweise geschieht dies durch das Umgehen von wirtseigenen 
Abwehrmechanismen.  
  
Schlüsselbegriffe 
Salmonella/Antimikrobielle Peptide/PmrA/B und PhoP/Q Zwei Komponenten Systeme/LPS 
O-Antigen
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1. INTRODUCTION 
 
1.1. Salmonella and Salmonellosis 
Salmonella is a Gram-negative, motile, rod-shaped bacteria belonging to the family 
Enterobacteriaceae. Classification of Salmonella based on serology and phage susceptibility 
assays has currently identified more than 2500 serovars. The Salmonella genus contains two 
species, enterica and bongori (Brenner et al., 2000). Based on the variation in their biotypes, 
S. enterica is further divided into six subspecies, including enterica (group I), salamae (group 
II), arizonae (group IIIa), diarizonae (group IIIb), houtenae (group IV), and indica (group VI) 
containing 2443 serovars (Le Minor & Popoff, 1987; reviewed by Tindall et al., 2005). Most 
of the Salmonellae that cause disease are in the subspecies Salmonella enterica subspecies 
enteria (Mastroeni and Maskell, Book Chapter 1, 2006). Salmonella causes a wide range of 
diseases in human and animal hosts ranging from a self-limiting enteritis to systemic 
infections, depending on Salmonella serotypes as well as the host and immune status 
(Marmion et al., 1953; reviewed by Coburn et al., 2007). While the serovars Typhi and 
Paratyphi are strict human pathogens (Hornick et al., 1970; Thong et al., 1994), Salmonella 
enterica serovars Typhimurium and Enteritidis are broad host-range pathogens, infecting both 
human and animal hosts (Mastroeni and Maskell, Book Chapter 3, 2006). Over the last 25 
years, some of the most commonly detected serovars from chickens, including S. Enteritidis 
and S. Heidelberg are also among the top five serovars associated with human infections 
(Centers for Disease Control and Prevention, 2008; Foley et al., 2008). 
 Salmonella enterica is a food-borne pathogen of continuing global significance. The 
strict human-adapted serovars, S. Typhi and S. Paratyphi, cause typhoid fever characterized 
by fever, abdominal pain and transient diarrhoea. It has been estimated that there are 
approximately 21 million cases with a mortality of 1% (Crump et al., 2004). Non-typhoid 
Salmonella infections in humans usually result from consumption of contaminated food and 
water and causes a self-limiting gastroenteritis. As reported in 1999, in the USA alone there 
were estimated 1.4 million cases of non-typhoid Salmonella infections annually, resulting in 
approximately 600 deaths (Mead et al., 1999). In Germany, more than 80% of the human 
isolates from the cases reported to the Enteric Reference Centre at the Robert Koch Institute 
in 1995 were comprised of serovar Enteriditis (61.3%) and serovar Typhimurium (23.4%) 
(Rabsch et al., 2001). Worldwide estimates of cases of non-typhoid Salmonella infection 
range from 200 million to 1.3 billion, with an estimated death toll of 3 million each year 
(Hohmann, 2001).  
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 Human salmonellosis is typically associated with the consumption of contaminated 
foods, such as fresh and processed meat and poultry, eggs, and fresh products (Benenson and 
Chin, 1995; Mead et al., 1999; Tauxe, 1991). Symptoms of salmonellosis include diarrhea, 
fever, vomiting, and abdominal cramps (McGhie et al., 2009). Intermittent shedding of the 
pathogen by domestic animals is thought to provide a constant reservoir for infection and 
contamination of food. Salmonellosis in domestic animal species is also important for public 
health as the major reservoir and source of food-borne human infections. Industrialisation and 
large scale food distribution, increased consumption of raw or slightly cooked foods, an 
increase in immuno-compromised patient populations, deteriorated public infrastructure and 
evolution of multi-drug-resistant Salmonella have been all proposed as possible reasons for 
the steady increase in the incidence of Salmonella infections (Darwin and Miller, 1999a). 
 
1.2. Salmonella host cell infection 
Salmonella enterica species are facultative intracellular pathogens that infect and replicate 
within non-phagocytic epithelial cells, enterocytes, hepatocytes as well as professional 
phagocytic macrophages. Carter and Collins (1974) suggested that there are two major sites 
of infection in the intestinal lumen: Peyer’s patches and the epithelium covering the villi, both 
of which are important for Salmonella invasion of the intestinal wall. Peyer’s patches and 
solitary intestinal lymphoid tissues are sites of organized lymphoid structures in the distal 
ileum. Salmonella can pass through the epithelium through different mechanisms. Salmonella 
can traverse the barrier either through M cells in the follicle-associated epithelium (FAE) or 
epithelial cells forming the FAE (Tam et al., 2008). Following invasion of non-phagocytic 
host cells, Salmonella survives and replicates within a modified phagosome known as the 
Salmonella-containing vacuole (SCV) (Fig. 1, see page 15). Successful invasion and further 
infection processes of Salmonella in host cells are mediated by chromosomally-encoded 
virulence genes, which are clustered on Salmonella pathogenicity islands (SPIs; Fitts, 1985; 
Groisman et al., 1993; Groisman and Ochman, 1997; reviewed by McGhie et al., 2009). Two 
major pathogenicity islands, SPI1 and SPI2 encoding type III secretion systems (T3SS), are 
required for invasion and SCV biogenesis/ intracellular survival, respectively. During 
invasion, SPI1-encoded virulence genes manipulate host cell processes such as actin 
polymerisation, membrane trafficking and signal transduction (reviewed by McGhie et al., 
2009; reviewed by Steele-Mortimer, 2008); whereas SPI2-encoded genes are expressed only 
after Salmonella entry into host cells and alters the maturation of the SCV and promotes 
intracellular replication (Hensel et al., 1998). 
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Fig. 1. Schematic representation of Salmonella infection. Salmonella invades host cells by inducing 
actin polymerization seen as membrane ruffles on the plasma membrane (1). After infecting host cells, 
Salmonella is internalised into the early SCV, within which Salmonella is able to survive and replicate 
(2). Within 15–60 min of post-infection, early endosomal proteins are replaced by proteins normally 
found on late endosomes or lysosomes and SCVs are predominantly localised near the nucleus (3). 
Within 4-6 hr of post-infection, Salmonella replication is initiated and SCV tubules (Sifs)* extend 
radially along microtubules (4). The movement and localisation of these cell compartments are 
mediated largely by interactions with microtubule-based motors such as dynein and kinesin, which 
mediate retrograde (blue arrows) and anterograde movement (red arrows), respectively. Salmonella 
utilises the same cellular system for translocation of SCVs towards the nucleus and subsequent 
extension of Sifs. The figure is modified from Steele-Mortimer, 2008. 
*Sifs: Salmonella-induced filaments (Sifs) are tubular structures utilised by Salmonella to elongate the 
vacuole, within which it resides (Brumell et al., 2001). 
 
1.3. Salmonella virulence factors 
Approximately 200 genes or 4% of the S. Typhimurium genome are considered to be 
virulence factors (Bowe et al., 1998). While these virulence genes can be found scattered 
throughout the Salmonella chromosome, analysis of the genetic structure reveals that these 
genes often cluster in regions referred to as Salmonella pathogenicity islands (SPIs) 
(Groisman and Ochman, 1997; reviewed by McGhie et al., 2009). Pathogenicity islands have 
also been described in many Gram-negative animal and plant pathogenic bacteria. Examples 
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include the locus of enterocyte effacement (LEE) region of enterohemorrhagic Escherichia 
coli (Elliot et al., 1998); the Mix/Spa region of Shigella spp. (reviewed in Hueck, 1998); the 
Exs/Psc region of Pseudomonas aeruginosa (reviewed by Hueck, 1998); and the Hrc/Hrp 
region of Ralstonia solonacearum (Van Gijsegem et al., 1993). In Salmonella, these islands 
contain multiple functionally related genes, which are necessary for a specific virulence 
phenotypes and in general have a lower GC content compared to the rest of the bacterial 
genome, supporting the idea that these pathogenicity islands were horizontally acquired 
(McClelland et al., 2001). To date, at least 12 SPIs have been characterised in Salmonella, of 
which five SPIs have been most studied (Hensel, 2004). 
 
1.3.1. Salmonella Pathogenicity Island 1 (SPI1) 
Salmonella pathogenicity island 1 (SPI1) is a 40-kb region located at centosome 63 on 
Salmonella chromosome flanked by flhA (STM1913) and mutS (STM2909) (Mills et al., 
1995; Hensel, 2004). Based on sequence and hybridization data, SPI1 is highly conserved and 
has been reported to be present in S. bongori and all subspecies of Salmonella enterica 
(Ochman and Groisman, 1996). Unlike the majority of the pathogenicity islands, SPI1 is not 
associated with a tRNA gene. SPI1, which harbours at least 35 genes, encodes a type III 
secretion system (T3SS) and associated secreted effector proteins (Kimbrough and Miller, 
2002). A number of reports indicate that many SPI1-encoded genes are involved in mediating 
macrophage apoptosis in vitro (Chen et al., 1996) and trigger enteritis and intestinal 
inflammation (Galyov et al., 1997; Wallis and Galyov, 2000). 
The main regulators encoded within SPI1 participating in Salmonella invasion include 
HilA, HilC, HilD, InvF and SprB (Bajaj et al., 1995; Darwin and Miller, 1999b; Eichelberg 
and Galán, 1999; Lostoh et al., 2000; Rakeman et al., 1999; Schechter et al., 1999). HilA 
plays a central role as a major transcriptional regulator to activate the expression of S. 
Typhimurium invasion genes (Bajaj et al., 1995). Expression of the genes within SPI1 and 
multiple loci encoded outside of SPI1 are under the control of the local regulator InvF. 
Currently, 12 Salmonella serovar Typhimurium effector proteins, which are transported via 
the SPI1 T3SS have been identified (Galan, 2001). The gene products encoding the T3SS 
include those for the core apparatus (SpaO, SpaP, SpaQ, SpaR, SpaS, InvA, InvC and OrgB), 
needle complex components (PrgH, PrgI, PrgJ, PrgK, InvG and InvJ) and translocon (SipB, 
SipC and SipD) (Collazo and Galán, 1997; Kimbrough and Miller, 2002). Many additional 
effector proteins, including SopE, SopE2, SopA, SopB/SigD, SopD, SlrP, and SspH1 are 
encoded elsewhere in the chromosome (Bakshi et al., 2000; Jones et al., 1998; Miao et al., 
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1999; Wood et al., 1996; Wood et al., 1998; Wood et al., 2000). Zhang et al. (2002) reported 
that SipA, SopA, SopB, SopD, and SopE2 are important for S. Typhimurium to induce 
diarrhea in calves. InvB (Bronstein et al., 2000), SicA (Tucker and Galan, 2000) and SicP (Fu 
and Galan, 1998) encode the main chaperones protecting secreted proteins during 
translocation. 
  
1.3.2. Salmonella Pathogenicity Island 2 (SPI2) 
Salmonella pathogenicity island 2 (SPI2) is a 40-kb region mapped to 31 minutes on the 
chromosome and associated with the valV tRNA. Of the 40-kb sequence, only a region of 15-
kb is present in both S. enterica and S. bongori while the remaining 25-kb region, harbouring 
genes encoding a second T3SS, is restricted to subspecies of S. enterica and is required for 
the systemic virulence. Recent studies indicate that the function of the T3SS encoded within 
SPI2 is central for the ability of S. enterica to cause systemic infections and for intracellular 
proliferation (Hensel et al., 1998). Genes encoding of the SPI2 regulatory proteins have been 
given designations related to their functions, and are termed ssr (secretion system regulator), 
ssa (secretion system apparatus), sse (secretion system effector) and ssc (secretion system 
chaperone), respectively.  
 
1.3.3. Salmonella Pathogenicity Island 3 (SPI3) 
Salmonella pathogenicity island 3 (SPI3) is a 17-kb locus, which has been horizontally 
acquired and is present as an insertion in the selC tRNA locus. Although it is conserved in 
both S. Typhi and S. Typhimurium, there are large variations in other subspecies. SPI3 
harbours 10 open reading frames organised in six transcriptional units, which include the 
mgtCB operon encoding the macrophage survival protein MgtC and the Mg2+ transporter 
MgtB (Blanc-Potard et al., 1999). Interestingly, MgtC, which is encoded by a Salmonella-
specific gene, is required for intracellular survival within macrophages, virulence in mice, and 
growth in low-Mg2+ media. The mgtC gene is transcriptionally controlled by the PhoP/Q 
regulatory system, which is involved in the adaptation to a low-Mg2+ environment and is a 
major regulator of virulence functions in Salmonella (Alix and Blanc-Potard, 2007) (see 
section 1.3.8.1. for further details, p. 19). 
 
1.3.4. Salmonella Pathogenicity Island 4 (SPI4) 
Salmonella pathogenicity island 4 (SPI4) is a 27-kb region that carries six genes designated 
siiABCDEF. Unlike SPI1 and SPI2, the genes including siiC, siiD and siiF encode a type I 
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secretion system (T1SS) for the secretion of SiiE, a large (~600 kDa) protein contributing to 
the colonization of the bovine intestine (Gerlach et al., 2007; Kiss et al., 2007). SiiE has been 
demonstrated to function as a large, non-fimbrial adhesin to mediate Salmonella adhesion to 
epithelial cells (Gerlach et al., 2007). The role of SPI4 remains unclear, but a recent study 
using signature-tagged mutagenesis identified SPI4 as a colonization factor during infection 
of calves (Morgan et al., 2007). Lawley et al., (2006) identified a strain defective in SPI4 
genes as being attenuated in a model for long-term persistence. 
  
1.3.5. Salmonella Pathogenicity Island 5 (SPI5) 
Salmonella pathogenicity island 5 (SPI5) is a 7.6-kb insertion within the serT-copS/R 
intergenic region. This region appears to be conserved in Salmonella serovars; however, it is 
absent in other pathogenic bacteria. SPI5 also encodes pipABCD and orfX in addition to 
sopB/sigD, which have been identified previously (Wood et al., 1998). SopB/SigD is secreted 
through the SPI1 T3SS and has been shown to be involved in actin rearrangement, 
phagocytosis, biosynthesis of SCV, fluid secretion and diarrhoeal symptoms. Similar to the 
activity of SopB, S. Dublin pip mutants were attenuated for their enteropathogenicity in calf 
ileal loop models (Wood et al., 1998). 
 
1.3.6. Other Salmonella pathogenicity islands  
Besides the five major pathogenicity islands as mentioned above, different serovars of 
Salmonella spp also hold other pathogenicity islands, which still have not been well studied. 
For example, the safABCD operon is located within Salmonella enterica centisome seven 
genomic island (SCI), also known as SPI6 in S. Typhi (Folkesson et al., 2002; Parkhill et al., 
2001). This operon encodes Salmonella-specific putative atypical fimbriae; however, the S. 
Typhimurium saf operon was not required for virulence in mice (Folkesson et al., 1999; 
Morgan et al., 2004). SPI7, which is also referred to as the major pathogenicity island (MPI) 
of serovar Typhi, harbours genes involved in expression of the Vi antigen, a capsular 
exopolysaccharide (Hacker et al., 1997; Liu and Sanderson, 1995). 
 
1.3.7. Plasmid-encoded virulence genes 
Plasmids of Salmonella spp vary in size from 2- to more than 200-kb. The best-described 
group of plasmids are virulence plasmids (50 - 100-kb in size), which are present in serovars 
Enteritidis, Typhimurium, Dublin, Choleraesuis, Gallinarum, Pullorum and Abortusovis. 
These large virulence plasmids are involved in Salmonella systemic infections and increase 
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the growth rate of the bacteria at sites beyond the intestine in mice models (Gulig, 1990; 
Guling and Doyle, 1993). One common region conserved among virulence plasmids is the 
7.8-kb region spvRABCD operon. SpvR is a positive transcriptional regulator of the spvABCD 
operon. Signals for expression of the spv locus are growth restriction, reduced nutrient supply 
or low pH (Guiney et al., 1995). SpvB and SpvC are the central effector genes of this operon, 
since the presence of spvBC genes alone is sufficient to complement for the missing virulence 
plasmid in S. Typhimurium (Matsui et al., 2001). 
In addition to the spv virulence plasmid, other plasmids, which are present in some, 
but not all other serovars, harbour additional virulence-related genes such as rck (resistance to 
complement killing) (Ho et al., 2010), pef (plasmid-encoded fimbriae), srgA (SdiA-regulated 
gene, putative disulphide bond oxidoreductase) (Jarrott et al., 2010) and mig-5 (macrophage-
inducible gene coding for putative carbonic anhydrase). 
 
1.3.8. Regulation of Salmonella virulence genes 
The ability of an organism to orchestrate responses to environmental changes depends on 
transcriptional regulatory factors and networks used to control expressions of multiple genes. 
Currently, many regulators which are important to this response have been reported: the two 
component systems (TCSs) PhoP/Q, PmrA/B, OmpR/EnvZ; the alternative sigma factors 
RpoS and RpoE; and signal molecules such as cyclic adenosine monophosphate (cAMP), 
cyclic diguanosine monophosphate (diGMP), diadenosine tetraphosphate (Ap4), and 
guanosine penta- and tetraphosphate ((p)ppGpp) (De Las Penas et al., 1997b ; Fang et al., 
1996; Groisman et al., 1989; Gunn, 2008; Pizarro-Cerdá and Tedin, 2004; Prost and Miller, 
2008). 
 
1.3.8.1. The PhoP/Q two component system 
S. Typhimurium has known to have three periplasmic phosphatases: an acid hexose 
phosphatase, a cyclic 2',3'-nucleotide phosphodiesterase and a non-specific acid phosphatase 
(Kier et al., 1977). The function of PhoP in Salmonella was originally found to regulate the 
locus encoding non-specific acid phosphatase (Kier et al., 1978). Later, the phoP mutant 
(designated MS7953s by Fields et al., 1986) identified by Tn10 insertional transposon 
mutagenesis also showed a defensin-sensitive phenotype and a defect in intracellular survival 
within macrophages (Fields et al., 1986; Fields et al., 1989). The PhoP/Q TCS is composed of 
a membrane-bound sensor histidine kinase PhoQ and the cytosolic response regulator PhoP. 
Miller et al. (1989) first reported that PhoQ serves as a sensor kinase for PhoP response 
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regulator. PhoQ has been sequenced and found to encode a membrane protein with homology 
with the C-terminal kinase domains of a sensor kinase, EnvZ, which belongs to the 
Salmonella OmpR/EnvZ two component system (Miller, et al., 1989) (see section 1.3.8.3. 
OmpR/EnvZ for further details, p. 22). Activation of the PhoQ sensor kinase in response to 
specific environmental signals leads to trans-autophosphorylation of PhoQ and subsequently 
transfers phosphate to PhoP. Phosphorylated PhoP is able to control expression of a number 
of PhoP-activated genes (pag) and PhoP-repressed genes (prg) (Perez et al., 2009). To date, 
more than 200 pag and prg genes have already been identified in S. Typhimurium through 
microarray analyses and motifs sceening (Monsieurs et al., 2005). The major pag gene 
products whose functions have been defined include PagA, PagB, PagC, PagD, PagJ, PagK 
and PagM. pagC is the first gene to be reported that its expression is required PhoP (Miller et 
al., 1989). PagC (188 amino acid long), which encodes a membrane protein is similar to the 
ail-encoded eucaryotic cell invasion protein of Yersinia enterocolitica and the lom-encoded 
protein of bacteriophage lambda (Pulkkinen and Miller, 1991). In addition, expression levels 
of pagA and pagB have also been shown increases inside macrophages (Alpuche-Aranda et 
al., 1992). Moreover, Belden and Miller (1994) reported that mutations in pagD, pagJ, pagK, 
and pagM were significantly attenuated for mouse virulence. PagP, which encodes an outer 
membrane palmitoyl transferase is able to catalyze the addition of palmitate to lipid A by 
transfer of fatty acid from the inner leaflet of the outer membrane of lipid A (Guo et al., 
1998).  
 To date, functions of the PhoP/Q TCS have been reported to be involved in many 
aspects of Salmonella pathogenesis, including the Mg2+ transporter (García Véscovi et al., 
1996; Soncini et al., 1996), survival within macrophages (Fields et al., 1986; Groisman and 
Saler, 1990), modifications of lipopolysaccharide (LPS) (Mouslim and Groisman, 2003) (see 
section 1.5.2.2. for further details, p. 32), and actives a further two component system, e.g. the 
PmrA/B TCS (Groisman, 2001; Kato et al., 2007; Kox et al., 2000) (see section 1.3.8.2. for 
further details).  
 
1.3.8.2. The PmrA/B two component system 
The pmrA locus was originally isolated by selection of mutants growing on plates containing 
various concentrations of Colistin E sulfate (Mäkelä et al., 1978). Colistin (polymyxin E) 
discovered in 1949 is a compound belonging to polymyxin antibiotics and is non-ribosomally 
synthesized by Bacillus polymyxa subspecies colistinus Koyama (reviewed by Falagas and 
Kasiakou, 2005; Komura and Kurahashi, 1979; Koyama et al., 1950). Roland et al. (1993) 
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further identified and sequenced this pmrA locus and found that this locus encodes the pmrA 
gene, which contributes to the resistance to polymyxin B and the neutrophil peptides CAP37 
(azurocidin) and CAP57 (bactericidal permeability-increasing protein) challenges. Later, 
expression of the PmrA response regulator was found to be activated by Fe3+, which is a 
signal sensed by the PmrB sensor histidine kinase (Wosten et al., 2000). The PmrA/B TCS is 
also indirectly activated by Mg2+, which is involved in a pathway that requires the Mg2+-
responsive PhoP/Q TCS via the connection by the PhoP-activated PmrD protein (Kox et al., 
2000; Kato and Groisman, 2004; Kato et al., 2007).  
Vaara et al. (1981) reported that the pmrA mutant showed an increased level of 
substitution by 4-amino-4-deoxy-L-arabinose (Ara4N) at bacterial lipopolysaccharide (LPS) 
lipid A phosphoryl groups. To date, many of the characterized PmrA-regulated genes are 
believed to participate in the modification of LPS (see section 1.5.2.2.2.1. for further details, 
p. 35). These modifications include the addition of 4-amino-4-deoxy-L-arabinose and 
phosphoethanolamine (pEtN) to bacterial LPS lipid A and the LPS core region (Heptose I). 
Ara4N addition occurs on the outer surface of the inner membrane before LPS is flipped 
outside of the outer membrane. According to microarray studies, mutagenesis and in silico 
analysis (Marchal et al., 2004), the PmrA/B TCS has been found to regulate up to 100 genes 
in Salmonella, of which many of the PmrA/B-associated genes are involved in LPS 
modifications. The well-studied PmrA-regulated genes include pmrF (pbgP or arn) (Gunn et 
al., 1998; Trent et al., 2001), pmrC (Lee et al., 2004), pmrE (Gunn et al., 1998; Zhou et al., 
2001) and cptA (Tamayo et al., 2005). PmrF, which encodes an inner membrane enzyme 
utilises the novel lipid undecaprenyl phosphate-α-L-Ara4N as its sugar donor and transfers L-
Ara4N to lipid A (Trent et al., 2001). PmrC mediates the addition of pEtN to the 1-phosphate 
of LPS lipid A (Lee et al., 2004; Tamayo et al., 2005). PmrE (Ugd/PagA), which encodes an 
UDP-glucose dehydrogenase is necessary to produce aminoarabinose or for the addition of 
aminoarabinose to LPS lipid A (Gunn et al., 1998). CptA is required for the addition of pEtN 
to the LPS core region; however, mice infected by the intraperitoneal or oral routes with a 
mutation of cptA showed no differences in the 50% lethal dose (Tamayo et al., 2005). It has 
also been reported that some of the PmrA/B-regulated downstream genes, e.g. those encoding 
PmrE and Wzz, which determine the LPS O-antigen chain length, are also regulated by 
another Salmonella two component system, the RcsC/YojN/RcsB TCS (Delgado et al., 2006). 
The RcsC/YojN/RcsB TCS is composed of the sensor RcsC, the response regulator RcsB and 
the histidine-containing phosphotransfer protein YojN, which is used as a mediator in the 
phosphoryl transfer from RcsC to RcsB (Majdalani and Gottesman, 2005). The Rcs system in 
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Salmonella spp is activated by a mutation of igaA (Tierrez and Garcia-del Portillo, 2004) or 
tolB (Mouslim et al., 2003) as well as growth under conditions of low Mg2+ and Fe3+ 
(Mouslim and Groisman, 2003). However, not all PmrA-regulated genes are involved in LPS 
modifications, e.g. dgoA, yibD, aroQ, mig-13 and sseJ (Gunn, 2008).  
Orthologs of the Salmonella PmrA/B TCS exist in several Gram-negative pathogens, 
e.g. Yersinia spp. (Flamez et al., 2007), Escherichia coli (Raetz, 2001) and Pseudomonas 
aeruginosa (Moskowitz et al., 2004). Modifications of LPS mediated by the PmrA/B TCS 
result in the resistance to host antimicrobial peptides (AMP) killing subsequently. In both 
Legionella pneumophila and Coxiella burnetii, orthologs of the PmrA/B TCS, which have 
been described to control the icm/dot type IV secretion pathway are essential for the transfer 
of virulence effectors into host cells (Zusman et al., 2007). 
 
1.3.8.3. The OmpR/EnvZ two component system 
The EnvZ/OmpR system is one of the ancestral two component system used by various 
bacteria, including Escherichia coli (Kanamaru et al., 1989), Salmonella spp (Lindgren et al., 
1996) and Shigella spp (Bernardini et al., 1990). This two component system mediates signal 
transduction in response to environmental osmolarity changes in Escherichia coli (Kanamaru 
et al., 1989; Yang and Inouye, 1991). The histidine kinase EnvZ, which consists of 450 amino 
acid residues exists as a dimer located in the inner cytoplasmic membrane of E. coli. EnvZ 
undergoes trans-autophosphorylation on the highly conserved Histidine-243 residue (Yang 
and Inouye, 1993) and regulates the phosphorylation state of the transcriptional response 
regulator OmpR to respond to the osmolarity changes in the environment (Cai and Inouye, 
2002). The phosphoryl group is further subsequently transferred to the conserved Asparagine-
55 residue of OmpR (Yang and Inouye, 1993). Phosphorylated OmpR therefore serves as a 
transcription factor differentially to modulate expressions of major outer membrane porins 
encoded by ompC and ompF (Nikaido and Vaara, 1985; reviewed by Nikaido, 2003). The 
OmpC and OmpF products are able to form channels in the outer membrane, which allow 
diffusion of small hydrophilic molecules of less than 650 Dalton (Nikaido and Vaara, 1985). 
In Salmonella spp, both OmpR/EnvZ and PhoP/Q TCSs participate in the regulation of the 
expression with SPI2 genes as well (Feng et al., 2003; Kim and Falkow, 2004). OmpR is able 
to bind to the promoter and induces expression of the SpiR/SsrB TCS encoded in SPI2 in 
order to activate SPI2 genes; PhoP directly binds to the ssrB promoter and induces spiR 
transcription indirectly by inducing transcriptional activation of the transcription factor SlyA 
(Fass and Groisman, 2009). 
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1.3.8.4. Alternative sigma factors RpoS and RpoE 
In Escherichia coli, RNA polymerase consists of the subunits of α2, β, β’, and a specific σ. A 
sigma factor (σ factor) is a prokaryotic transcription initiation factor that enables specific 
binding of RNA polymerase to gene promoters (reviewed by Gruber and Gross, 2003). RpoS 
(σ38), which is an alternative sigma factor functions in many aspects of bacterial physiologies, 
including tolerance of environmental stress challenges (osmotic, oxidative stress and acid 
shock) and the growth transition to stationary phase (Hengge R, 2008; McMeechan et al., 
2007). Expression of RpoS is regulated by complex mechanisms combining with multiple 
stimulations at transcription, translation and protein stability levels (Hengge-Aronis, 2002). In 
Salmonella spp, RpoS is also involved in the regulation of Salmonella-encoded virulence 
plasmids (spvRABCD genes) (Fang et al., 1992; Norel et al., 1992) and Salmonella infections 
as well (Nickerson and Curtiss, 1997). 
 The rpoE gene encodes the σE transcription factor, which positively regulates the 
envelope-stress response to extracytoplasmic unfolded proteins (De Las Penas et al., 1997). 
The σE factor is originally identified as a heat shock factor (Rouviere et al., 1995) and is 
essential for E. coli growth at high temperature (Hiratsu et al., 1995). In E. coli, the σE factor 
up- and down-reguates as many as 200 genes involved in the field of metabolism during its 
expression at either the exponential or the stationary phase (Kabir et al., 2004; Rhodius et al., 
2006). In Salmonella spp, functions of RpoE have been reported to be involved in the 
activation of expressions of flagellar genes under hyperosmotic stress (Du et al., 2011), in the 
regulation of a subset of SsrB-regulated virulence factors (Osborne and Coombes, 2009) and 
in the association with the Hfq-mediated regulation (Figueroa-Bossi et al., 2006). 
 
1.4. Host immune system 
Interactions of pathogens with mammalian cells are complex processes including numerous 
bacterial products, which are sensed by mammalian hosts. Myeloid-derived phagocytes, such 
as macrophages, monocytes, neutrophils, and dendritic cells are critical to control bacterial 
infections, and these cells have complementary functions to ensure host survival (Tam et al., 
2008). Depending on cell types, a cascade of anti-bacterial processes is initiated by the initial 
binding and engulfment of pathogens. Salmonella can enter various types of the host cells by 
either SPI1-induced macropinocytosis or non-SPI1 phagocytosis depending on different cell 
types, and is initially enclosed in a spacious phagosomal compartment called the Salmonella-
containing vacuole (Introduction 1.2.; Fig. 1) (Alpuche-Aranda et al., 1994). Depending on 
the mechanism of uptake, e.g. opsonization of the bacteria through complement proteins 
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(complement-mediated uptake), Fc-mediated uptake (binding of antibodies to the bacteria and 
binding of the Fc receptor), host cells are also activated to increase microbicidal and 
degradative as well as secretory functions (Webster et al., 2008). The initiation of the host 
innate immune response is also stimulated by the recognition of pathogen-associated 
molecular patterns (PAMPs). To date, the Toll-like receptor (TLR) family, which actives 
downstream signals, e.g. interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α), are the 
most well-studied receptors for sensing PAMPs. Other classes of host receptors including 
NACHT [domain present in NAIP (neuronal apoptosis inhibitor protein), CIITA (class II 
transactivator), HET-E (plant het product), and TP-1 (telomerase-associated protein 1)]-
leucine rich repeat receptors (NLRs) exist in the cell cytoplasm and activate intracellular 
PAMPs (Inohara et al., 2005). 
 
1.4.1. Extracellular detection of pathogen-associated molecules 
1.4.1.1. Toll-like receptors (TLRs) 
Host receptors have developed a number of germline-encoded receptors to recognize PAMPs 
referred to as pattern-recognition receptors (PRRs) (Janeway and Medzhitov, 2002). PRRs in 
the innate immune system can be in a soluble, membrane-bound or cytosolic forms and 
function in both extracellular and intracellular recognition. One well-known family of PRRs 
is the Toll-like receptors (TLRs). TLRs contain several extracellular leucine-rich repeat 
(LRR) domains involved in direct or indirect pathogen recognition and an intracellular signal 
transducing domain called Toll/Interleukin-1 Receptor (TIR) domain. The TLR are 
transmembrane proteins localized at the cell surface or within phagosome/endosomes, thereby 
scanning the extracellular milieu for bacteria (Medzhitov, 2001). The Toll pathway was first 
discovered in Drosophila where it was found to function in the detection of both Gram-
positive bacteria and fungi (Anderson et al., 1985a; Anderson et al., 1985b). Activation of 
TLRs leads to NF-?B-dependent production of innate immune cytokines such as TNF-?, 
IL-6 or IL-12, which contribute to the recruitment of inflammatory cells to the site during 
infection or inflammation. 
 
1.4.2. Intracellular detection of pathogen-associated molecules  
Recently two other families of signalling PRRs have been described as well: the Nod-like 
receptors (NLRs) and the RIG-like helicases (RLHs). 22 NLRs have been described in 
humans, among which are the nucleotide binding and oligomerization domain (NODs), 
NACHT-, LRR- and PYD-containing (Nalps) and neuronal apoptosis inhibitory protein 
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(Naip) (Fritz et al., 2006). 
 
1.4.2.1. Nod1 and Nod2  
Nod1 and Nod2 were the first two intracellular PRRs of the NLR superfamily to be identified 
(reviewed by Inohara and Nuñez, 2003; Le Bourhis et al., 2007; Murillo et al., 2003; Ogura et 
al., 2001). The NLR protein consists of an N-terminal effector domain followed by a central 
nucleoside-binding NACHT/NAD domain and a C-terminal LRR domain. Girardin et al. 
(2001) showed that invasive Shigella flexneri activates NF-κB in a Nod1-dependent manner 
after intracellular detection of the bacterium in epithelial cells and leads to production of pro-
inflammatory mediators, such as IL-6 and TNF-α. Nod2 is another NLR protein, which is also 
able to activate NF-κB in a Receptor interacting protein-2 (RIP2)-dependent manner 
(Kobayashi et al., 2005). 
Both Nod1 and Nod2 recognize components of peptidoglycan (PG) within the 
bacterial cell wall, although their specificities are different. Nod1 senses PG-derived meso-
diaminopimelic acid (DAP)-containing muramyl peptides, which are structural componentes 
of the cell wall in Gram-negative bacteria (Chamaillard et al., 2003; Girardin et al., 2003a; 
Girardin et al., 2003b). Magalhaes et al. (2005) reported that DAP-containing muramyl 
tripeptides could trigger Nod1 activity; however, murine Nod1 is also activated by DAP-
containing muramyl tetrapeptides. Nod2, which is expressed in monocytes, macrophages, 
dendritic cells and intestinal epithelial cells senses muramyl depeptides (MDP) found in both 
Gram-positive and Gram-negative bacteria (Girardin et al., 2003c).  
 
1.4.2.2. Nalps  
Nalp proteins are characterized by C-terminal LRRs, a central NACHT/NAD domain and an 
N-terminal effector pyrin domain. In addition to Nalps, other pyrin domain-containing 
proteins have been found as well, e.g. the protein ASC (apoptosis-associated speck-like 
protein containing a CARD), which is composed of a C-terminal CARD and an N-terminal 
PYD (Chamaillard et al., 2003). Caspase recruitment domains (or called Caspase activation 
and recruitment domains [CARDs]) are interaction motifs found in numerous proteins, 
including helicases, kinases, mitochondrial proteins, caspases, and other cytoplasmic factors 
involved in the processes of inflammation and apoptosis (Hiscott et al., 2006; Hong and Junk, 
2002). Pyrin domains (PYD domains or PAAD/DAPIN domain) are a subclass of protein 
motifs evolutionarily related to the Death domain family (Fairbrother et al., 2001; Pawłowski 
et al., 2001); it allows a pyrin domain containing a protein to interact with other proteins that 
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contain pyrin domains. Proteins containing a pyrin domain are frequently involved in 
biological processes called inflammation and apoptosis (Bertin and DiStefano, 2000). There 
are 14 Nalps, which are predicted to be located in the cytosol in human beings (Tschopp et al., 
2003). Nalp2–14 all exhibit the following tripartite structure: PYD-NBS (non-binding site)-
LRR. Interestingly, an additional CARD domain is found at the C-terminal end of Nalp1. 
Currently, Nalp1b has been shown to mediate caspase-1 activation and necrosis in response to 
the treatment together with anthrax lethal toxin (LeTx), which is composed of protective 
antigen and lethal factor (LF), within macrophages extracted from inbred mice (Boyden and 
Dietrich, 2006). Scobie and Young (2005) reported that lethal factor is able to translocate into 
the cytosol via protective antigen binds to the von Willebrand factor type A or integrin 
inserted domain containing an anthrax toxin receptor 1 and an anthrax toxin receptor 2, 
indicating that lethal factor might be the ligand directly or indirectly sensed by NALP1b. Liao 
and Mogridge (2009) also reported that Nalp1b recognizes activity of B. anthracis lethal toxin 
in the host cytosol to initiate anthrax lethal toxin-induced caspase-1-dependent cell death 
signaling pathways inside macrophages and dendritic cells. However, no evidence has been 
released that Nalp1b is able to recognize other types of toxins. Nalp3 (also known as 
cryopyrin or CIAS1) is recognized by multiple ligands (Masumoto et al., 2003). Similar to the 
NOD proteins, the human Nalp3 LRR is crucial for induction of IL-1? secretion in response 
to muramyl dipeptide. Additionally, Nalp3 also acts as a sensor for non-microbial “danger” 
signals (Mariathasan, 2007). Frederick et al. (2008) reported that following neuronal injury is 
able to induce expression levels of death domain genes Nalp1 and Nalp5. Kempster et al. 
(2011) reported that the Nalp6 inflammasome and IL-18 function in mammalian intestines. 
Ohno et al. (2008) showed that the expression of Nalp7 is inducible in endometrial cancer 
tissues. Bovine Nalp8 and Nalp9 serve as oocyte marker genes (Dalbiès-Tran et al., 2005; 
Ponsuksili et al., 2006). Jéru et al. (2008) reported that a mutation of Nalp12 cause hereditary 
periodic fever syndromes. Westerveld et al. (2006) reported that Nalp14 has a function in 
spermatogenesis, which is the process of the cell division of male primary germ cells. 
 
1.4.2.3. Ipaf, Naip 
Ipaf and Naip are two members in the NLR family, which have been linked to the 
intracellular detection of bacteria. Both Ipaf and Naip bear C-terminal LRR domains and 
central NACHT domains; however, Ipaf contains a CARD in a N-terminal part and Naip 
presents 3 BIR domains in a N-terminal part (Fritz et al., 2006). S. Typhimurium (Lara-Tejero 
et al., 2006) and Legionella pneumophila (Amer et al., 2006) infections in macrophages result 
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in Ipaf-dependent activation of caspase-1, which leads to IL-1β maturation and caspase-1-
dependent cell death. Ipaf has been implicated in the detection of flagellin using S. 
Typhimurium as an infection model system. Flagellin delivered to the cytosol activates 
caspase-1 through the Ipaf-mediated signal pathway. This process is independent of TLR5, 
which recognizes flagellin (Franchi et al., 2006). Naip5 also responds to flagellin in S. 
Typhimurium to initiate caspase-1-dependent macrophage cell death. 
  
1.4.3. Host defense mechanisms 
The first defense mechanism, which is triggered by invasive pathogens for phagocytic killing, 
is contributed by NADPH oxidase (Vazauez-Torres et al., 2000). Patients deficient in this 
enzymatic activity are susceptible to salmonellosis (Mouy et al., 1989). This mechanism 
includes the production of reactive oxygen species (ROS) and nitrogen molecules through 
phagocyte oxidase and inducible nitric oxide synthase, respectively. In addition to this 
oxygen-dependent microbicidal mechanism, engulfing of bacteria also stimulates host cells to 
release antimicrobial peptides (AMPs) into the lumen of the intestinal tract as one of the 
oxygen-independent mechanisms (Veldhuizen et al., 2009).  
 
1.4.3.1. Host antimicrobial peptides (AMPs) 
Host antimicrobial peptides form a crucial part of the human innate host defense for direct 
killing of a wide variety of bacteria. Most of these peptides are cationic in nature, and interact 
with the bacterial cytoplasmic membrane, which usually comprises negatively charged 
phospholipids (Eswarappa et al., 2008). These antimicrobial components, including 
lactoferrin (Lf), bactericidal/permeability-increasing protein (BPI), peptidoglycan recognition 
proteins (PRGP), serprocidins (NE, CatG, PR3 and Azu), neutrophil gelatinase-associated 
lipocalin (NGAL), histones, cathelicidins, lysozyme (Lz), phospholipase (PLA2), calprotectin, 
granulysin and defensins perform different mechanisms to eliminate pathogens. In this study, 
I chose the subclasses of defensins and cathelicidin for further investigation. 
 
1.4.3.1.1. Defensins 
Defensins are small (Mr 3,500 – 4,000), cysteine-rich peptides comprising one of the major 
subclasses of AMP (reviewed by Ganz, 2003; Lehrer et al., 1989). They are classified into α- 
(HD) and β-defensins (hBD). Six α-defensins have been identified in human beings; two 
(HD-5 and HD-6) are expressed by Paneth-cells in the small intestine and in the female 
reproductive tract (Ouellette et al., 2001; Selsted and Ouellette, 2005). Among them, four 
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human neutrophil peptides (HNP)-1-4 are expressed mainly in neutrophils (Fahlgren et al., 
2004). α-defensins express broad-spectrum microbicidal activity against bacteria, fungi, 
enveloped viruses, and parasites (Ayabe et al., 2000; Levy, 2004). The microbicidal activity 
of α-defensins is limited by the physiological concentrations of mono- and divalent cations as 
well as some components of plasma/serum (Levy, 2004). Another major subclass is the β-
defensins, which are characterized by a distinct pairing of cysteines and have a higher lysine-
to-arginine ratio than α-defensins (Lehrer et al., 2002). Based on the in silico analysis, 28 β-
defensins have been predicted in the human genome (Schutte et al., 2002). Expression of 
human β-defensins is apparently restricted to epithelial cells including those of the respiratory 
tract (Ali et al., 2001; Singh et al., 1998). hBD-1 and -2 display antibacterial activity against 
Gram-negative bacteria (Valore et al., 1998), whereas hBD-3 is also active against Gram-
positive bacteria and Saccharomyces cerevisiae (Garcia et al., 2001).  
 
1.4.3.1.2. Cathelicidins 
Cathelicidin is a putative cysteine-proteinase inhibitor, first isolated from pig leucocytes 
(Ritonja et al., 1989). The cathelicidin-protein family contains more than 20 members, which 
constitute a significant part of mammalian peptide antibiotics in a variety of species including 
humans (Agerberth et al., 1991; Agerberth et al., 1995; Storici and Zanetti, 1993). Most of the 
cathelicidin precursors are stored in cytoplasmic granules of neutrophil leucocytes. Upon 
leucocyte activation, mature forms of cathelicidins are released (Scocchi et al., 1992; Zanetti 
et al., 1991). 
One member in the cathelicidin-protein family expressed in human beings is LL-37 
(170 amino acids) (reviewed by Doss et al., 2010). LL-37 was isolated from human 
granulocytes and was detected in human wounds and blister fluids (Frohm et al., 1996). 
Recently, the gene encoding LL-37 was found to be induced in human keratinocytes during 
inflammatory disorders (Frohm et al., 1997). These findings suggest that LL-37 plays an 
important role in the first line of host defense against local infections and systemic invasion of 
pathogens at sites of inflammation and wound. LL-37 mediates a wide range of biological 
responses, including direct killing of microorganisms, chemotaxis and chemokine induction, 
regulation of inflammatory responses as well as adjuvant, angiogenic and wound healing 
effects (Nijnik et al., 2009). Although LL-37 is the first α-helical antimicrobial peptide 
isolated from a human source, it exhibits cytotoxic activity to eukaryotic cells as well, which 
is different from most known antimicrobial peptides (e.g. cecropin, magainin, dermaseptin) 
(Johansson et al., 1998). Recently, growing evidence indicates that the cathelicidin-protein 
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family have functions which extend beyond their antimicrobial activity (Gallo et al., 1994, 
Verbanac et al., 1993).  
 
1.4.3.1.3. Thrombocidins 
Thrombocidins are released from platelets and are derived from carboxy-terminal deletions of 
the CXC chemokines neutrophil-activating peptide II as well as connective tissue-activating 
peptide III in humans (Krijgsveld et al., 2000). Most of data regarding thrombocidin activity 
and the bacterial ability to resist thrombospondin are available for the rabbit peptides, which 
damage bacterial membranes. Thrombocidins are believed to be able to recognize other 
intracellular targets. 
 
1.4.3.1.4. Polymyxin B 
Polymyxin B, which is a cationic lipopeptide antibiotic derived from the bacteria Bacillus 
polymyxia is used to resist Gram-negative bacteria infection (Kwa et al., 2007; reviewed by 
Mitrophanov et al., 2008). It has a bactericidal action against almost all Gram-negative bacilli 
except the Proteus group (Falagas and Kasiakou, 2005; Russell, 1963). The basic structure of 
polymyxin B consists of a polycationic peptide ring and a tripeptide side chain with a fatty 
acid tail (Fig. 2) (Hancock, 1997). Polymyxin B is a mixture of at least four closely related 
components, polymyxin B1 to B4, with polymyxin B1 and B2 being the two major components 
(Kang et al., 2000; Orwa et al., 2001). The difference among these four components is only in 
the fatty acid moiety (Kang et al., 2000; Orwa et al., 2001).  
 
Fig. 2. The structure of polymyxin B. Fatty acid: 6-methyloctanoic acid for polymyxin B1, 6-
methylheptanoic acid for B2, octanoic acid for B3 and heptanoic acid for B4. Thr, threonine; Leu, 
leucine; Dab, a,g-diaminobutyric acid; Phe, phenylalanine; where a and g indicate the respective 
amino group involved in the peptide linkage. The chemical structure of polymyxin B is drawn based 
on the reference published by Zavascki et al. (2007). 
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 Polymyxin B is a rapid-acting bactericidal agent, with a detergent-like mechanism of 
action (Evans et al., 1999; Hermsen et al., 2003). The mechanism of polymyxins is to interact 
with bacterial LPS of Gram-negative bacteria and be subsequently taken up via the “self-
promoted uptake” pathway (Hancock, 1997). The polycationic peptide ring therefore binds to 
the bacterial outer membrane and displaces the calcium and magnesium bridges, which are 
used to stabilize the structure of LPS (Evans et al., 1999; Hermsen et al., 2003). Fatty acid 
side chains of polymyxins further interact with LPS, contributing to the insertion of 
polymyxins into the outer membrane. Polymyxins are able to produce disruptive 
physicochemical effects, which lead to permeability changes in the outer membrane (Hermsen 
et al., 2003). The affected membrane is thought to develop transient breaks, which permit 
passage of various molecules, including hydrophobic compounds and small proteins and 
promote the uptake of the perturbing peptide itself and lead to cell death (Hermsen et al., 
2003; Zavascki et al., 2007), hence the term “self-promoted uptake” (Hancock, 1997). In 
addition to its antibiotic function, polymyxin B has been used to clear endotoxin 
contamination in reagents (Suzuki and Shoji, 2010). It is also commonly used in the topical 
first-aid preparation Neosporin (Dasaraju et al., 1997). 
 
1.4.3.2. Mechanisms of AMPs in elimination of intracellular pathogens 
Membrane-targeting mechanisms are the most conserved killing mechanisms performed by 
AMPs. AMPs have been identified in many species, including plants, insects and vertebrate 
animals (Sang and Blecha, 2008). AMPs undergo a pore-forming process consisting of 
membrane attachment, insertion and permeabilization through positive charges on its surface 
as well as an amphipathic structure (Brogden, 2005). Currently, a two-state model, which is 
based on studies of representative cysteine-rich AMPs has been proposed. It is proposed that 
AMPs initially assemble parallel to the plane of the membrane and cause a membrane 
thinning in proportion to the peptide/lipid ratio of a membrane. Once peptides continuously 
assemble on membrane surfaces and exceed the peptide/lipid ratio threshold, the interaction is 
allowed to enter a second state, where the alignment of the peptide assemblages forms 
transmembrane pores (Huang, 2006; Jang et al., 2006). 
 
1.5. Bacterial defense mechanisms against AMPs killing 
Most AMPs function by forming multimeric pores in the cytoplasmic membrane of bacteria. 
As membrane integration by AMPs is dependent on the physicochemical properties of the 
membrane, mechanisms used by bacteria to resist AMP challenges can be achieved by 
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altering those properties, e.g. by altering the fluidity of the phospholipid bilayer through the 
introduction of fatty acids with different chain lengths (Jing et al., 2005; reviewed by Peschel, 
2002). AMP resistance by bacteria includes two major mechanisms: efflux pumps and 
alteration of the bacterial cell surface composition. 
 
1.5.1. Efflux pumps 
Efflux is a general mechanism responsible for bacterial resistance to antibiotics. This active 
drug transport functions in a low intrinsic susceptibility, cross-resistance to chemically 
unrelated classes of molecules, and selection/acquisition of additional mechanisms of 
resistance to waste (Mahamoud et al., 2007). Multidrug resistance efflux pumps have been 
described in both Gram-positive and Gram-negative bacterial pathogens. For example, 
Staphylococcus aureus QacA-encoded energy-dependent efflux pumps are able to export 
toxic substances out of the cell (Rouch et al., 1990; Kupferwasser et al., 1999). Regarding 
Gram-negative bacteria, they are in general more resistant to antibiotics due to the 
sophisticated architecture of their cell membranes, including the outer and the inner 
membranes. The Gram-negative bacterial cell membrane contains a variety of protein 
channels used to transport (influx or efflux) various nutrition (sugars, amino acids, salts, 
metals) and noxious compounds (metabolites, drugs, biocides, detergents) (Li and Nikaido, 
2004; Poole, 2005; Van Bambeke et al., 2003). These transporters are able to recognize toxic 
agents such as antibiotics and extrude agents from the periplasmic space to the extracellular 
environment, thereby reducing the intracellular accumulation of host bactericidals 
(Mahamoud et al., 2007). For example, the MtrCE system of Neisseria gonorrhoeae (Hagman 
et al., 1995), MexABOprK proteins of Pseudomonas aenrginosa (Poole et al., 1993) and 
AcrAE and EnvCD proteins of Escherichia coli (Pan and Spratt, 1994) belong to the group of 
bacterial efflux/transport proteins involved in resistance against drugs, dyes, and detergents. 
 
1.5.2. Alteration of the bacterial cell surface composition 
Prokaryotes produce a variety of glycoconjugates and polysaccharides, which contribute to 
the large structural diversities and complexities of the outer cell surface. These glycans 
include many unusual sugars, e.g. 3-deoxy-D-manno-octulosonic acid (Kdo), heptoses, and 
variously modified hexoses, which are important in the biology and bacterial pathogenicity 
(Horstman et al., 2004; Schnaitman and Klena, 1993).  
 In Gram-negative bacteria, the cell wall consists of inner and outer membranes 
separated by a space termed the periplasm. Peptidoglycan (PG) (also known as murein) makes 
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up approximately 10% of the dry weight of the cell wall and constitutes the major structural 
component of the periplasm. PG consists of parallel strands of polysaccharides composed of 
N-acetylglucosamine and N-acetylmuramic acid (MurNAc) in β1-4-linkage, which surround 
the bacterium (van Heijenoort, 2007). Each MurNAc is attached to a short (4- to 5-residues) 
amino acid chain, containing D-alanine, D-glutamic acid, and meso-diaminopimelic acid in 
Gram-negative bacteria and L-alanine, D-glutamine, L-lysine, and D-alanine in Gram-positive 
bacteria (Bouhss et al., 2008; van Heijenoort, 2007). The dibasic amino acid, meso-
diaminopimelic acid (m-DAP) is responsible for the cross-link. The cross-linked structure of 
PG not only confers mechanical strength and shape on the cell wall, but also provides a 
barrier to withstand an internal osmotic pressure. Antibiotics, e.g. β-lactams and vancomycin, 
which inhibit PG biosynthesis, are the most widely used in current clinical practice (review by 
Koch, 2003). The largest family corresponding to β-lactams is an analogue of D-alanyl-D-
alanine and mainly inhibits the transpeptidation, thus stopping cell growth (review by Gootz, 
1990; review by Kitano and Tomasz, 1979). The most frequent mechanism used by bacteria 
against β-lactams is to produce β-lactamases to hydrolize the β-lactam ring (Bush and Jacoby, 
2010; Wilke et al., 2005). Vancomycin is a glycopeptide, which binds to terminal D-alanyl-D-
alanine and blocks the incorporation of peptides to the cell wall, thus inhibiting 
peptydoglicane elongation (review by Kahne et al., 2005). Bacteria are able to alter subunits 
of N-acetylglucosamine and N-acetylmuramic acid, which recognized by vancomycin to 
decrease drug affinity (de Niederhäusen et al., 2011). 
 
1.5.2.1. Modifications of teichoic acids and phospholipids 
The permeability, thickness and physicochemical properties of the cell envelope are also 
involved in the susceptibility of bacteria against AMP challenges, since AMPs have to 
traverse the multi-layered bacterial cell envelope and reach the cytoplasmic membrane. For 
example, Gram-positive bacteria, e.g. Staphylococci, are remarkable because of its thick cell 
wall composed of peptidoglycan and teichoic acid polymers. Nannini et al. (2010) reported 
that vancomycin-resistance of Staphylococcus aureus (VRSA) is due to an increase in the cell 
wall thickness and remodelling of peptidoglycan in order to defend against AMP challenges. 
 
1.5.2.2. Modifications of bacterial lipopolysaccharide (LPS) 
1.5.2.2.1. Genetics of LPS biosynthesis 
1.5.2.2.1.1. Lipid A 
R-3-hydroxymyristoyl-acyl carrier protein (ACP), an unique early precursor of lipid A, is a 
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common intermediate, since it can be incorporated into the biosynthesis of lipid A and 
glycerol-based phospholipids (reviewed by Raetz and Whitfield, 2002; Raetz and Dowhan, 
1990). The first committed step of lipid A biosynthesis is to transfer the acyl group from R-3-
hydroxymyristoyl-ACP to the 3-OH group of UDP-N-acetylglucosamine (UDP-GlcNAc). 
UDP-GlcNAc is another central intermediate involved in cell surface biosynthesis and serves 
as the common precursor of peptidoglycan and lipid A. Acyl-transferase is encoded by lpxA, 
which belongs to a cluster of 11 genes organized into a complex operon termed the 
macromolecular synthesis II operon (Tomasiewicz, 1990). In addition to LpxA, this operon 
includes PolC, which encodes the α core subunit of DNA polymerase; the rnh gene, which 
encodes RNase H; and LpxB and LpxD, which are also involved in the lipid A biosynthetic 
pathway. Further steps involved in the lipid A biosynthesis pathway include N-deacetylation 
of the O-acylated from R-3-hydroxymyristoyl-ACP to the amino group in order to form UDP-
2,3-diacylglucosamine referred to as a precursor of the non-reducing end of lipid A. LpxB 
functions to condense one molecule of UDP-2,3-diacylglucosame and one molecule of lipid X 
as well. This process leads to form a β-1,6-linked glucosamine disaccharide, in which each 
sugar is substituted with two 3-hydroxymyristoyl groups and carry a single phosphate residue 
on the first position of the reducing sugar (Crowell et al., 1987). 
 
1.5.2.2.1.2. The LPS core region 
The LPS core region always contains an oligosaccharide component that attaches directly to 
LPS lipid A and commonly contains sugars such as heptose and 3-deoxy-D-
mannooctulosonic acid (also known as Kdo, keto-deoxyoctulosonate) (Hershberger and 
Binkley, 1968). LPS core regions in many bacteria also contain non-carbohydrate 
components, such as phosphate, amino acids, and ethanolamine substitutents. KdsA and KdsB 
are the first two gene products involved in biosynthesis of the LPS core region. The kdsA 
gene encodes the Kdo-8-phosphate synthetase, which combines D-arabinose 5-phosphate and 
phosphoenolpyruvate to generate Kdo-8-phosphate (Woisetschlager et al., 1987). Following 
the removal of the phosphate, free Kdo is activated to form CMP-Kdo by the CMP-Kdo 
synthase encoded by kdsB (Goldman et al., 1986). The third gene, kdtA, encodes a 
bifunctional enzyme (Belunis and Raetz, 1992), which is able to sequentially transfer two 
molecules from CMP-kdo to the lipid A precursor lipid IVA. This process generates both Kdo 
backbone residues, Kdo I and Kdo II, which are linked in the α2,6- and the α2,4-position to 
the lipid A disaccharide, respectively. KdtA has been reported to serve as a transmembrane 
segment anchor (Clementz and Raetz, 1991). The late stage of the LPS core completion is to 
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add an additional α2,4-linked Kdo residue on Kdo II to form Kdo III (Schnaitman and Klena, 
1993). KdtA has been considered to serve as a Kdo III transferase as well based on the study 
regarding the Chlamydia trachomatis GseA protein, which shares extensive regions of 
homology with the KdtA protein (Belunis et al., 1992). However, which gene encoding the 
hypothetical Kdo III transferase has not been identified yet (Schnaitman and Klena, 1993).  
 The rfaD, rfaE, rfaC and rfaF gene products function to synthesize heptose and the 
inner core. RfaE encodes ADP-heptose synthase (Sirisena et al., 1992); RfaD performs 
epimerization of ADP-heptose to L-glycero-D-manno form (Coleman, 1983); RfaC is 
involved in the addition of heptose I to Kdo I of the inner core region (Sirisena et al., 1992); 
and RfaF is involved in the addition of heptose II to heptose I in order to complete the inner 
core region backbone (Wilkinson et al., 1972). Furthermore, the function of the 
rfaQGPSBIJYZK operon is to sequentially attach glucose and galactose residues on the inner 
core region in order to provide the structural framework for the outer membrane and hexose 
region of the LPS core region (Carstenius et al., 1990; Creeger and Rothfield, 1979; 
Maclachian et al., 1991; Parker et al., 1992; Pradel et al., 1992). This operon is regulated by a 
positive regulator RfaH, which functions as a transcriptional antitermination factor (Pradel 
and Schnaitman, 1991). 
 
1.5.2.2.1.3. LPS O-antigen 
Functions of a second cluster of genes, the rfb cluster, comprising the rfbBCAD, rfbKM and 
rfbFG genes, are involved in the synthesis of TDP-rhamnose, GDP-mannose and CDP-4-
keto-3,6-dideoxyglucose, respectively, and form the backbone of LPS O-antigen. In general, 
the backbone of LPS O-antigen consists of mannose, rhamnose and galactose and is identical 
in Salmonella serovars groups A, D and E1. The structure of Salmonella LPS O-antigen is 
represented in the following cartoon: 
 
Fig. 3.  Salmonella LPS O-antigen structure. The LPS O-antigen repeat unit contains mannose, 
rhamnose and galactose. Numerous LPS O-antigen repeat units form the backbone of Salmonella LPS 
O-antigen. Another sugar, abequose, is extended from mannose. n, numbers of LPS O-antigen repeat 
!"#$%&'(#)*+,
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nuits. 
 
 Mannose can be substituted for dideoxyhexose abequose and galactose can be partially 
replaced by glucose in other serotypes of Salmonella spp. Once sugars used for the synthesis 
of the LPS O-antigen backbone are ready to use, RfbP and Rfe function to initiate synthesis of 
LPS O-antigen repeat units. At present, the mechanism for the attachment of the first sugar on 
antigen carrier lipid (ACL) is divided into two classes, rfbP-dependent class and rfe-
dependent class (Jann and Jann, 1984; Mäkelä and Stocker, 1984) in different genera of 
enteric bacteria. Salmonella spp, belong to the rfbP-dependent class further sub-divided into 
the O groups A, B, C2, D and E1. RfbP initiates synthesis of the LPS O-antigen repeat units 
by the addition of galactose-phosphate to ACL to form galactose-pyrophosphate-ACL; in 
contrast, Rfe initiates to synthesize of the O-antigen repeat units by the addition GlcNac-
phosphate to ACL to form GlcNAc-pyrophosphate-ACL. The second stage for LPS O-antigen 
biosynthesis is to transfer those backbone sugars on either galactose-pyrophosphate-ACL or 
galactose-pyrophosphate-ACL. This process is controlled by a group of glycosyl transferases. 
For example, RfbN, RfbU and RfbV determine the rhamnose, mannose and abequose 
transferases, respectively. The rest of the genes, which are involved in O-antigen assembly 
and processing are wzx, wzy and wzz. The wzx gene encodes a flippase, which functions to 
transport LPS O-antigen repeat units across the inner membrane into the periplasmic space. 
The wzy gene encodes O-antigen polymerase, which functions to link each O-antigen repeat 
units via a glycosidic linkage and ligates them into a long LPS O-antigen chain. The wzz gene 
is involved in the determination of the LPS O-antigen chain length (Samuel and Reeves, 
2003). Salmonella has been reported to contain two homologues of wzz genes. For details, see 
Discusstion section 5.3. (p. 91). 
 
1.5.2.2.2. The Regulation of LPS modifications 
1.5.2.2.2.1. Lipid A and the core region 
Several enzymes have been reported to modify the fatty acyl chain region in LPS lipid A, 
including PagP, PagL, LpxR and LpxO. PagP, which is regulated by the PhoP/Q TCS, 
encodes a palmitoyl transferase located in the outer membrane; it transfers a palmitate from 
glycerophospholipids to the β2-position of LPS lipid A, resulting in a hepta-acylated structure 
(reviewed by Ernst et al., 2001; Ahn et al., 2004). Guo et al. (1998) also reported that this 
modification occurs during the period of LPS lipid A synthesis while LPS lipid A is 
transported to the inner leaflet of the outer membrane. The hepta-acylated structure of LPS 
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lipid A might prevent the insertion from host antimicrobial peptides (Bishop et al., 2008). 
pagL encodes 3-O-deacylase, which functions to remove the 3-O-linked acyl chain of LPS 
lipid A (Geurtsen et al., 2005); however, PagL plays no role in the resistance to AMP killing 
(Kawasaki et al., 2004). Although PagL is controlled by the PhoP/Q TCS, it is not active in 
the outer membrane while Salmonella was grown under the Mg2+-limiting condition (Wang 
and Quinn, 2010). LpxR is another outer membrane protein, which removes the 3’-
acyloxyacyl moiety from Salmonella LPS lipid A (Reynolds et al., 2006). LpxR is not 
regulated by neither the PhoP/Q- nor the PmrA/B TCS, but it requires the divalent cation Ca2+ 
for enzymatic activity (Rutten et al., 2009). Orthologs of Salmonella LpxR have been found 
in various Gram-negative bacteria including Helicobacter pylori, Yersinia enterocolitica, E. 
coli O157:H7 and Vibrio cholera. LpxO is an inner membrane protein, which generates a 2-
OH group at the?α,β-3’-position of Salmonella LPS lipid A (Gibbons et al., 2000; Gibbons et 
al., 2008). Like LpxR, LpxO is not regulated by the PhoP/Q- or the PmrA/B TCS. 
The addition of amino groups on LPS lipid A is believed to be another important 
strategy for Salmonella to escape the host immune system. This function is mainly controlled 
by the PmrA/B TCS through the activation of genes whose products are involved in the 
addition of 4-amino-4-deoxy-L-arabinose (Ara4N) and phosphoethanolamine (pEtN). PmrE 
and PmrF contribute to add Ara4N on LPS lipid A (Gunn et al., 1998; Trent et al., 2001). This 
process occurs on the outer face of the inner membrane before LPS is flipped out to the outer 
membrane, where PmrC mediates the addition of pEtN to the 1-phosphate of LPS lipid A 
(Lee et al., 2004).  
PmrG, which is encoded upstream of the pmrHFIJKLM operon, is involved in 
dephosphorylation of heptose II (HepII) in the LPS core region (Nishino et al., 2006). Other 
proteins, including LpxT, LmtA and LpxQ contribute to modify LPS lipid A as well. LpxT 
adds a second phosphate group at 1-phosphate of LPS lipid A by using undecaprenyl 
pyrophosphate as the substrate donor (Touzé et al., 2008). LmtA, which is a membrane 
enzyme in Leptospira interrogans transfers a methyl group from S-adenosylmethionine 
(SAM) to 1-phosphate of LPS lipid A (Boon Hinckley et al., 2005). In Rhizobium, LpxQ 
oxidizes glucosamine on LPS lipid A while O2 is sufficient to form an aminogluconate unit 
(Que-Gewirth et al., 2003). 
Taken together, these modifications increase positively charged moieties of LPS and 
affect the electrostatic interaction of cationic AMPs with the bacterial cell surface (Gunn et 
al., 1998; Zhou et al., 2001). 
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1.5.2.2.2.2. LPS O-antigen 
The LPS O-antigen is an important component of the outer membrane of Gram-negative 
bacteria involved in resistance against host bactericidal compounds and which is localized at 
the outer surface of the bacterial membrane and protects bacteria from host killing (Samuel 
and Reeves, 2003). Various mechanisms have been found in numerous pathogens to modify 
or regulate structures and/or conformations of LPS O-antigen in order to avoid host 
challenges, e.g. Escherichia coli (Eder et al., 2009), Salmonella spp (reviewed by Gunn, 
2008), Helicobacter pylori (Stead et al., 2005; Stead et al., 2010).  
To date, several LPS-O-antigen modifications in many aspects of remodelling LPS O-
antigen structures, acetylation and glucosylation modifications are found to increase structural 
diversities of LPS O-antigen (Whitfield et al., 2003). In S. Typhimurium, a PmrA/B-regulated 
gene, wzzST (cld or rol), which is located downstream of pmrE is involved in the 
determination of the LPS O-antigen chain length (Batchelor et al., 1991; Murray et al., 2003; 
Murray et al., 2006) (see section 5.3. for further details, page 91). Functions of acetylation 
and glucosylation occur after polymerisation of LPS O-antigen repeat units (Samuel and 
Reeves, 2003). The glycosyl transfer mediated by GtrB and GtrA takes place after LPS O-
antigen repeat units have been translocated to the periplasmic face of the cytoplasmic 
membrane (Sanderson et al., 1995; Vander Byl and Kropinski, 2000). For instance, S. 
enterica serogroup B strains modify LPS O-antigen by the addition of glucose at the galactose 
residue (Vander Byl and Kropinski, 2000). This process occurs either via a (1à4) linkage, 
determined by chromosomal genes, or a (1à6) linkage, determined by the gene carried on the 
P22 lysogenic phage. 
 In addition to glycosylation, acetylation is a common form of LPS O-antigen 
modifications as well. Genes involved in LPS O-antigen acetylation could sometimes be 
found outside of the O-antigen cluster. For example, Salmonella OafA, which acetylates the 
second position of abequose locates outside of the main LPS O-antigen synthesis gene cluster. 
Slauch et al. (1995) reported that acetylation of O-antigen by OafA affects the three-
dimensional structure of LPS. The function of OafA has been characterized. It belongs to a 
member of a family of integral membrane trans-acylases (Slauch et al., 1996) and determines 
the Salmonella O5-antigen (Slauch et al., 1995; Hauser et al., 2011). However, there are no 
further recent studies to investigate genetics of these phenomena in Salmonella strains. 
Kubler-Kielb et al. (2007) reported that bacteriophage-mediated glucosylation and acetylation 
of the LPS O-antigen specific chain are important for Shigella flexneri serotype 2a LPS 
antigenicity and consequently for immunogenicity of the LPS-based vaccines against 
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shigellosis. Additionally, increased variations of LPS O-antigen is also a strategy used by 
plant pathogens (Lerouge and Vanderleyden, 2002).  
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2. RATIONALE and AIM 
 
In S. Typhimurium, the bacterial signal molecule, guanosine-3´,5´-bispyrophosphate 
(guanosine tetraphosphate or ppGpp), was found to play a pivotal role in the process of 
invasion and intracellular survival in Salmonella Typhimurium (Pizarro-Cerdá and Tedin, 
2004; Thompson et al., 2006). ppGpp is a global regulatory molecule of gene expression in 
bacteria. Best known for its effects during amino acid starvation, ppGpp accumulates to high 
levels and causes a rapid down-regulation of stable RNA synthesis and ribosome production, 
a phenomenon known as the stringent response to amino acid deprivation. Mutants of E. coli 
were described which showed a "relaxed" response to amino acid deprivation, in which RNA 
continued to accumulate after amino acid starvation (Fiil and Friesen, 1968; Stent and 
Brenner, 1961). The gene was identified which was responsible for this effect and referred to 
as rel or relA (Alfoldi et al., 1962; Borek et al., 1956). Later, another gene involved in ppGpp 
metabolism was identified based on the absence of the spots on thin layer chromatograms of 
labelled guanosine nucleotides and referred to as spoT, in reference to the "spot-less" 
phenotype (Laffler and Gallant, 1974). SpoT was later found to be the major ppGpp-
hydrolase responsible for degradation of ppGpp to allow recovery of RNA synthesis after 
amino acid starvations (Chaloner-Larsson and Yamazaki, 1976; deBoer et al., 1977; Fiil et al., 
1977). It remained for many years unexplained why the low, basal levels of ppGpp were the 
same in relA+ (wildtype) and relA strains. Eventually, two, independent laboratories found 
that the basal levels of ppGpp present during normal growth in the absence of amino acid 
starvation were in fact synthesized by the SpoT gene product, which is also responsible for 
the degradation of ppGpp (Hernandez and Bremer, 1991; Xiao et al., 1991). The SpoT 
enzyme is responsible for adjustment of the basal ppGpp levels to match the availability of 
nutrients to the rate of ribosomal RNA (and ribosome) synthesis needed for maximal growth 
rates. The SpoT enzyme modulates the basal ppGpp levels in response to a number of 
different environmental/growth signals such as carbon source, metal ions, etc. Although the 
precise mechanism is not known, it is believed that the SpoT enzyme senses the charging 
status of transfer-RNAs (tRNAs). Current models therefore associate the RelA protein with 
the high level ppGpp synthesis during amino acid starvation conditions, the signal being 
uncharged tRNAs bound to the ribosome (RelA is ribosome-associated), whereas the growth-
rate determining basal levels of ppGpp are synthesized by the cytosolic SpoT enzyme, either 
through low-level synthesis or adjustment of the rate of degradation. 
A ppGpp-deficient (?relA?spoT) strain of Salmonella showed reduced expression of 
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nearly all SPI-encoded virulence genes of S. Typhimurium without affecting the expression of 
the major known global regulators (Thompson et al., 2006). The model proposed to explain 
this observation is based on the idea that in the absence of ppGpp, strong promoters such as 
the ribosomal RNA promoters and house-keeping genes which are generally GC-rich are 
capable of acquiring free RNA polymerase, whereas AT-rich promoters, including many of 
the horizontally-acquired virulence and pathogenicity-island associated genes, remain at a 
disadvantage based on the instability of such RNA polymerase: AT-rich promoter 
interactions. 
In the previous study, a number of additional pathogenicity island- and virulence-
associated genes were found to show severe reductions in expression by loss of ΔrelAΔspoT, 
as determined by microarray studies. Therefore, the working hypothesis in our laboratory has 
been that many of these uncharacterized genes may be involved in virulence and/or 
pathogenesis of Salmonella. The expression level of one putative transcriptional regulator 
STM0029 is strongly influenced by ppGpp (encoded by RelA and SpoT) in S. Typhimurium, 
implying that STM0029 might also be involved in Salmonella invasion and/or intracellular 
survival. Since there is no information or prior studies investigating the possible biological 
function of STM0029, I was therefore interested in the identification and characterization of 
the possible biological function(s) and involvement of STM0029 in virulence. 
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3.  MATERIALS and METHODS 
 
3.1. Molecular biology methods 
3.1.1. DNA isolation 
3.1.1.1. Plasmid preparation from E. coli and Salmonella 
A single colony of bacteria was inoculated into 6 ml L-broth (Lennox, 1955) containing the 
appropriate antibiotic and incubated at 37ºC with shaking until the cultures reached OD600 
approx. 2. Plasmid DNA of bacterial cultures was isolated by QIAGEN Plasmid Midi Kit 
(Qiagen, Inc.) according to the manufacturer’s instructions. 
 
3.1.1.2. Genomic DNA isolation 
L-broth was inoculated with a signal colony of bacteria and incubated at 37ºC with shaking 
until the cultures reached OD600 approx. 2. The culture was centrifuged to pellet the bacteria 
and discarded the supernatant. High molecular weight chromosomal DNA was isolated by 
QIAGEN Genomic DNA preparation kit (Qiagen) according to the manufacturer’s 
instructions. 
 To remove contaminating proteins and salts from DNA, the volume of the samples 
were adjusted to 300 µl with water and extracted with 500 µl of Tris-equilibrated phenol. The 
lower organic phase and the denatured proteins were discarded. The aqueous phase was 
further extracted twice with chloroform to remove traces of phenol and DNA was 
concentrated by ethanol precipitation. 
 One-tenth volume of 3M sodium acetate (pH 5.5) and 2.5 volumes of ice-cold 100% 
ethanol were added to the sample containing DNA. The mixture was mixed well by shaking 
and was allowed to cool at -80ºC for overnight. The sample was centrifuged at full speed for 1 
hour next day. The pellet was washed twice with 70% ethanol, air-dried and re-suspended in 
sterile water. 
 
3.1.2. RNA isolation 
Total RNA was extracted from bacteria grown to the late log phage (OD600 approx. 2). To 
stabilise RNA, 5 ml of bacteria culture was added to 1 ml of 5% (v/v) phenol in ethanol 
maintained on ice followed by incubation for at least 30 minutes (Tedin and Blasi, 1996). The 
cells were centrifuged, resuspended in resuspension buffer (25 mM Tris-HCl, 1 mM EDTA) 
and lysed by adding an equal volume of 100ºC lysis solution (0.6 M NaOAc, 4 mM EDTA 
and 3% SDS) and boiling for 30 seconds to 1 minute. Repeated phenol and chloroform 
Chen,	  HC	   42	  
 
 
extractions were performed to purify the lysate. Total RNA was treated with RNase-free 
DNase according to the manufacturer’s instructions (Promega) to remove contaminating 
chromosomal DNA. The resultant RNA was further extracted with phenol and chloroform to 
obtain purified total RNA. DEPC-treated water was used in preparation of all the reagents. 
 
3.1.2.1. Electrophoresis and detection of nucleic acids on agarose gels 
Agarose gel electrophoresis was used for the routine analysis of DNA and RNA. Agarose gels 
were cast in 1X Tris-borate buffer (TBE) containing 0.5 µg/ml ethidium bromide. The DNA 
samples were mixed with DNA loading buffer and separated in agarose gels at 10 V/cm. The 
agarose concentration of the gels used was dependent upon the size of DNA fragments to be 
resolved, and ranged from 0.7 to 1.2% (w/v). 
 
3.1.2.2. Determination of concentration of nucleic acids 
The concentration of DNA and RNA were measured by Nanodrop Spectrophotometer 
(PeqLab) according to the manufacturer’s instructions. Calculations were performed by used 
the absorption determined by the instrument and the following conversions: 
 
1 unit of absorbance of dsDNA at a wavelength of 260 nm (A260) = 50 µg/ml dsDNA 
1 unit of absorbance of RNA a wavelength of 260 nm (A260) = 40 µg/ml RNA 
 
 The A280 was also measured and the ratio between A260 and A280 was used to 
determine the purity of the sample. DNA sample are considered adequately pure if the ratio of 
A260 and A280 is between 1.6 to 1.8; RNA sample are considered adequately pure if the ratio 
of A260 and A280 is between 1.8 to 2.0. 
 
3.1.3. Genome-wide microarray analysis 
3.1.3.1. Nucleic acid extraction and purification 
Bacterial culture samples (5 or 10 ml) were added to one-fifth of the sample volume of a 
solution of 5% (v/v) phenol in ethanol maintained on ice to stabilize total RNA. Total RNA 
was extracted and purified as described above. Chromosomal DNA was removed by digestion 
with 50-100 units of RNase-free DNase (Promega Corporation) and re-extracted with phenol 
and chloroform to obtain purified total RNA. The absence of contaminating DNA was 
verified by PCR involving primers targeting bacterial housekeeping genes. 
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3.1.3.2. Microarray construction 
The ‘Salsa’ Salmonella serovar microarray was used in this study. Each ‘Salsa’ Salmonella 
serovar microarray consisted of 5080 protein coding regions or open reading frames (ORF), 
including 4414 S. Typhimurium LT2a (and pSLT) genes, 155 S. Typhimurium DT104 
specific genes, 229 S. Typhimurium SL1344 specific genes, 196 S. Enteritidis PT4 specific 
genes and 86 S. Gallinarum 287/91 specific genes (http://www.ifr.ac.uk/Safety/Microarrays/ 
default.html). The construction of the S. Typhimurium microarray has been described 
previously (Clements et al., 2002; Eriksson et al., 2003; Kelly et al., 2004).   
 
3.1.3.3. Template labeling 
RNA for microarray analysis was reverse transcribed into cDNA and labeled according to 
protocols described on the IFR microarray website (www.ifr.bbsrc.ac.uk/safety/microarrays/). 
Briefly, a random priming reaction consisting of 10 µg of total RNA and 5 µg of random 
hexamers (Invitrogen) was set up in a total volume of 9.4 µl of ultra-pure water (Sigma 
Aldrich) at 70ºC for 5 minute in the dark. Following incubation, the reaction was chilled on 
ice for 10 minutes and centrifuged. Finally, 4.6 ml of RT reaction mix, 2 µl of 1 mM Cy5-
dCTP (GE Health Care Lifesciences) and 4 µl of Affinity script multi-temperature reverse 
transcriptase (Stratagene) were added to the random primed RNA, mixed and incubated at 
25ºC for 10 minutes. The incubation was further continued overnight at 42ºC. The following 
day, RNA was hydrolysed by the addition of 15 µl of freshly prepared 0.1 M NaOH and the 
alkali was neutralized with a equal volume of 0.1 M HCl. Regarding to direct labeling of 
chromosomal DNA, 2 µg of Salmonella chromosomal DNA, brought up to 21 µl with ultra-
pure water, 20 µl of 2.5X random primer/reaction buffer from BioPrime® DNA labeling 
system (Invitrogen) was added, boiled and chilled on ice for 5 minutes each. While on ice, 
components were added as followed: 5 µl of 10X dNTP mix, 3 µl of 1 mM Cy3-dCTP (GE 
Health Care Lifesciences) and 1 µl of Klenow enzyme. The reaction was centrifuged and 
incubated at 37ºC overnight in the dark. The labeled chromosomal DNA was used as a 
common reference and internal hybridization control in each experiment.  
 
3.1.3.4. Hybridization 
The hybridization was performed as indirect comparison (type II) experiments using genomic 
DNA as the common reference and internal hybridization efficiency control. Generally, the 
labeled cDNA and one-fifth volume of labeled genomic DNA (10 µl) were mixed and 
purified by using Qia-quick PCR purification kit (Qiagen) to remove 
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unincorporated/quenched Cy dyes. The labelled nucleic acid mixture was eluted twice with 50 
µl ultra-pure water. To 10 µl of dried labeling reactions consisting of labelled RNA and 
genomic DNA, 5.625 µl of the hybridization buffer was added, incubated at 100ºC for 2 
minutes and followed by a room temperature incubation for 5 to 10 minutes. The mixture was 
centrifuged twice at 13,500 rpm for 5 minutes and the supernatant was transferred to a new 
tube in order to remove particulate matter. The hybridization reaction was performed by 
pippetting the hybridization buffer to one edge for a coverslip placed on the genomic array 
placed in the hybridisation chamber [Custom made by Monterey Industries or purchased at 
Corning Costar (#2551)]. Humidity in the hybridization chamber was maintained by 
pippetting 20 µl of 3X SSC buffer on each side of the slide. The hybridisation chamber was 
place in a water bath at 63ºC overnight. 
 
3.1.3.5. Washing and stringency for reduction of background 
The array was washed twice directly placing the slides in a heated wash solution containing 
2X SSC and 0.1% SDS at 63ºC and agitated for 5 minutes to remove the coverslips. A 
thermocouple attached to a hot-plate stirrer was used to maintain the temperature. The arrays 
were subsequently washed twice in 1X SSC and 0.2X SSC at room temperature for 5 minutes 
with agitation. The slides were further spin dried in an enclosed slide chamber at 12,000 rpm 
for 5 minutes at room temperature and stored in plastic slide chamber until scanning. 
 
3.1.3.6. Data acquisition and analysis 
The process for microarray data acquisition and analysis was based on instructions reported 
by Eriksson et al. (2003) and Kelly et al. (2004). Fluorescence intensities of scanned 
microarrays were quantified using GenePix Pro software, version 3.0 (Axon Instruments, 
Inc.). The data were filtered and spots showing a reference signal lower than background plus 
two standard deviations or obvious blemishes were omitted from evaluations. The local 
background was subtracted from spot signals, and fluorescence ratios were calculated. To 
compensate for unequal dye incorporation or any effects of the amount of template, data 
centering was performed by adjusting the median natural logarithm of the ratios for each 
group of spots printed by the same pin to zero. Only coding regions whose expression showed 
at least a two-fold difference (the median natural logarithm ≥ 0.33) in the experimental strain 
compared to the wildtype were further analysed. The significance of the data at P = 0.05 was 
determined using a parametric-based statistical test adjusting the individual P value with the 
Benjamini and Hochberg false discovery rate multiple test correction. All of the expression 
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data for genes discussed in the text have passed this filter and are therefore statistically 
significant. These tests are features of the Gene-SpringTM 6.2 (Silicon Genetics) microarray 
analysis software package, which was used for both data visualization and analysis. 
 
3.1.4. Reverse-transcriptase PCR (RT-PCR) and Quantitative RT-PCR (qRT-PCR) 
Total RNA was extracted and purified as described above. The RNA samples were further 
treated with RQ1 RNase-freeDNase (Promega, USA) at 37ºC for 4 hours and subsequently 
purified by phenol /chloroform extraction. The following day, purified RNA sample was 
utilised for further reverse-transcriptase reaction. A total of 2.0 µg of each RNA sample 
combined with 1 µg Random Primer (Promega, USA) was reacted at 70ºC for 2 minutes and 
subsequently stayed at 4ºC for following step. 5 µg M-MLV 5X Reaction Buffer (Promega, 
USA), 6.75 µl dNTPs (ROTI®-MIX PCR 1), 0.625 µl RNA inhibitor (Promega, USA) and 1 
µl reverse transcriptase (Promega, USA) were added in each reaction and reacted at 37ºC for 
1 hour. dnaA was used as internal controls for total RNA loaded on RT-PCR and qRT-PCR. 
 150 ng cDNA in 2 µl treated with 10.0 µl Power SYBR® Green Master Mix (Applied 
Biosystems, UK), 1.8 µl forward and reverse primers flanked an interested gene and 4.4 µl 
H20 in total volume 20 µl was reacted in 96 well plate and follow the PCR program described 
in Supplement I (p. 132).  
 
3.2. Microbiological methods 
3.2.1. Bacterial strains, plasmids and growth conditions 
The bacterial strains and plasmids used in this study are described in Table I. The wildtype, 
virulent S. Typhimurium strain SL1344 (Hoiseth and Stocker, 1981) was originally obtained 
from B.A.D. Stocker and provided by F. Norel (Institut Pasteur) and re-isolated from the 
spleens of infected Balb/c mice. Bacteria were maintained in either L-broth (Lennox, 1955) or 
M9 minimal medium (Sigma-Aldrich). When necessary, the growth media were 
supplemented with antibiotics (Sigma-Aldrich, Carl Roth) at the following concentrations: 
kanamycin, 50 µg/ml; carbenicillin, 100 µg/ml; and chloramphenicol, 10 µg/ml. The cultures 
were plated on L-broth agar plates with appropriate antibiotics at 37ºC overnight and 
subcultured in L-broth liquid media (OD600 approx. 2) for following experiments; for strains 
containing the temperature-sensitive plasmid pCP20 or pKD46 that were growth at 30ºC. The 
medium was supplemented with carbenicillin and kanamycin for the selection of strains, 
respectively. M9 minimal medium was prepared by M9 Minimal Salts (5X) (Sigma-Aldrich), 
which contains 33.9 g/L Na2HPO4, 15 g/L KH2PO4, 2.5 g/L NaCl and 5 g/L NH4Cl. 
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 Synthetic medium affecting SPI2 gene expression and SPI2-T3SS secretion have been 
described previously (Deiwick et al., 1999). The composition of PCN medium (TEKnova, 
Inc.) was as follows: 80 mM MOPS or 80 mM MES; 4 mM Tricine; 100 mM FeCl3; 376 mM 
K2SO4; 50 mM NaCl; x (as specified in the Results section) mM K2HPO4/KH2PO4, 0.4 % 
glucose, 15 mM NH4Cl; 1 mM MgSO4, 10 mM CaCl2; micronutrients (10 nM Na2MoO4; 10 
nM NaSeO3; 4 nM H3BO3; 300 nM CoCl2; 100 nM CuSO4; 800 nM MnCl2; 1 nM ZnSO4).  
 
3.2.2. Electroporation of bacteria 
3.2.2.1. Preparation of competent bacteria 
3.2.2.1.1. Preparation of electrocompetent bacteria for mutagenesis 
Salmonella harbouring plasmid pKD46 was first inoculated into 6 ml L-broth containing 100 
µg/ml carbenicillin at 30ºC for growth overnight. The pre-culture was sub-cultured into 500 
ml L-broth with 1:100 dilution in following day at 30ºC. Once bacterial cultures reached an 
OD600 of approx. 0.6, expression of the the bacteriophage λ Red recombinase cloned under 
transcriptional control of the araBAD operon promoter on plasmid pKD46 was induced for 2 
hours by the addition of arabinose in a final concentration of 5 mM for a further 2 hours. 
Bacterial culture was poured into 250 ml plastic tubes and centrifuged at 8,000 x g for 15 
minutes at 4ºC. All subsequent manipulations were performed on ice. The pellet was 
resuspended in 250 ml with ice-cold 10% glycerol and re-centrifuged twice as above. The 
pellet was then carefully resuspended with 30 ml of 10% glycerol and centrifugated at 3,750 x 
g for 10 minutes and 1,650 x g for another 10 minutes. The supernatant was discarded and 
resuspended bacterial pellet in 2 ml of 10% glycerol. Aliquots of 100 µl were stored in pre-
frozen 1.5 ml eppendorf tubes at -80ºC. 
 
3.2.2.1.2. Preparation of electrocompetent bacteria for transformation with plasmids 
(rapid method) 
A single colony of bacteria was used to inoculated into 6 ml of L-broth containing appropriate 
antibiotic and grown at either 30ºC or 37ºC depending on bacterial strains. Once bacterial 
culture reached OD600 approx. 2, 1 ml bacterial culture was transferred to 1.5 ml eppendorf 
tubes and centrifugated at 13,500 rpm 5 minutes at room temperature. Discard the supernatant 
and concentrate pellet of each 2 eppendorf tubes in 1 ml of ice-cold 10% glycerol. From this 
step onwards, all subsequent manipulations were performed on ice. Centrifugation was 
repeated with decreasing speeds of 6000 x g, 3000 x g, 2000 x g twice at 4ºC as follows. 
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Finally, the pellet was resuspended in 100 µl of 10% ice-cold glycerol in pre-frozen 1.5 ml 
eppendorf tubes and stored at -80ºC. 
 
3.2.2.1.3. Electroporation 
Electrocompetent bacterial cells were thawed on ice just before electroporation. One to two 
microliters of DNA preparation was added to the thawed competent cells and the mix was 
transferred to a 2 mm electroporation cuvette. EasyjecT Prima (PeqLab) apparatus was used 
for electroporation. The mix was pulsed at 2.5 kV according to standard protocols. The 
samples were immediately resuspended in 1 ml L-broth without antibiotics and incubated for 
one hour at room temperature. Transformants were selected by plating onto selective agar 
plates followed by incubation at 32°C or 37°C overnight. 
 
3.2.3. Bacteriophage 
3.2.3.1. Preparation of P22 phage stocks 
Bacteria were inoculated in 6 ml L-broth containing 10 mM MgSO4 and 5 mM CaCl2 and 
grown to OD600 approx. 2 at 37ºC. 5 to 10 µl of bacterial culture was transferred to a pre-
warmed sterile test tube containing 6 ml of 0.7% soft agar, 10 mM MgSO4 and 5 mM CaCl2 
and maintained at 70ºC before adding bacterial culture. The mixture of warm soft agar and 
bacteria was immediately poured onto a LB agar plate and left for 10 minutes at room 
temperature to allow hardening of the soft agar. 100 µl of a dilution of the wildtype P22 
particles were spotted onto the soft agar and spread by tilting the plates. The dried plates were 
incubated overnight at 37ºC. The following day, cleared zones on the soft agar plates were 
collected using a sterile spatula and transferred to a 15 ml polypropylene tube (Falcon). 1 ml 
L-broth containing 10 mM MgSO4 and 5 mM CaCl2 and 1 µl of chloroform were added in to 
polypropylene tube and incubated overnight at 4ºC to allow diffusion of the bacteriophage out 
of the agar. The following day, the tubes were centrifuged at 7,500 rpm 15 minutes at 4ºC to 
remove the agar and cell debris. The clear supernatants were transferred to eppendorf tubes 
and stored at 4ºC for further usage. 10 µl of chloroform/ml supernatant was added into each 
phage stock to prevent bacterial growth and maintain sterile stocks of bacteriophage. 
 
3.2.3.2. Transduction of Salmonella with phage P22 
The recipient bacterial strain was cultured to OD600 approx. 2 in 6 ml L-broth containing 10 
mM MgSO4 and 5 mM CaCl2 at 37ºC. 2 to 5 µl of the donor P22 phage lysate was further 
added to 100 µl of the bacterial culture and incubated at 37ºC for 20 minutes. EGTA was 
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added with a final concentration of 20 mM to chelate the metal ions necessary for phage 
infection to stop the reaction. The volume of the mixture was brought to 1 ml with L-broth 
containing 20 mM EGTA and 100 µl aliquots of the mixture was plated on L-broth agar plate 
containing the appropriate antibiotic. The resulting transductants were further screened on 
green plates (Sternberg and Maurer, 1991). For the protocol of standard green plates see 
Supplementary Table I (p. 132). to eliminate lysogens and infected cells. Infected bacterial 
colonies are dark blue/green due to lysis of bacterial cells followed by a pH change, whereas 
uninfected colonies maintain a pale green colour.  
 
3.2.3.3. Generation of mutants 
All experimental strains constructed in this study are isogenic derivates of the wildtype S. 
Typhimurium SL1344 strain which have the indicated deleted genes replaced by a kanamycin 
resistance cassette using the bacteriophage recombinase (Datsenko and Wanner, 2000; 
Murphy, 1998; Zhang et al., 1998). For strains where no kanamycin cassette is indicated at 
the site of deletion, the kanamycin cassette has been removed by introduction of the plasmid 
pCP20, encoding the yeast FLP resolvase, followed by loss of the plasmid by growth at 37°C 
(Cherepanov and Wackernagel, 1995). Single-copy lacZ transcriptional fusion strains in 
various strain backgrounds were constructed by using plasmid pKG136 as described for a 
related plasmid (pCE36) (Ellermeier et al., 2002). 
 
3.2.3.4. Polymerase chain reaction (PCR) 
The DNA fragment was amplified by the standard BioTherm Taq polymerase (Rapidozym). 
For the protocol of standard PCR reactions see Supplementary Table I (p. 132). 
 
3.3. Biochemical methods  
3.3.1. β-galactosidase assay 
Expression of lacZ fusions was assessed using β-galactosidase assays as described by 
Thompson et al., (2006). Bacterial cultures were growth to the late log/early stationary phase 
of growth (OD600 approx. 2) in L-broth or subcultured 4 hours in the M9 minimal medium. 1 
ml culture was transferred to reaction tubes containing 1 ml Z buffer. 25 µl 0.1% SDS and 50 
µl chloroform were added to each tube to permeabilized the bacteria. Samples of 0.4 ml (4 
mg/ml) o-Nitrophenyl-?-D-galactopyranosid (ONPG) (Sigmal-Aldrich) were added to start 
the reaction, and 1 ml of 1M NaCO3 was added to stop the assay. Samples were determined of 
absorbance at 420 nm and culture density was assessed at 550 nm. 
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3.3.2. In vitro assays for assessing tolerance to antimicrobial peptides (AMPs) 
The wildtype S. Typhimurium SL1344 and each mutant strains were propagated in L-broth 
until OD600 approx. 2 and the assay was followed the protocol described by Fields et al. 
(1989) with slightly modifications. Bacteria (105 cfu pro well) were seeded into a 96-well 
plate (Costar) containing one of the substances diluted in appropriate media with indicated 
concentrations and incubated at 37?C for 1 hour. Polymyxin B (Biochrom AG) was 
reconstituted in the 0.1% sodium chloride buffer; human α-defensin-1, β-defensin-2 and LL-
37 (Peptide Institute, INC., Japan) were diluted by the Iscove?s modified Dulbecco?s Eagle
?s medium as the minimal medium. Samples from each concentration were plated at 
different dilutions in LB plates. For the β-defensin-1 reaction, 10 mM potassium phosphate 
buffer was used since sodium chloride is known to inhibit the activity of ?-defensin-1 
(Singh et al., 1998). Data are presented as percentage survival relevant to the untreated 
sample. 
  
3.3.3. Serum sensitivity assay 
To analyse the sensitivity of various Salmonella strains to serum complement, bacteria were 
grown in L-broth, washed twice in phosphate-buffered saline containing 5 mM MgCl2 
(PBSM), and diluted in PBSM to 1 × 108 cfu/ml. To test serum sensitivity, 50 ?l of the 
bacterial suspension was mixed with an equal volume of 100% normal non-heated sera (NNS) 
or 100% heat-inactivated sera (HIS) and incubated for 60 minutes at 37°C, respectively. 
Serial dilutions of the samples were prepared in PBSM and plated onto MH plates to 
determine the number of viable bacteria. The percent survival of the wildtype strain was 
calculated as follows: 100 × [mean (cfu ml−1 in NNS/cfu ml−1 in HIS) of mutant]/[mean (cfu 
ml−1 in NNS/cfu ml−1 in HIS) of wildtype]. 
 
3.4. Cell culture methods 
3.4.1. Cell culture preparation 
J774A.1 (ATCC TIB-67) murine macrophage cells were used in this study for cell culture and 
cell invasion assay. Briefly, cells were grown and maintained in Iscove’s modified 
Dulbecco’s Eagle’s medium (Biochrom AG). The medium was supplemented with 10% fetal 
calf serum (PAN Biotech) at 37°C and 5% CO2. To passage culture cells, the cells were first 
washed with 1X PBS and treated with Trypsin/EDTA solution at 37ºC for 5 minutes to loosen 
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the attachment of the cells. The cells were centrifuged and washed with appropriate medium 
to remove trypsin and an aliquot of the cell culture was added in the cell culture flask.  
 
3.4.2. Preparation of stocks 
The cells were suspended in appropriate culture medium to obtain the concentration of 107 
cell/ml. Sterile dimethyl sulfoxide (DMSO) was added to a final concentration of 10% and 
frozen overnight at -80ºC. The stocks were transferred to liquid N2 for long term storage on 
next day. 
 
3.4.3. Cell invasion assay 
The bacteria were grown with aeration to an OD600 of between 2 and 3 (late log phase), 
collected by centrifugation, resuspended in cell culture medium, and diluted to the appropriate 
concentrations for infection. Duplicate wells of monolayers of cells grown in 24-well culture 
plates (105 cells per well) were infected to yield a multiplicity of infection of ≤ 1 per host cell. 
After a centrifugation step (5 min, 250 × g), infected cells were incubated for 30 minutes prior 
to a change of medium containing 50 µg/ml of gentamicin (Biochrom AG). The medium was 
again replaced after 60 minutes with medium containing 10 µg/ml of gentamicin for the 
remainder of the experiment. At the times indicated in the figures, the wells were washed 
twice with phosphate-buffered saline and lysed by addition of 0.1% Triton X-100 in distilled 
water. Serial dilutions of lysates were plated for determination of intracellular bacteria. The 
data shown are representative of at least three independent assays for all strains. 
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                      Table I. List of bacterial strains and 
                     plasmids used in this study 
 
Strain or 
plasmid Properties Reference or source 
Strains   
KT2958 SL1344 wildtype S. Typhimurium hisG46 rpsL Hoiseth and Stocker, 1981 
KT5476 SL1344 hisG46 rpsL ?STM0029::kan This study 
KT6192 SL1344 hisG46 rpsL ?(PSTM0029::lacZY::kan) This study 
KT6266 SL1344 hisG46 rpsL ?(PpagD::lacZY::kan) This study 
KT6268 SL1344 hisG46 rpsL ?(PpagP::lacZY::kan) This study 
KT6272 SL1344 hisG46 rpsL ?(PpagD::lacZY::kan) ?STM0029 This study 
KT6274 SL1344 hisG46 rpsL ?(PpagP::lacZY::kan) ?STM0029 This study 
KT6342 SL1344 hisG46 rpsL ?pmrAB::kan This study 
KT6360 SL1344 hisG46 rpsL ?(PpagC::lacZY::kan) This study 
KT6362 SL1344 hisG46 rpsL ?(PpagC::lacZY::kan) 
phoP60::Tn10d(Tc) 
This study 
KT6364 SL1344 hisG46 rpsL ?(PpagD::lacZY::kan) 
phoP60::Tn10d(Tc) 
This study 
KT6366 SL1344 hisG46 rpsL ?(PpagP::lacZY::kan) 
phoP60::Tn10d(Tc) 
This study 
KT6478 SL1344 hisG46 rpsL ?(PpagC::lacZY::kan) ?STM0029 This study 
KT6480 SL1344 hisG46 rpsL ?pmrAB ?(PpagC::lacZY::kan) This study 
KT6482 SL1344 hisG46 rpsL ?pmrAB ?(PpagD::lacZY::kan) This study 
KT6484 SL1344 hisG46 rpsL ?pmrAB ?(PpagP::lacZY::kan) This study 
KT6486 SL1344 hisG46 rpsL ?pmrAB ?(PSTM0029::lacZY::kan) This study 
KT6488 SL1344 hisG46 rpsL ?(PSTM0029::lacZY::kan)  phoP60::Tn10d(Tc) This study 
KT6546 SL1344 hisG46 rpsL ?(PpcgL::lacZY::kan) This study 
KT6548 SL1344 hisG46 rpsL ?(PpcgL::lacZY::kan) ?STM0029 This study 
KT6778 SL1344 hisG46 rpsL ?pmrAB ?(PpcgL::lacZY::kan) This study 
KT6782 SL1344 hisG46 rpsL ?(PpcgL::lacZY::kan) 
phoP60::Tn10d(Tc) 
This study 
KT7074 SL1344 hisG46 rpsL ΔoafA::kan This study 
   
Plasmids   
pCP20 bla cat pSC101(ts) cI857(ts) pL-FLP+ Cherepanov and Wackernagel, 1995 
pKD4   bla kan oriRg (pir-dep.) Datsenko and Wanner, 2000 
pKD46 bla araC pBAD-g-b-exo repA101(ts) oriR101 Datsenko and Wanner, 2000 
pKG136 kan(aph) FRT lacZY+ oriR6K Ellermeier et al., 2002 
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Table II. List of primers used in this study 
Primer Name Sequence 
dnaAFor GGCGAAGTAGCGTTCTTTAT 
dnaARev TTCACGCAGTTGCTCAATTT 
k1 CAGTCATAGCCGAATAGCCTa 
k2 CGGTGCCCTCAATGAACTGCa 
Km CGATCGCTGTTAAAAGGACAa 
Lac GACCATTTTCAATCCGCAb 
oafAFor AAACATTATGATATTGAGTT 
oafARev GCTTGCAGTTCTCTGCGTAA 
P1 TGTGTAGGCTGGAGCTGCTTCGA 
P2 CATATGAATATCCTCCTTAG 
rfaHFor GCTCTTTCCTAATTATCTGT 
rfaHRev TAAGCAGTAACATCGAACGC 
rfeFor GTAGTACACTGATTGGCTTT 
rfeRev ATGAGAGTATTCTGCCGTTA 
STM0029H1P1 GAAACGTACCTTATGAATATCAAAACGGAGTGAATTCATGTGTGTAGGCT
GGAGCTGCTTCGAc,d 
STM0029H2P2 GTTCTCACCTTCCCGGGACACGGTCTACAGACTTTATCTTCACATATGAAT
ATCCTCCTTAGe,f 
  
  
a Primers are designed according to Datsenko and Wanner (2000) 
b Primers are designed according to Ellermeier et al. (2002) 
c Bold letters represent the start code of the STM0029 gene 
d Underlined bases represent the P1 primer sequence according to Datsenko and Wanner (2000) 
e Bold letters represent the stop code of the STM0029 gene 
f Underlined bases represents the P2 primer sequence according to Datsenko and Wanner (2000) 
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4. RESULTS 
  
4.1. Salmonella STM0029 contributes to the resistance to antimicrobial peptide killing 
In a previous study, a ppGpp-deficient strain of Salmonella (?relA?spoT), which is non-
invasive and avirulent in mice, showed severe reductions in expression of nearly all genes 
previously shown to be involved in invasion and intracellular survival and replication 
(Thompson et al., 2006). In addition, many previously uncharacterized genes and open 
reading frames (ORFs) also showed altered patterns of expression. Based on the hypothesis 
that many of these genes might be involved in virulence or pathogenesis (see Introduction), I 
set out to determine in this study the possible role(s) of one of these candidate genes, a 
putative transcriptional regulator referred to as STM0029. STM0029 (NP_459034) is an open 
reading frame, which consists of 447 base pairs. The STM0029 gene is flanked by 
STM0028.1n, which encodes a hypothetical protein and STM0030, which is predicted to 
encode a putative transcriptional regulator belonging to the LysR family (Fig. 4A). 
 
Fig. 4. The organization of the Salmonella genome around STM0029. (A) The cartoon shows the 
gene organization of the chromosomal region around the STM0029 open reading frame at bp 
2440125-2441063 of the Salmonella genome. STM0029 is predicted to encode a putative 
transcriptional regulator of 129 amino acids. (B) The position of the primers (STM0029H1P1 and 
STM0029H2P2) used to carry out completed in-frame deletion of the STM0029 gene. Red letters 
represent the start codon of STM0029; blue letters represent the stop code of STM0029. 
447bp 
!"
!TCTTCA!        !CATGAA! 
STM0029 
In-frame deletion 
#"
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 First, a directed, chromosomal deletion mutation of STM0029 (Fig. 4B, p. 53) was 
constructed via ? Red recombinase mutagenesis, verified by PCR and transferred back into 
the isogenic wildtype strain via bacteriophage P22 transduction (see section 3.2.3.2., p. 47). 
Colony morphology and growth kinetics of both the wildtype and mutant strains in culture 
showed no significant differences, confirming the mutation did not confer a general growth 
defect (data not shown).  
 Initially in this study, host cell invasion assays were performed with a murine 
macrophage cell line (J774A.1) during different independent time periods (2008 - 2010 and  
2011) with bacterial strains including the wildtype, ΔSTM0029-, ΔpmrA/B-, and ΔoafA 
mutants because host cells (both phagocytes and non-phagocytic cells) have been known to 
employ multiple mechanisms to kill intracellular pathogens, including the release of pore-
forming cationic antimicrobial peptides (AMPs). Briefly, equal amounts of the wildtype and 
mutants (MOI=1) grown to an OD600 between 2 and 3 (late log phase) were used to infect 
macrophages (see section 3.4.3. for details, p. 50). Samples were collected after 2, 4 and 24 
hours post-infection. Based on results obtained in 2008 – 2010, the ΔSTM0029 and ΔoafA 
strains showed similar rates of host cell invasion to the wildtype after 2 and 4 hours post-
infection, respectively; however, the intracellular bacteria (cfu) present at time points post-
infection for both mutant strains showed about 50% reductions compared to the wildtype 24 
hours post-infection (Table III, see page 56 below). In contrast, the ΔpmrA/B strain exhibited 
both reduced invasion and intracellular survival at both early time points (2- and 4 hours post-
infection) and the late time point (24 hours post-infection). Based on the “doubling time” (g) 
(open source offered by Dr Alan Cann) 
(http://www.microbiologybytes.com/LabWork/bact/bact18.htm), the mean intracellular 
generation time was calculated after bacteria infected macrophages. The formula used for 
calculation is as follow: 
 
Ng = (log10 Nt - log10 N0) / log102 
 g = (Tt – T0) / Ng 
    
   Ng : the number of generations 
   N0 : the number of bacteria at the zero time point 
   Nt : the number of bacteria at the t time point   
    g : doubling time or mean generation time 
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 As shown in Table III, the mean intracellular generation time obtained from the 
ΔSTM0029, the ΔpmrA/B and ΔoafA strains showed reduced growth from 2 to 24 hours post-
infection compared to the wildtpye (data from 2008 - 2010). However, when these same 
experiments were repeated in 2011, the intracellular survival rates obtained for the 
ΔSTM0029 and ΔpmrA/B strains were not as severely reduced as previously observed 
compared to the wildtype 24 hours post-infection. Furthermore, the intracellular cfu for the 
ΔpmrA/B strain were much higher at the early time points 2 and 4 hours post-infection as 
observed in 2008 – 2010. Unexpectedly, the ΔoafA strain had lost its original phenotype in 
macrophages. At this time we have been unable to explain the discrepencies between these 
independent experiments, possibly a change in the source or charge of serum used in the cell 
culture medium may be responsible (see Discussion 5.1. for further details, p. 88). Although 
the phenotypes of the ΔSTM0029 and the ΔoafA strains were therefore not consistently 
reproducible in the macrophage cell lines in independent experiments, the ΔSTM0029 strain 
appeared to show a macrophage-specific defect for intracellular survival in macrophage cell 
lines compared to the wildtype. A macrophage-specific defect in intraceulluar survival is a 
rare phenotype Salmonella, which implied a role for STM0029 in Salmonella intracellular 
survival and/or pathogenesis. Such phenotypes have been reported in Salmonella strains with 
mutations of SPI2 effectors, including SsaR, SifA (Brumell et al., 2001), SpiA (Ochman et 
al., 1996), SsaV, SsaM (Yu et al., 2004) and the PhoP/Q TCS (Fields et al., 1986). 
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Table III. Phenotypic characterization of bacteria  
after infecting macrophagesa 
 
 Bacterial strains 
 Wildtype ΔSTM0029 ΔpmrA/B ΔoafA 
Experiments performed in 2008 - 2010   
Time after 
infection (h)	   Intracellular cfu (% input)
b 
2 40.11 36.42 6.74 54.77 
4 70.85 54.40 15.72 66.83 
24 613.61 213.24 35.56 349.74 
Time intervel 
after 
infection (h) 
Mean intracellular generation time (g)c 
2 - 24 5.24 8.06 9.17 8.22 
Experiments performed in 2011     
Time after 
infection (h)	   Intracellular cfu (% input)
b 
2 56.68 43.33 31.52 56.60 
4 78.27 54.65 61.21 60.75 
24 1067.11 575.32 620.2 975.93 
Time intervel 
after 
infection (h)	  
Mean intracellular generation time (g)c 
2 - 24 5.19 5.89 5.11 5.35 
 
a  Murine macrophage cell line J774A.1 was used for cell invasion assays. 
b  The intracellular survival rate was calculated with a formula: 
  100 × [mean (cfu ml−1at the indicated time)]/[mean (cfu ml−1 from input)]  
c  Mean intracellular generation time (g) was calculated with a formula described in the text. The 
value of mean intracellular generation time (g) indicates the doubling time in hours.   
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Phagocytes in particular are known to produce a number of AMPs involved in 
elimination of intracellular bacteria (Sang and Blecha, 2008; Wiesner and Vilcinskas, 2010). 
To address this question, I therefore investigated the suseptibility of the ?STM0029 strain 
after the treatment of human α-defensin-1, β-defensin-1 and β-defensin-2 (Fig. 5, p. 58; also 
see section 1.4.3.1., p. 27). The susceptibility of strains with a mutant in phoP and pmrA/B 
was also investigated in this study, respectively, since one of the major functions contributed 
by the PhoP/Q- and the PmrA/B TCS has been reported to be involved in the resistance to 
AMP killing (Fields et al., 1989; Mäkelä et al., 1978; Miller et al., 1990; Roland et al., 1993; 
Shi et al., 2004). The ΔSTM0029 strain showed similar susceptibility patterns as the ΔpmrA/B 
strain against α-defensin-1 (Fig. 5A, C) and β-defensin-2 (Fig. 5G, I), although the ΔpmrA/B 
strain appeared somewhat tolerant to β-defensin-1 compared to the wildtype, with bacterial 
killing apparent only at the highest concentration (Fig. 5F). The ΔphoP strain showed 
susceptibilities against α-defensin-1 (Fig. 5B) and β-defensin-2 (Fig. 5H); however, in 
contrast to the ΔSTM0029 and the ΔpmrA/B strain, the ΔphoP strain was apparently tolerant 
to β-defensin-1 (Fig. 5E). 
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Fig. 5. The ΔSTM0029 strain is sensitive to human defensin killing. The wildtype (○, open circles) 
and mutant strains (●, filled circles) were grown in L-broth to an OD600 of approx. 2 and were treated 
with the indicated concentrations of defensins, including α-defensin-1 (A, B, C), β-defensin-1 (D, E, 
F), and β-defensin-2 (G, H, I), respectively. Bacteria were incubated with each AMP at 37°C for 1 
hour and dilutions of the bacterial samples were plated for determination of colony-forming units 
(cfu). Percent survival is the mean ± standard deviation (SD) of three independent experiments with 
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similar results. All experiments were performed in triplicate measurements, and error bars indicate 
standard deviations. *, P < 0.01; **, P < 0.005. 
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 In addition to defensins, the cathelicidin-protein family is another main group of host 
AMPs (Nijnik et al., 2009; Wu et al., 2010; also see section 1.4.3.1., p. 27). Cathelicidin 
expressed in humans is called LL-37 (170 amino acids). LL-37 is expressed in various cell 
types, including both phagocytic leucocytes and epithelial cells. As shown in the figure 6, 
susceptibility of the ΔSTM0029 strain (Fig. 6A) to LL-37 was similar to that found in the 
ΔpmrA/B strain (Fig. 6C); however, the killing pattern obtain from the ΔSTM0029 strain was 
intermediate between the highly sensitive ΔphoP strain (Fig. 6B) and the ΔpmrA/B strain. 
These observations indicated that STM0029 is involved in Salmonella resistance against 
mammalian AMP challenges.  
 
Fig. 6. The ΔSTM0029 strain is sensitive to human cathelicidin LL-37 killing. The wildtype (○, 
open circles) and mutant strains (●, filled circles) were grown in L-broth to an OD600 of approx. 2 and 
were treated with the indicated concentrations of LL-37. Bacteria were incubated with LL-37 at 37°C 
for 1 hour and dilutions of the bacterial samples were plated for determination of colony-forming unit 
(cfu). Percent survival is the mean ± standard deviation (SD) of three independent experiments with 
similar results. All experiments were performed in triplicate measurements, and error bars indicate 
standard deviations. *, P < 0.01; **, P < 0.005. 
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 A number of the mechanisms utilized by Salmonella spp against polymyxin B 
challenges have been well studied. The PmrA/B TCS is currently believed to be one of the 
major regulatory systems in defense against polymyxin B challenges (Roland et al., 1993). 
Polymyxin B is also a major component in clinical treatments against multidrug-resistant 
Gram-positive and Gram-negative bacteria. Therefore, I determined whether STM0029 
contributes to resistance against polymyxin B challenges as well. All strains showed 
susceptibility to polymyxin B, including the wildtype strain (Fig. 7), although clearly the 
ΔSTM0029, ΔphoP and, as expected, the ΔpmrA/B strain were far more susceptible than the 
wildtype strain. Taken together, the results indicated that STM0029 is critical for Salmonella 
resistance to both mammalian AMPs and polymyxin B, suggesting the importance of 
STM0029 for Salmonella intracellular survival in host cells.  
  
 
Fig. 7. The ΔSTM0029 strain is sensitive to polymyxin B killing. The wildtype (○, open circles) and 
mutant strains (●, filled circles) were grown in L-broth to an OD600 of approx. 2 and were treated with 
the indicated concentrations of polymyxin B. Bacteria were incubated with polymyxin B at 37°C for 1 
hour and dilutions plated for determination of intracellular colony-forming unit (cfu). Percent survival 
is the mean ± standard deviation (SD) of three independent experiments with similar results. All 
experiments were performed triplicate measurements, and error bars indicate standard deviations. *, P 
< 0.01; **, P < 0.005. 
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4.2. Expression of the Salmonella STM0029 gene is affected by PmrA/B and not by 
PhoP/Q 
PhoP/Q and the PmrA/B are two component regulatory systems (TCS) involved in 
Salmonella virulence gene expression and intracellular survival (see Introduction). The 
PhoP/Q TCS in particular has been found to regulate numerous genes involved in the 
resistance to host bactericidal compound challenges. Since the ΔSTM0029 strain shared some 
similarity in phenotypes against AMP challenges compared to the ΔphoP and the ΔpmrA/B 
strains, I therefore further determined whether expression of STM0029 was associated with 
the PhoP/Q and/or the PmrA/B TCS regulatory networks. As Mg2+ limitations are considered 
one of the essential signals for the activation of the PhoP/Q and the PmrA/B TCS, strains 
harbouring transcriptional lacZ fusions with STM0029 in the wildtype, the phoP and the 
ΔpmrA/B mutant backgrounds were grown in either L-broth or defined M9 minimal medium 
with high  (10 mM) or low (50 µM) Mg2+ concentrations, and β-galactosidase activities 
were quantified at various time points during the growth phase (Fig. 8, see page 63). The 
expression of STM0029 in the wildtype strain background showed only low levels of 
expression, which did not change significantly throughout the growth phase in any of the 
media tested (Fig. 8A, B, C). The significance of the slight increase observed late in the 
growth phase in L-broth (Fig. 8A) remains unclear. Essentially the same results were obtained 
for STM0029 expression in the phoP mutant background (Fig. 8E, F, G), indicating that loss 
of PhoP did not affect expression of STM0029, and independent of the Mg2+ concentration in 
the media. In contrast, a deletion of the pmrA/B genes resulted in a 50- to 100-fold increased 
expression of STM0029 in all media used (Fig. 8G, H, I). This surprising observation 
indicated that rather than a dependence on the PmrA/B TCS for activation and/or expression 
of STM0029, the PmrA/B regulatory system apparently acts to repress expression of 
STM0029. These results further indicated that expression of STM0029 was independent of 
the PhoP/Q TCS, although it remained possible that STM0029 itself might be involved in 
expression of PhoP/Q-dependent genes in a similar manner as PmrA/B-dependent genes are 
directly or indirectly regulated by PhoP/Q (Kato and Groisman, 2004). 
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Fig. 8. Expression of STM0029 is repressed by the PmrA/B two component system, but is 
independent of the PhoP/Q two component system. Strains harbouring transcriptional lacZ fusions 
with the STM0029 gene promoter in either the wildtype (upper row), phoP (middle row) or pmrA/B 
(bottom row) mutations were grown in L-broth or M9 minimal medium containing high (10 mM) or 
low (50 µM) concentrations of Mg2+. Bacteria were cultured in baffled glass flasks at 37°C with 
aeration. The culture growth was recorded by measurement of OD600 (circles, left scale). Samples were 
taken at various time points during culture and processed for quantification of β-galactosidase activity 
(filled bars, right scale). β-Galactosidase activity determinations reflecting the promoter activity are 
reported in Miller units with standard deviations of the means shown (error bars).   
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 In order to determine whether the putative regulator STM0029 might be involved in 
the regulation of PhoP/Q-dependent genes, I determined the expression of transcriptional 
fusions of four PhoP-activated genes (pagP, pagD, pagC and pcgL) (see introduction 1.3.8.1. 
for functions of PagP, PagD and PagC, p. 19). PcgL was reported to encode a periplasmic D-
alanyl-D-alanine dipeptidase involved in Salmonella peptidoglycan synthesis (Hilbert et al., 
1999). β-Galactosidase activities of transcriptional fusions to indicated genes were measured 
in the wildtype, the ΔSTM0029, the phoP and the ΔpmrA/B mutant backgrounds, respectively 
(Fig. 9, see page 65). Expression levels of pagP (Fig. 9A), pagD (Fig. 9B), pagC (Fig. 9C) 
and pcgL (Fig. 9D) in the ?phoP strain were highly reduced compared to the wildtype, 
consistent with the PhoP-dependence for expression of these genes. In contrast, expression 
levels of all these genes in the ?STM0029 background remained comparable to the wildtype 
and the ΔpmrA/B strain background. These results strongly suggested that the reductions in 
resistance to defensins and polymyxin B were not due to reduced expression of PhoP/Q-
dependent genes in the absence of STM0029. 
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Fig. 9. Expression levels of PhoP/Q-dependent genes are not affected by loss of STM0029. β-
Galactosidase activities were determined for the indicated transcriptional gene fusions in the wildtype, 
?phoP, and ?pmrA/B strain backgrounds. The transcriptional activities of the indicated genes in the 
wildtype strain are shown in open bars, and for the mutant strain backgrounds in filled bars. The data 
shown are representative of at least three independent experiments. Means for relative units and 
standard deviations are shown (bars). **, P < 0.005. 
Chen,	  HC	   66	  
 
 
4.3. Microarray analysis of gene expression affected by STM0029 
To gain insight into the molecular basis for differences in pathogenesis between the wildtype 
and the ?STM0029 strain, microarray analyses were performed to compare the global 
genome expression patterns of the two strains. Strains were grown in either in L-broth or 
minimal PCN media with low concentrations of inorganic phosphate (Pi) (0.4 mM). Löber et 
al. (2006) have previously reported that limiting concentrations of Pi is encountered by 
intracellular Salmonella and which is one of the signals which induces expression of the 
Salmonella SPI2 regulon. The gene expression values (normalized fluorescence signal values) 
were compared to the ΔSTM0029 strain versus the wildtype, where the signal ratio of the 
ΔSTM0029/wildtype strain yields a relative value of 1.0 when no difference in expression is 
observed, or 0.0 when the natural log value (base 10) is reported (regarding data acquisition 
and analysis see Introduction 3.1.3.6. for details, p. 44). Consistent with previous findings 
(Löber et al., 2006), genes encoded within SPI2 were up-regulated in PCN medium (Data not 
shown). 891 genes (19.4%) and 569 genes (12.3%) of the S. Typhimurium genome revealed 
significant changes at the transcriptional level in the ?STM0029 strain in L-broth (Table IV, 
see page 80) and 0.4 mM Pi-PCN medium (Table V, see page 81) relative to the wildtype, 
respectively. Among these genes, great numbers of genes [85 (13.9% of total down-regulated 
genes) in L-broth and 48 genes (12.5% of total down-regulated) in 0.4 mM Pi-PCN medium] 
were involved in the function category of “process of cell wall, membrane and envelope 
biosynthesis” by loss of STM0029.   
 The category of 20 PhoP/Q-regulated genes was based on the reference of Groisman, 
E.A. (2001) (Fig. 10A, B, see page 68; Supplementary Table II, see page 137), and were 
selected for comparison of mRNA expression levels between the ?STM0029 strain and the 
wildtype. In L-broth media, mRNA expression levels of phoQ (STM1230), pmrF 
(STM2298), pgtE (STM2396), prgJ (STM2872) and mgtC (STM3764) showed slight 
increases and the expression level of ugtL (STM1601) showed a slight decrease and the prgI 
(STM2873) and pmrB (STM4291) genes showed 1.3- and 2-fold decreased expression levels, 
respectively, in the absence of STM0029 (Fig. 10A, see page 68; Supplementary Tabel II, see 
page 137). Expression levels of the other PhoP/Q-dependent genes showed no significant 
differences in expression, consistent with the previous results with the fusion strains (see Fig. 
9). Expression levels of pagP (STM0628), pagL (STM1645) and pagA (STM2080), which are 
involved in the function of LPS lipid A modifcations, were not affected by loss of STM0029. 
The expression level of pagD (STM1244) also showed a slight decrease; however, pagD is 
not considered as one of the PhoP/Q-regulated genes according to a reference from Groisman, 
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E.A. (2001). In PCN medium, the expression level of pagA (STM2080), which is mainly 
regulated by the PmrA/B TCS showed a slight decrease and expression levels of prgK 
(STM2871), prgJ (STM2872) and prgI (STM2873) showed increases in the ?STM0029 
strain (Fig. 10B, see page 68; Supplementary Tabel II, see page 137).  
 Regarding PmrA/B-regulated genes, 50 genes were chosen based on the in silico study 
reported by Marchal et al. (2004) (Fig. 10A, B, see page 68; Supplementary Table II, see page 
139). Among them, ten genes, including sdhC (STM0115), ybjG (STM0865), pntA 
(STM1479), yejG (STM2220), pgtP (STM2399), govA (STM2982), yhcN (STM3361), glgB 
(STM3538), yibD (STM3707), pmrB (STM4291) and yjdB (STM4293) were down-regulated 
and nine genes, including leuO (STM0115), yceP (STM1161), pmrF (STM2298), pmrD 
(STM2304), STM2400, stdA (STM3029), ipfA (STM3640) and slsA (STM3761) were up-
regulated by loss of STM0029 in the L-broth growth condition (Fig. 10A, see page 68; 
Supplementary Table II, see page 139). In the PCN medium growth condition, stfA 
(STM0195), yafC (STM0273) and STM2400 were down-regulated and ycaR (STM0987), 
pgtP (STM2399) and slsA (STM3761) were up-regulated by loss of STM0029 (Fig. 10B; 
Supplementary Table II, see page 139). 
 In summary, the expression of 28 genes involved in the PhoP/Q and the PmrA/B 
regulatory systems were also affected by loss of STM0029 in the L-broth growth conditions 
and expression of 11 genes were affected by loss of STM0029 in the PCN medium growth 
conditions. 
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Fig. 10. Microarray analysis of the effect of STM0029 on PhoP/Q-regualted, PmrA/B-regulated 
and LPS-, PG- and cell wall-associated genes. Bacterial RNA was extracted from bacteria grown in 
L-broth (A, C) and PCN defined medium with low phosphate (0.4 mM Pi) (B, D), respectively. The 
relative expression pattern of phoP/Q- and pmrA/B-regualted genes (A, B) as well as LPS, PG and cell 
wall-associated genes (C, D) are shown. The natural log of hybridisation signal ratios (?STM0029 
strain/wildtype) are shown in left scales. Expressions of the genes shown in red bars are up-regulated 
by loss of STM0029; expressions of the genes shown in blue bars are down-regulated by loss of 
STM0029. The full data on which the figure is based are found in Supplementary Table II.  
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4.4. STM0029 regulates genes involved in LPS O-antigen biosynthesis and modifications 
The results of this study indicated that expression levels of genes involved in the process of 
cell wall, membrane and envelope biosynthesis showed decreases in expression by loss of 
STM0029, suggesting that STM0029 is involved in the process of bacterial cell wall 
biosynthesis and/or modifications. To date, numerous well-studied Salmonella virulence 
genes involved in modifications of LPS lipid A are known to be regulated by the PhoP/Q 
TCS; however, genes involved in PhoP/Q-mediated LPS lipid A modifications, including 
pagP (STM0628) and pagL (STM1465) showed no difference or only slight changes in 
expression based on the microarray results (Fig. 10A, B) and MALDI-TOF studies of LPS 
(data not shown). Interestingly, the expression of numerous genes involved in LPS O-antigen 
biosynthesis and modifications showed decreases after loss of STM0029, including rfbM 
(STM2084, synthesis of GDP-rhamnose), rfbX (STM2088, assembly or transfer of LPS O 
units), rfbJ (STM2089, synthesis of CDP-abequose), oafA (STM2232, acetylation of the O-
antigen), mreC (STM3921, rod shape-determining protein), wzzE (STM3919, 
lipopolysaccharide biosynthesis protein), wecB (STM3920, reversible interconversion of 
UDP-GlcNAc and UDP-ManNAc), wecD (STM3924, glucose-1-phosphate 
thymidylyltransferase), wzxE (STM3926, TDP-4-oxo-6-deoxy-D-glucose transaminase), 
STM3927 (O-antigen translocase in LPS biosynthesis) and rfaH (STM3977, biosynthesis of 
lipopolysaccharide core) in L-broth (Fig. 10C, D, see page 68; Table VI, see page 82). In the 
PCN medium growth conditions, the expression of genes, including wcaF (STM2110, 
putative acyltransferase), wcaE (STM2111, glycosyltransferase 2 family enzymes), oafA, 
mreC, rfe (STM3918, undecaprenyl-phosphate N-acetylglucosaminyltransferase), wzzE, 
wecB, wecD, wzxE and rhaT (STM4050, L-rhamnose-H+ transport protein) showed decreases 
after loss of STM0029 (Fig. 10C, D, see page 68; Table VI, see page 82). 
 In addition to bacterial LPS, the peptidoglycan layer, which forms a barrier between 
the cytoplasm and the outer membrane, is also a target for certain antibiotics and host pattern 
recognition molecules as well (reviewed by Davis and Weiser, 2011). According to results of 
this study, the expression of a number of genes involved in the peptidoglycan biosynthesis 
were affected by loss of STM0029 as well, including lppB (STM1376, putative methyl-
accepting chemotaxis protein) and mrcA (STM3493, peptidoglycan synthetase) (Table VI, see 
page 82).  
 In order to confirm results obtained from the microarray analysis, I chose three genes 
(oafA, rfaH and rfe), which are critical for LPS O-antigen biosynthesis and modifications to 
verify their expression levels by quantitative RT-PCR using total RNA and cDNA isolated 
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from cultures grown in L-broth (Fig. 11A) and 0.4 mM-Pi PCN medium (Fig. 11B). The 
dnaA gene was chosen as an internal control, since its expression obtained from microarray 
analyses showed no difference in both L-broth (rel. mRNA expression level [log -0.04]) and 
in PCN medium (rel. mRNA expression level [log -0.05]) between the wildtype and the 
ΔSTM0029 strain. Relative mRNA expression levels of oafA, rfaH and rfe exhibited 
decreases in expression in the DSTM0029 strain compared to the wildtype, in particular, oafA 
showed more than an 80% reduction in expression under both growth conditions.  
 
 
Fig. 11. Loss of STM0029 affects expressions of genes involved in LPS biosynthesis and 
modifications. Bacterial RNA was extracted from cells grown in L-broth (A) or PCN defined medium 
with low concentrations phosphate (0.4 mM Pi) (B). The bar chart shows the relative levels of oafA, 
rfaH and rfe mRNA in the STM0029 deletion mutant (filled bars) compared to the wildtype strain 
which was set at 100% (open bars) as determined by quantitative real-time PCR using the dnaA gene 
transcript as an internal control. **, P < 0.005.
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4.5. Transcriptomic profile reveals genes specifically regulated by STM0029 
Based on the in vitro β-galactosidase analyses (Fig. 8G, H, I), the expression of STM0029 
was found to be strongly repressed by the PmrA/B TCS. Furthermore, the expression levels of 
additional PmrA/B-related genes, including pmrF (STM2298), pmrD (STM2304) and pmrB 
(STM4291) were also affected by loss of STM0029 in L-broth (Supplementary Table II, see 
page 139), suggesting that STM0029 might be associated with the PmrA/B regulatory system. 
In order to determine whether STM0029 is directly involved in the PmrA/B regulatory 
cascade or serves as a co-factor, which functions in regulatory networks in addition to the 
PmrA/B regulatory system, I compared the transcriptomic profiles obtained in four different 
experimental strains, including the wildtype, the ΔSTM0029, the ΔpmrA/B and the 
ΔSTM0029/ΔpmrA/B-double mutant strains in order to determine the full set of genes 
regulated specifically by STM0029. Genes which showed the same or similiar (≥ 2-fold 
changes) relative mRNA expression levels in both the ΔSTM0029 and the 
ΔSTM0029/ΔpmrA/B-double deletion strain were considered as specifically STM0029-
regulated genes. As shown in the figure 12A (see page 72), the expression of 730 genes were 
found to be co-regulated by both STM0029 and PmrA/B. In contrast, the expression of 150 
genes were only affected by loss of the PmrA/B; and the expression of a total of 161 genes 
(3.5% of the Salmonella genome) were specifically affected by loss of STM0029 (Table VII, 
see page 83). Among these 161 genes, 112 genes showed reduced expression in the absence 
of STM0029. Based on categories in the Clusters of Orthologous Groups of proteins (COG) 
database, proteins encoded by these 112 genes were divided into 19 groups (Fig. 12B, see 
page 72). The first large group (category) was assigned as the category “Function unknown” 
(14.3%). The second and the third group was aassigned as the category “General function 
prediction only” (13.4%) and “Cell wall/membrane/envelop biogenesis” (13.4%), 
respectively. Interestingly, the oafA gene, which is involved in LPS O-antigen acetylation was 
found in the category “Cell wall/membrane/envelop biogenesis” as a specific, STM0029-
regulated gene (Table VIII, see page 84). 
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(Figure Legend the see next page) 
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(Figure see the previous page) 
 
Fig. 12. Transcriptomic profile of the genes specifically regulated by STM0029 in S. 
Typhimurium. Bacterial RNA was extracted from the wildtype, the ΔSTM0029, the ΔpmrA/B and 
the ΔSTM0029/ΔpmrA/B double mutant strains grown in L-broth. Candidate genes whose expressions 
were only affected in the ΔSTM0029 mutant background were selected by comparison to genes, 
whose expressions were affected under the ΔpmrA/B- and ΔSTM0029/ΔpmrA/B-deleted backgrounds. 
(A) The pie chart indicates numbers of the genes selected from the microarray analysis. The portion 
with the black background represents the number of the genes specifically regulated by STM0029 
(left). The portion with the gray background represents the number of the genes co-regulated by 
STM0029 and the PmrA/B two component system (middle). The portion with the white background 
represents the number of the genes specifically regulated by the PmrA/B two component system 
(right). (B) The pie chart indicates the relative abundance of categories of the genes with reduced 
expressions affected specifically by loss of STM0029. Colours correspond to categories in the COG 
database. A detailed list of the genes are found in Table VI.  
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4.6. Role of Salmonella STM0029 in resistance to human and mouse sera 
Based on results obtained from microarray analyses and quantitative RT-PCR, the expression 
of oafA showed a reduction in expression after loss of STM0029. OafA belongs to a member 
of a family of integral membrane trans-acylases and it is involved in acetylation of 
Salmonella LPS O-antigen (Slauch et al., 1995). Acetylation is a post-translational 
modification believed to be important for host-microbes interactions (Ribet and Cossart, 
2010). For instance, Listeria monocytogenes is able to induce deacetylation of histone H4 
during early phases of infection in order to assist its pathogenesis (Hamon et al., 2007). 
Moreover, a deletion of oafA in Heamophilus influenzea has also been reported to result in a 
loss of the resistance againt host serum challenges (Fox et al., 2005).  
 Serum opsonisation via the complement binding is required for activation of the host 
innate immune response to eliminate invasive pathogens (Heffernan et al., 1992; Joiner at al., 
1982; Stemmer et al., 1985), and pathogens have evolved various mechanisms against 
complement challenges. The proper distribution of O-antigen chain length/modifications has 
been reported to be required for complement resistance in Salmonella spp (Morona et al., 
1995; Murray et al., 2003). McConnel and Wright (1979) reported that the growth 
temperature affected the size and the distribution of Salmonella anatum LPS O-antigen. 
Murray et al. (2006) have indicated that incubation of S. Typhimurium in heat-inactivated 
guinea pig serum induced the production of very-long O-antigen (VL-OAg), which conferred 
a higher level of survival against serum killing. However, little is known about the regulation 
of LPS O-antigen and its effect on serum resistance. I therefore tested the sensitivity of the 
ΔSTM0029 strain against human and mouse sera compared to the wildtype (Fig. 13, see page 
75). The wildtype and the ΔSTM0029 strains were grown to early stationary phase (OD600 
approx. 2.0) and incubated with 100% normal non-heated human/mouse sera (NNS) or 100% 
heat-inactivated human/mouse sera (HIS) at 37°C for one hour, and the relative ratio of 
survival was determined as described in Materials and Methods (see section 3.3.3., p. 49). 
The ΔSTM0029 strain showed a 60% and a 50% reduction in survival compared to the 
wildtype strain after human and mouse serum challenges, respectively.  
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Fig. 13. The ΔSTM0029 strain is susceptible to human and mouse sera. The wildtype (open bars) 
and the ?STM0029 strain (filled bars) were incubated with 100% normal non-heated human/mouse 
sera (NNS) or heat-inactivated human/mouse sera (NIS), respectively. Bacteria were grown till OD600 
approx. 2 and incubated with NNS and NIS at 37°C for 1 hour, respectively. Dilutions were plated for 
determination of intracellular colony-forming unit (cfu). The ratio of survival of NNS and NIS was 
calculated with the formula 100 × [mean (cfu ml−1 in NNS/cfu ml−1 in HIS) of mutant]/[mean (cfu 
ml−1 in NNS/cfu ml−1 in HIS) of wildtype]. Percent survival is the mean ± standard deviations (SD) of 
three independent experiments with similar results. All experiments were performed triplicate 
measurements, and error bars indicate standard deviations. **, P < 0.005.  
Chen,	  HC	   76	  
 
 
4.7. Alignments of the Salmonella putative transcriptional regulator STM0029 amino 
acid sequence and promoter region analysis  
According to results obtained from AMP killing assays and microarray analyses, I found that 
the putative transcriptional regulator STM0029 is important for Salmonella resistance against 
host bactericidal challenges through the regulation of the genes involved in LPS O-antigen 
and peptidyglycan biosynthesis and modifications. In order to determine possible homologues 
existing in other pathogenic and/or non-pathogenic bacterial strains, I therefore performed 
alignments based on the Salmonella enterica subsp. enterica serovar Typhimurium str. LT2 
STM0029 amino acid sequence provided by the NCBI database 
(http://www.ncbi.nlm.nih.gov/protein/16763419?). 100 different bacterial species which share 
similarities of the amino acid sequence to the Salmonella putative transcriptional regulator 
STM0029 were found based on the NCBI BLAST algorithm 
(http://blast.ncbi.nlm.nih.goc/Blast.cgi). Among which, a total of 15 strains with identical 
amino acid sequences all belonged to Salmonella spp. (Table IX, see page 86). However, in 
the same Family (Enterobacteriaceae) as Salmonella spp, no other Genera of bacteria were 
found to have near-identical amino acid sequence to the Salmonella STM0029 protein. This 
observation suggested that the putative transcriptional regulator STM0029 should be 
Salmonella-specific. For the low-homology homologues, the STM0029 amino acid sequence 
showed similarity to the transcriptional regulator ToxR in Erwinia pyrifoliae Ep1/96 (identity, 
35%; similarity, 46%), Erwinia tasmaniensis Et1/99 (identity, 38%; similarity, 55%), Vibrio 
cholerae HC-02A1 (identity, 34%; similarity, 5%8), Vibrio cholerae 12129(1) (identity, 34%; 
similarity, 58%) and the CadC family transcriptional regulator in Rahnella spp Y9602 
(identity, 47%; similarity, 69%), Pantoea spp aB (identity, 32%; similarity, 57%), 
Burkholderia spp Ch1-1 (identity, 34%; similarity, 56%), Enterobacter asburiae LF7a 
(identity, 33%; similarity, 54%) and Burkholderia xenovorans LB400 (identity, 33%; 
similarity, 55%). In V. cholera, ToxR is a transmembrane regulatory protein required for the 
synthesis of cholera toxin (Miller et al., 1984). Mathur and Waldor (2004) reported that ToxR 
controls the resistance to bactericidal/permeability-increasing (BPI), an antimicrobial protein, 
by regulating the production of the outer membrane protein OmpU. In Escherichia coli, 
CadC, which belongs to the ToxR-like protein family (Miller et al., 1987), is a membrane-
integrated positive transcriptional activator (Watson et al., 1992). CadC is located at an 
upstream of the cadBA operon and encodes a 58 kDa inner membrane protein (Küper and 
Jung, 2005; Watson et al., 1992). Currently, the Cad proteins are believed to be involved in 
the expression of genes associated with colonization, and production of polyamines 
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associated with protection of some pathogenic Escherichia coli against stress conditions 
(Torres, 2009). Similiarity to ToxR and CadC might emphasize the importance of the 
Salmonella-specific gene, STM0029, to Salmonella pathogenesis as well. 
 I further compared the conserved protein domain of the Salmonella STM0029 gene to 
the full list of conserved domains, which are present in the current proteins as determined by a 
Conserved Domain Database search using RPS-BLAST. This dataset includes all domain 
models that meet or exceed the RPS-BLAST threshold for statistical significance, as well as 
the conserved domain superfamilies to which they belong. The Salmonella STM0029 protein 
harbours a conserved domain, which belongs to the Helix-turn-helix_XRE Superfamily 
(HTH_XRE) (Accession: cl00088). HTH_XRE-family-like proteins are prokaryotic DNA 
binding proteins belonging to the xenobiotic response element family of transcriptional 
regulators. Proteins which are known to be involved in this family have functions in bacterial 
plasmid copy control, bacterial methylases, various bacteriophage transcription control 
proteins and a vegetative specific protein from Dictyostelium discoideum (Slime mould) 
based on the SMART (Simple Modular Architecture Research Tool) mode description 
(http://smart.emblheidelberg.de/smart/do_annotation.pl?ACC=SM00530&BLAST=DUMM). 
 Moreover, the promoter region of STM0029 was analyzed as well to predict possible 
transcriptional factor binding sites (Fig. 14, see page 79). The positive sense of the sequence 
(369 bases; the sequence with the yellow background) between the STM0029 start codon (the 
CAT codon with the red underline) and STM0030 start codon (the ATG codon with the black 
underline) was chosen for further analyses. The open source BPROM (Prediction of bacterial 
promoters) (http://linux1.softberry.com/berry.phtml?topic=bprom&group=programs&subgro 
up=gfindb) was chosen to analyze the possible -10 and -35 boxes. BPROM (Softberry) is a 
bacterial sigma70 promoter recognition program with about 80% accuracy and specificity. It 
is best used in regions immediately upstream from the open reading frame start for an 
improved gene and operon prediction in bacteria (a list of references with BPROM 
applications, see the link: http://linux1.softberry.com/publ_topic.htm#BPROM). As shown in 
Fig. 14, putative -10 and -35 boxes were predicted as TTATAAAAT (the purple codon) and 
GTGCCA (the blue codon), respectively. Furthermore, the indicated promoter region of 
STM0029 was also analyzed by the Virtual Footprint programme Version 3.0 
(http://www.prodoric.de/vfp/) (Münch, et al., 2005) to find out transcriptional factors, which 
might possibly bind on the STM0029 promoter region. 31 transcriptional factors from the 
database were shown to possibly bind on the STM0029 promoter region. Among them, 
OmpR (Kanamaru et al., 1989) and OxyR (Christman et al., 1989) were two transcriptional 
Chen,	  HC	   78	  
 
 
factors displayed the highest score compared to other transcriptional factors. OmpR is a 
response regulator involved in the OmpR/EnvZ TCS that responds to osmotic stresses (see 
introduction, p. 22). OxyR acts as a positive regulator for hydrogen peroxide-inducible genes 
in E. coli and S. Typhimurium. Taken together, this finding suggested that STM0029 might 
have high potential to play serve as a transcriptional regulator, e.g. ToxR and CadC and/or be 
regualed by other well-unknown transcriptional regulators, e.g. OmpR and OxyR. 
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Fig. 14. Analysis of the predicted STM0029 promoter region. The Virtual Footprint programme 
Version 3.0 was used to analyze the STM0029 promoter region based on the positive sense of the gene 
sequence. The sequence in the yellow background indicates the predicted STM0029 promoter region. 
Underlined (CAT, red) bases represents the start codon of the STM0029 gene; underlined (TCA, 
green) bases represents the stop codon of the STM0029 gene; underlined (ATG, black) bases 
represents the start codon of the STM0030 gene. Predicted -10 and -35 boxes were indicated in the 
purple colour and the blue colour, respectively. Red and green enclosed boxes represent binding 
domains of the transcription factors OmpR and OxyR, respectively. (+) indicates the positive sense of 
the transcriptional factor binding sequence; (-) indicates the negative sense of the transcriptional factor 
binding sequence. 
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Table IV. Genes affected by loss of STM0029 in L-broth 
(rel. expression level [?STM0029/wildtype])a 
COG Description No. of genes 
 up-regulated 
down-
regulated 
Information storage and processing   
  Translation, ribosomal structure and biogenesis 3 4 
  RNA processing and modification 3 24 
  Transcription 1 1 
  Replication, recombination and repair 3 13 
  Chromatin structure and dynamics   
Cellular processes and signaling   
  Cell cycle control, cell division, chromosome partitioning 1 8 
  Nuclear structure   
  Defense mechanisms 5 5 
  Signal transduction mechanisms 5 20 
  Cell wall/membrane/envelope biogenesis 4 85 
  Cell motility 7 26 
  Cytoskeleton  2 
  Extracellular structures 8 18 
  Intracellular trafficking, secretion, and vesicular transport 6 9 
  Posttranslational modification, protein turnover, chaperones 9 16 
  Regulation 28 76 
Metabolism   
  Energy production and conversion 4 14 
  Carbohydrate transport and metabolism 33 70 
  Amino acid transport and metabolism 27 34 
  Nucleotide transport and metabolism 4 11 
  Coenzyme transport and metabolism 3 7 
  Lipid transport and metabolism 11 14 
  Inorganic ion transport and metabolism 30 41 
  Secondary metabolites biosynthesis, transport and catabolism 13 34 
Poorly characterised   
  General function prediction only 49 54 
  Function unknown 23 25 
  Amount 280 611 
 
a Genes, whose expressions showed the log of hybridization signal ratios (rel. expression level [ 
?STM0029/wildtype]) ≥ 0.33 were selected. 
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Table V. Genes affected by loss of STM0029 in PCN medium 
(rel. expression level [?STM0029/wildtype])a 
COG Description No. of genes 
 up-regulated 
down-
regulated 
Information storage and processing   
  Translation, ribosomal structure and biogenesis  1 
  RNA processing and modification 7 11 
  Transcription   
  Replication, recombination and repair 3 4 
  Chromatin structure and dynamics  1 
Cellular processes and signaling   
  Cell cycle control, cell division, chromosome partitioning 1 3 
  Nuclear structure   
  Defense mechanisms 5 4 
  Signal transduction mechanisms 1 9 
  Cell wall/membrane/envelope biogenesis 13 48 
  Cell motility 2 11 
  Cytoskeleton  1 
  Extracellular structures  5 
  Intracellular trafficking, secretion, and vesicular transport  6 
  Posttranslational modification, protein turnover, chaperones 4 13 
  Regulation 16 20 
Metabolism   
  Energy production and conversion 3 15 
  Carbohydrate transport and metabolism 30 60 
  Amino acid transport and metabolism 8 17 
  Nucleotide transport and metabolism 1 6 
  Coenzyme transport and metabolism 3 7 
  Lipid transport and metabolism 5 9 
  Inorganic ion transport and metabolism 5 9 
  Secondary metabolites biosynthesis, transport and catabolism 10 26 
Poorly characterised   
  General function prediction only 25 47 
  Function unknown 42 52 
  Amount 184 385 
 
a Genes, whose expressions showed the log of hybridization signal ratios (rel. expression level [ 
?STM0029/wildtype]) ≥ 0.33 were selected. 
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Table VI. List of LPS O-antigen and PG-related genes regulated by STM0029 
compared to the wildtypea, b 
No. Gene Predicted functions (or Homolog) Fold Change Reference 
   L-broth PCN c  
STM1376 lppB Putative methyl-accepting chemotaxis 
protein 
-2.5 -2.0 Fadl et al., 
2005 
STM2084 rfbM Synthesis of GDP-rhamnose from 
mannose-1-phosphate 
-3.3 -0.7 Jiang et al., 
1991 
STM2088 rfbX Assembly or transfer of LPS O unit -3.3 -0.6 Reeves, 
1993 
STM2089 rfbJ Synthesis of CDP-abequose -3.0 -0.5 Reeves, 
1993 
STM2110 wcaF Biosynthesis of the extracellular 
polysaccharide colanic acid 
 0.5 -6.2 Ophir et al., 
1994 
STM2111 wcaE Glycosyltransferase 2 family enzymes 
involved in O-antigen biosynthesis 
 0.5 -2.5  
STM2232 oafA Acetylation of the O-antigen (LPS) -1.3 -1.4 Slauch et 
al., 1995  
Slauch et 
al., 1996 
STM3373 mreC Rod shape-determining protein -2.1 -1.7 Costa et al., 
1993 
STM3493 mrcA Peptidoglycan synthetase -1.0 -8.1  
STM3918 rfe Undecaprenyl-phosphate N-
acetylglucosaminyltransferase 
-0.7 -1.7 Keenleyside 
et al., 1994 
STM3919 wzzE Enterobacterial common antigen (ECA) 
polysaccharide chain length modulation 
protein 
-3.1 -3.1  
STM3920 wecB Reversible interconversion of UDP-
GlcNAc and UDP-N-acetylmannosamine 
(UDP-ManNAc) 
-1.9 -1.3 Barua et al., 
2002 
STM3924 wecD Glucose-1-phosphate 
thymidylyltransferase 
-1.7 -1.3 Hung et al., 
2006  
Ramos-
Morales et 
al., 2003  
STM3926 wzxE TDP-4-oxo-6-deoxy-D-glucose 
transaminase 
-2.5 -2.0  
STM3927  O-antigen translocase in LPS biosyntesis -3.3 -0.7  
STM3977 rfaH Transcriptional activator affecting 
biosynthesis of lipopolysaccharide core 
-3.0 -0.5 Kong et al., 
2009 
STM4050 rhaT L-rhamnose-proton symport  0.5 -6.2 Al-Zarban 
et al., 1984  
Tate et al., 
1992 
 
a Genes whose expression showed at least a two-fold difference (the median natural logarithm ≥ 0.33) 
were shown. 
b Protein encode by differentially expresssed genes were identified by annotation or homology to 
known proteins (http://www.ncbi.nlm.nih.gov/sites/entrez?db=genome) and assigned to categories 
based on description in clusters of orthologous groups of proteins (COGs). 
c  PCN medium contains 0.4 mM Pi. 
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Table VII. Genes specifically regulated by STM0029 in L-brotha 
(rel. expression level [?STM0029/wildtype])b 
COG Description No. of genes 
 up- regulated 
down-
regulated 
Information storage and processing   
  Translation, ribosomal structure and biogenesis   
  RNA processing and modification  8 
  Transcription   
  Replication, recombination and repair  4 
  Chromatin structure and dynamics   
Cellular processes and signaling   
  Cell cycle control, cell division, chromosome partitioning  1 
  Nuclear structure   
  Defense mechanisms   
  Signal transduction mechanisms  2 
  Cell wall/membrane/envelope biogenesis 3 15 
  Cell motility  2 
  Cytoskeleton   
  Extracellular structures  2 
  Intracellular trafficking, secretion, and vesicular transport  6 
  Posttranslational modification, protein turnover, chaperones 2 2 
  Regulation 3 7 
Metabolism   
  Energy production and conversion 2 3 
  Carbohydrate transport and metabolism 13 9 
  Amino acid transport and metabolism 4 6 
  Nucleotide transport and metabolism 1 2 
  Coenzyme transport and metabolism 2  
  Lipid transport and metabolism 2 4 
  Inorganic ion transport and metabolism 3 4 
  Secondary metabolites biosynthesis, transport and catabolism  4 
Poorly characterised   
  General function prediction only 3 15 
  Function unknown 11 16 
  Amount 49 112 
 
a Genes, whose expressions showed same or similiar (≥ two-fold changes) relative mRNA expression 
levels in both ?STM0029 and ?STM0029/ΔpmrA/B-double deletion conditions were chosen as 
considering as specifically STM0029-regulated genes. 
bGenes showing the log of hybridization signal ratios (rel. expression level [?STM0029/wildtype]) ≥ 
0.33 were selected.
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Table VIII. Specific STM0029-regulated genes involved in cell membrane proteinsa,b,c 
No. Gene Predicted functions (or Homolog) Fold Change Reference 
L-broth     
LPS (2)     
STM0776 galE UDP-glucose 4-epimerase -1.7  
STM2232 oafA Acetylation of the O-antigen (LPS)  -2.0 Slauch et al., 
1995  
Slauch et al., 
1996 
Outer membran protein (9)    
STM0282  Paralog of E. coli putative outer 
membrane protein  
-1.9  
STM0687 ybfM Putative outer membrane protein -1.5  
STM0816 ybhS Putative ABC superfamily 
(membrane) transport protein 
-1.4  
STM0833 ompX Outer membrane protease, receptor 
for phage OX2  
-1.7 Hu et al., 2009 
STM1254  Putative outer membrane 
lipoprotein 
-3.1  
STM1504 ynaI Putative integral membrane protein -2.2  
STM2685 smpA Small membrane protein A  -2.1 Lewis et al., 
2008 
STM4051  Putative outer membrane protein  -2.1  
STM4223 yjbF Putative outer membrane 
lipoprotein 
-4.1 Christopherso
n et al., 2008 
Periplasmic protein (6)    
STM0708 ybfA Putative periplasmic protein -2.0  
STM1123  Putative periplasmic protein -4.2  
STM1503 ynfB Putative periplasmic protein  -1.6  
STM1897 yebB Putative periplasmic protein  -1.5  
STM2148  Putative periplasmic protein -1.7  
STM2156  Hypothetical 16.9 kd lipoprotein 
precursor 
-1.8  
Inner membrane protein (6)    
STM1504 ynfA Putative inner membrane 
lipoprotein 
-1.5  
STM2779  Putative inner membrane protein -2.0  
STM3761 slsA Pathogenicity island encoded 
protein: SPI3; SlsA; putative inner 
membrane protein 
-1.8  
STM3774  Putative inner membrane protein -1.5  
STM4332 yjeJ Putative inner membrane protein -3.1  
STM4599 yjjY Putative inner membrane protein -1.5  
 
a Genes whose expression showed at least a two-fold difference (the median natural logarithm ≥ 0.33) 
were shown. 
b Genes, which showed same or similiar (≥ 2-fold changes) relative mRNA expression levels in both 
?STM0029 and ?STM0029/ΔpmrA/B-double deletion conditions were chosen as considering as 
specifically STM0029-regulated genes. 
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c Protein encode by differentially expresssed genes were identified by annotation or homology to 
known proteins (http://www.ncbi.nlm.nih.gov/sites/entrez?db=genome) and assigned to categories 
based on description in clusters of orthologous groups of proteins (COGs). 
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Table IX. List of Salmonella spp with identical 
STM0029 proteins (amino acid sequences)a 
Strains Locus_tag Accession Predicted functions Reference 
Salmonella enterica subsp. 
enterica serovar Typhimurium 
str. UK-1 
STMUK_0030 AEF05964.1 Putative 
transcriptional 
regulator 
Luo et al., 
2011 
Salmonella enterica subsp. 
enterica serovar Typhimurium 
str. ST4/74 
STM474_0031 ADX15777.1 Putative 
transcriptional 
regulator 
Richardson 
et al., 2011 
Salmonella enterica subsp. 
enterica serovar Typhimurium 
str. TN061786 
SEE_04593 EFX47474.1 Putative 
transcriptional 
regulator 
 
Salmonella enterica subsp. 
enterica serovar Typhimurium 
str. T000240 
STMDT12_C00
300 
BAJ34973.1 Putative 
transcriptional 
regulator 
Izumiya et 
al., 2010 
Salmonella enterica subsp. 
enterica serovar Typhimurium 
str. SL1344 
SL1344_0030 CBW16131.1 Putative 
transcriptional 
regulator 
 
Salmonella enterica subsp. 
enterica serovar Typhimurium 
str. 14028S 
STM14_0037 ACY86574.1 Putative 
transcriptional 
regulator 
Jarvik et al., 
2010 
Salmonella enterica subsp. 
enterica serovar Typhimurium 
str. D23580 
STMMW_0029
1 
CBG23048.1 Putative 
transcriptional 
regulator 
Kingsley et 
al., 2009 
Salmonella enterica subsp. 
enterica serovar Hadar str. 
RI_05P066 
SeH_A0245 EDZ35345.1 Conserved 
hypothetical 
protein 
 
Salmonella enterica subsp. 
enterica serovar 4,[5],12:i:- str. 
CVM23701 
SeI_A4349 EDZ18076.1 Conserved 
hypothetical 
protein 
 
Salmonella enterica subsp. 
enterica serovar Saintpaul str. 
SARA23 
ZP_03163308.1 ZP_03163308.
1?
Conserved 
hypothetical 
protein 
 
Salmonella enterica subsp. 
enterica serovar Saintpaul str. 
SARA23 
SeSPA_A0534 EDY24109.1 Conserved 
hypothetical 
protein 
 
Salmonella enterica subsp. 
enterica serovar Hadar str. 
RI_05P066 
SeH_A0245 ZP_02684280.
1 
Conserved 
hypothetical 
protein 
 
Salmonella enterica subsp. 
enterica serovar 4,[5],12:i:- str. 
CVM23701 
SeI_A4349 ZP_02570982.
1 
Conserved 
hypothetical 
protein 
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Salmonella enterica subsp. 
enterica serovar Typhimurium 
str. LT2 
STM0029 NP_459034.1 Putative 
transcriptional 
regulator 
McClelland 
et al., 2001 
Salmonella enterica subsp. 
enterica serovar Typhimurium 
str. LT2 
STM0029 AAL18993.1 Putative 
transcriptional 
regulator 
 
 
a List of Salmonella spp, which have the identical STM0029 protein (identical sequence) was released 
based on the NCBI BLAST algorithm. 
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5. DISCUSSION 
 
5.1. A putative Salmonella transcriptional regulator, STM0029, contributes to 
Salmonella intracellular survival through resistance against antimicrobial peptide 
killing 
S. Typhimurium is one of the leading causes of human acute food-borne diseases worldwide. 
The key virulence factors that enable Salmonella to elicit pathogenesis are its ability to not 
only infect epithelial cells, but also survive within macrophages, which possess innate 
immune defense mechanisms against bacterial pathogens. To successfully proliferate within 
macrophages, Salmonella requires numerous virulence factors encoded within Salmonella 
Pathogenicity Islands (SPIs) and two component system regulators (TCSs) for expression and 
coordination of multiple genes involved in resistance against host cell defense mechanisms 
and acquisition of nutrients within the intracellular niche. In addition to currently known 
genes, new virulence determinants are being continuously reported from studies of host-
microbes interactions in different animal models. In the present work, I have identified and 
characterised a putative transcriptional regulator STM0029 in S. Typhimurium SL1344 that 
contributes to Salmonella intracellular survival by affecting resistance to host antimicrobial 
peptide (AMP) killing. 
 Based on a previous study in our laboratory, we found that the expression of the 
Salmonella putative transcriptional regulator STM0029 is strongly reduced in a ppGpp-
deficient strain of Salmonella (ΔrelAΔspoT) (Thompson et al., 2006). A ppGpp-deficient 
strain is unable to invade host epithelial cells or survive within macrophages. Because ppGpp 
affects only the distribution of free RNA polymerase between ribosomal RNA (rRNA) and 
messenger RNA (mRNA) promoters, promoters responsive to particular growth or 
environmental conditions remain inactive in response to changes in growth conditions. We 
have used this characteristic of ppGpp-deficient strains to identify genes, which show loss or 
reduced expression (relative to the wildtype strain) under conditions favoring virulence gene 
expression in Salmonella Typhimurium (Thompson et al., 2006). The previously 
uncharacterised open reading frame STM0029 was identified in this manner, and we 
hypothesized that the biological function(s) of STM0029 might be involved in either 
Salmonella invasion and/or intracellular survival.  
 Because of lack of reproducibility of host cell invasion assay results in 2008 – 2010 and 
2011 (Table III), I also repeated antimicrobial peptide (AMP) killing assays to determine 
whether the phenotypes obtained for the ΔSTM0029 and ΔpmrA/B strains remained present 
regarding bactericidal peptide challenges in order to confirm the original observations. 
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Phenotypes (killing patterns) obtained from both strains remained consistent with prior results 
(shown in Fig. 6 and Fig. 7 for LL-37 and polymyxin B challenges), demonstrating that the 
experimental strains and their phenotypes against AMP challenges were correct. At present, I 
speculate that the different phenotypes regarding cell invasion assays might be due to serum 
effects, which have altered the cell physiology of the cell lines. Since both the ΔSTM0029 
and the ΔoafA strains exhibited sensitivity against human and mouse sera challenges, it 
should be interesting to take a detailed look at serum effects on both pathogens and host cells 
in the future. 
 Bactericidal compounds, e.g. AMPs, nitric oxide and oxygen radicals have been 
reported to play crucial roles in human innate host defense for killing of a wide variety of 
bacterial pathogens. Most of these antimicrobial peptides are cationic in nature, and interact 
with the bacterial cytoplasmic membrane, composed of negatively charged phospholipids 
(Eswarappa et al., 2008). Increasing numbers of studies have demonstrated numerous novel 
genes involved in Salmonella defense against host AMP killing mechanisms. Detweiler et al. 
(2003) reported that VirK, SomA and RcsC are important for S. Typhimurium systemic 
infection and resistance to cationic peptides. The yejABEF operon in Salmonella has also been 
reported to be involved in resistance to AMP killing and contribution to virulence, although 
the mechanism is still unknown (Eswarappa et al., 2008). Defensins and cathelicidins (a 
human cathelicidin is known as LL-37) are mainly expressed and stored in mast cells and 
macrophages (Nijnik et al., 2009; Ouellette et al., 2001). The AMP killing assay in this study 
revealed that the ?STM0029 strain exhibited higher sensitivity to killing by human ?-
defensin-1, ?-defensin-1, ?-defensin-2 (Fig. 5) and LL-37 (Fig. 6) compared to the 
wildtype. In addition to STM0029 investigated in this study, PgtE, which encodes outer 
membrane protease in S. Typhimurium has also been reported to contribute to resistance 
against LL-37 and cathelicidin-related antimicrobial peptide (CRAMP) (mouse) challenges 
(Guina et al., 2000). LL-37 is of particular interest because it has a broad antimicrobial 
spectrum and displayed high activities [minimum inhibitory concentration (MIC) /10 µg/ml] 
against both Gram-positive and Gram-negative bacteria, e.g. Pseudomonas aeruginosa, E. 
coli, Listeria monocytogenes, Staphylococcus epidermidis, and Staphylococcus aureus 
(Turner et al., 1998). Rosenberger et al. (2004) reported that the murine cationic AMP 
cathelicidin-related CRAMP impairs Salmonella intracellular replication as well. Moreover, 
LL-37 exhibits different chemo-physical characteristics compared to those of native ?-
helical antimicrobial peptides isolated from invertebrates or vertebrates (Oren et al., 1999). 
Most important and unique characteristics of LL-37 are: (I) LL-37 exists in the form of 
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oligomers in solution; (II) LL-37 is well protected from proteolytic degradation; and (III) LL-
37 recognizes both zwitterionic and negatively charged phospholipid vesicles as its targets.   
 I also determined the sensitivity of the ?STM0029 strain against one Gram-positive 
bacterium Bacillus polymyxa-produced antimicrobial peptide, polymyxin B (Fig. 7), since 
polymyxin has been reported to be mainly controlled by the Salmonella PmrA/B TCS 
(Mäkelä et al., 1978; Roland et al., 1993). In recent years, polymyxin B has re-emerged in 
medical practice for therapies (Evans et al., 2009; Falagas and Kasiakou, 2005) and its 
application will likely continue to increase, since few new drugs for the treatment of 
infections caused by multidrug-resistant (MDR) Gram-negative bacteria remain (Zavascki et 
al., 2007). In outbreaks caused by Salmonella spp, MDR strains have been reported for both 
S. Typhi (reviewed by Rowe et al., 1997) and S. Typhimurium (reviewed by Alcaine et al., 
2007). However, although polymyxin B is one of the older classes of cationic peptide 
antibiotics, a substantial gap still exists in the knowledge of polymyxin B in pharmacology 
and its application (Mogi and Kita, 2009). To date, there are still no well-designed clinical 
trials to evaluate the efficacy of polymyxin B against infections caused by MDR Gram-
negative bacteria (Zavascki et al., 2007). Based on the discussion from the reference reported 
by Zavascki et al. (2007), only three studies investigating the use of polymyxin B for 
treatment of MDR Gram-negative bacilli, mostly Acinetobacter spp and Pseudomonas 
aeruginosa are found (Holloway et al., 2006; Ouderkirk et al., 2003; Sobieszczyk et al., 
2004). Regarding the mechanism of resistance by Salmonella against polymyxin B, the 
PmrA/B TCS (Winfield and Groisman, 2004) and the gene mig-14 (Brodsky et al., 2002) 
have been reported to be involved. Based on the findings in this study, I found that loss of 
STM0029 led to reduced resistance of Salmonella against AMP challenges, including 
polymyxin B, LL-37 and defensins, which suggests that STM0029 is also critical for 
Salmonella resistance aginst not only natural AMPs in host cells, but also antibiotics in 
clinical treatment. 
  
5.2. Expression of STM0029 is repressed by the PmrA/B two component system, and is 
PhoP/Q-independent 
Similar to other bacterial pathogens, Salmonella requires numerous two component system 
(TCS) regulators for expression and coordination of multiple genes involved in virulence and 
pathogenesis. Currently, at least 38 TCSs have been found in S. Typhimurium, two of which, 
the PhoP/Q TCS and the PmrA/B TCS, have been well-studied and reported to be involved in 
Salmonella intracellular survival (Groisman and Saler, 1990; reviewed by Gunn, 2008; Miller 
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and Mekalanos, 1990; Miller, 1991). The Salmonella PhoP/Q TCS has been demonstrated to 
regulate hundreds of genes encoding the majority of virulence properties including 
intracellular survival, invasion, lipid A structure, resistance to AMPs, and phagosome 
alteration (Prost and Miller, 2008). Cheng et al. (2009) reported that the PhoP/Q TCS is also 
important for Klebsiella pathogenesis in addition to Salmonella. To date, more than 200 
PhoP/Q-dependent genes are considered to be involved in different aspects of virulences by 
microarray analyses and motifs sceening (Monsieurs et al., 2005). The expression of 
STM0029 during the in vitro culture was not affected by loss of the PhoP response regulator 
in either L-broth or M9 minimal medium (Fig. 8A-F); however, the expression of STM0029 
was sharply increased in a PmrA/B-deletion background (Fig. 8G-I). In addition, the 
expression levels of PhoP/Q-dependent genes including pagP (Ahn et al., 2004; Guo et al., 
1998), pagD (Belden and Miller, 1994; Gunn et al., 1995), pagC (Miller, 1989; Pulkkinen and 
Miller, 1991) and pcgL (Hilbert et al., 1999) were not affected in the ΔSTM0029 strain 
compared to the wildtype, ?phoP and ΔpmrA/B strains although the expression level of 
pagD appeared to be quite low compared to other genes (Fig. 9). These results indicate that 
STM0029 is not associated with the regulation of the expression of at least these four 
important PhoP-dependent genes within the PhoP/Q regulon. STM0029 is more likely present 
in a separate regulatory system. Moreover, results obtained from the β-galactosidase assays 
indicated that the PmrA/B TCS repressed the expression of STM0029; however, whether 
STM0029 directly or indirectly interacts with the PmrA/B TCS awaits further investigation. 
 At present, many Salmonella virulence factors involved in Salmonella intracellular 
survival and resistance to AMP challenges have been reported to be regulated by the PhoP/Q 
and the PmrA/B regulon (Groisman and Saler, 1990; Miller et al., 1989; Pulkkinen and 
Miller, 1991). In addition to these two well-studied two component systems, other Salmonella 
virulence factors, including Salmonella Pathogenicity Island-2 (SPI2) and Salmonella 
plasmid-encoded virulence factors, e.g. SpvB, SpvC and Rck have been reported to control 
critical regulatory systems involved in Salmonella pathogenesis as well (Hensel. et al., 2004; 
Matsui et al., 2001). However, the regulatory system(s) in which STM0029 is involved 
requires further investigation. 
 
5.3. STM0029 is involved in the regulation of the genes involved in LPS O-antigen 
biosynthesis and modifications 
In order to identify genes whose expressions might be affected/regulated by the putative 
transcriptional regulator encoded by STM0029, I performed microarray analyses and 
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compared whole genome expression profile obtained from the wildtype and the ΔSTM0029 
strains, respectively. In addition to L-broth, which is generally used for generation of highly 
invasive Salmonella cultures, I also grew bacteria in PCN defined medium with limiting 
phosphate (0.4 mM Pi) to mimic the Salmonella intracellular milieu for total RNA 
preparations. PCN defined medium has previously been shown to result in activation of genes 
involved in intracellular growth and/or survival (Gerlach et al., 2007). I selected 20 PhoP/Q-
regulated genes and 50 PmrA/B-regulated genes based on references from Groisman, E.A. 
(2001) and Marchal et al. (2004), respectively (Fig. 10; Supplementary Table II, see page 
137-141) and compared mRNA expression levels between the ΔSTM0029 strain and the 
wildtype. In L-broth, mRNA expressions obtained from phoQ (STM1230), pmrF (STM2298), 
pgtE (STM2396), prgJ (STM2872) and mgtC (STM3764) showed slight increases. In 
contrast, expression from ugtL (STM1601) showed a slight decrese and expressions of the 
prgI (STM2873) and pmrB (STM4291) genes released 1.3- and 2-fold decreases, 
respectively. In PCN medium, the expression level of pagA (STM2080) showed a slight 
decrease and expression of prgK (STM2871), prgJ and prgI showed increases (Fig. 10). The 
pagA (ugd) gene, which encodes UDP-glucose-6-dehydrogenase is involved in the LPS lipid 
A modification (Morona et al., 1995). According to the observation in this study, expression 
of pagA was affected by loss of STM0029 in PCN defined medium; however, LPS patterns 
(bacterial LPS profile) obtained from bacteria grown in PCN medium showed no difference 
(data not shown). Moreover, although expression of stfA (STM0195, major fimbrial subunit) 
was affect by loss of STM0029, no significant difference of motility between the wildtype 
and the ΔSTM0029 strain was found either (Motility assays; data not shown). Diverse gene 
expression patterns might be due to different media compositions between L-broth and PCN 
medium. Compositions of L-broth are more complicated than PCN defined medium. 
Therefore, the greater numbers of genes were found by loss of STM0029 in L-broth compared 
to those were found in PCN medium might be due to other signals in L-broth. Expression of 
hilA, which is one major regulator of Salmonella SPI1 genes was not affected by loss of 
STM0029 in either media. This phenomenon is consistent with the observation that STM0029 
is not involved in the process of Salmonella invasion (data not shown). 
 Gunn et al. (2008) reported that the contribution of the PmrA/B TCS to the resistance to 
polymyxin B challenge is through the regulation of genes involved in LPS lipid A 
modifications. Interestingly, genes affected by loss of STM0029 in this study were mainly 
involved in LPS O-antigen biosynthesis and modifications (Fig. 10; Table VI). This 
phenomenon could explain the observation that the ΔSTM0029 strain showed higher 
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sensitivity against various AMP challenges. Expression of the wcaF gene (STM2110), whose 
gene product functions in extracellular polysaccharide colonic acid synthesis showed a 
reduction by loss of STM0029 in PCN medium. Colonic acid has been reported to be 
important for E. coli to survive outside host cells and perhaps has a role involved in the 
resistance to desiccation (Ophir et al., 1994). The predicted function of WcaE, which encodes 
glycosyl transferase is involved in O-antigen biosynthesis. In addition, Mao et al. (2001) 
reported that WcaE also contributes to acid and heat tolerance in enterohemorrhagic 
Escherichia coli (EHEC) O157:H7.  
 Slauch et al. (1995) reported that acetylation of O-antigen by OafA affects the three-
dimensional structure of LPS and thus is involved in alterations in antigenic determinants. 
The function of OafA has been characterized. It belongs to a member of a family of integral 
membrane trans-acylases (Slauch et al., 1996) and determines the Salmonella O5-antigen 
(Slauch et al., 1995; Hauser et al., 2011). However, what genes and/or what regulatory 
systems in Salmonella control the function of OafA are still not clear. In this study, I showed 
that expression of oafA is specifically regulated by STM0029, since expression of oafA 
showed a decrease by loss of STM0029 instead of by loss of the PmrA/B TCS (Fig. 12). 
Moreover, the ?STM0029 strain displayed a similar phenotype against sera challenges as 
previously reported for an oafA deletion mutant in Heamophilus influenzae (Fig. 13; Fox et 
al., 2005), which suggests that STM0029 may be involved in the regulation of genes involved 
in post-translational modifications of Salmonella LPS required for resistance to host defense 
mechanisms. However, I was not yet able to detect a direct binding between the oafA 
promoter region and the purified STM0029 protein in electrophoretic mobility shift assays 
(EMSA; data not shown), indicating that other factors may be involved in regulation together 
with STM0029 and OafA. 
 Rfe has been reported to be required for the O:54 polysaccharide synthesis in 
Salmonella enterica serovar Borreze (rfbO:54) (Keenleyside et al., 1994). The rfe gene product 
functions to transfer UDP-GlcNAc-undecaprenyl Phosphate N-acetylglucosaminyl 1-
phosphate (GlcpNAc-1-P) to the carrier lipid in order to form the first lipid intermediated 
(lipid I) (Schnaitman and Klena, 1993). Lipid I, so called GluNAc-
pyrophosphorylundecaprenol, is the product involved in the initial step to synthesize LPS O-
antigen repeat units. Once lipid I is completed, lipid II and lipid III are allowed to attach on 
LPS O-antigen. The wec genes, including wecB (STM3920) and wecC (STM3921) are also 
identified from our microarray analysis. Functions of WecB and WecC are required for the 
synthesis of lipid III (Schnaitman and Klena, 1993). Additionally, Ramos-Morales et al. 
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(2003) reported that a mutation of wecD in Salmonella causes higher sensitivity against 
deoxycholate (DOC). 
RfaH, which encodes a transcriptional antiterminator is involved in the biosynthesis of 
S. Typhimurium LPS O-antigen and LPS core region (Kong et al., 2009). In the absence of 
RfaH, Salmonella is unable to synthesize LPS O-antigen and LPS core region sugars. 
Quantitative RT-PCR results also confirmed that expression level of rfaH, which was reduced 
by loss of STM0029 (Fig. 11). A recent study has reported that RfaH also regulates the wzy 
gene, which is involved in LPS O-antigen repeat unit polymerization (Bravo et al., 2008). 
Wzx, Wxy and Wzz are responsible for LPS O-antigen assembly and export (Samuel and 
Reeves, 2003). WzzE, which encodes the enterobacterial commen antigen (ECA) 
polysaccharide chain length modulation protein, has also been released in my microarray 
analysis. Batchelor et al. (1991) first reported the function of Wzz involved in the 
determination of the legth of LPS O-antigen chain. Later, the wzz gene has been named wzzST 
(also called cld or rol) in order to distinguish it from another wzz gene homologue, wzzfepE, 
which shares homology with Escherichia coli fepE (Murray et al., 2003). wzzST and wzzfepE 
are two major genes in Salmonella involved in the determination of the the length of LPS O-
antigen. The production of the LPS O-antigen modal banding pattern mediated by WzzST is 
around 16-35 subunits (are called Long O-antigen; L-O-antigen) (Morona et al., 1995); in 
contrast, WzzfepE is responsible for the very long modal banding pattern, which contains over 
100 subunits (are called Very-long O-antigen; VL-O-antigen) (Murray et al., 2003). A recent 
study has demonstrated that the production of O-antigen by S. Typhimurium SL1344 strain 
and S. Typhi are under the control of the bacterial growth phase: increased amounts of L-O-
antigen, which are produced by Salmonella grown to the stationary phase confer a higher 
ability to resist human serum (Bravo et al., 2008). Moreover, Shigella flexneri 2a has also 
been demonstrated to show a differential, growth-phase regulation of O-antigen production 
(Carter et al., 2007). 
Complement is one of the major bactericidal innate immune defense mechanisms in 
host cells (Dunkelberger and Song, 2010). Salmonella has been reported to be able to resist 
host complement in previous studies (Heffernan et al., 1992; Hölzer et al., 2009; Murray et 
al., 2006). To date, the mechanisms utilised by Salmonella for the resistance to host 
complement killing include shedding of C5b-9 from the cell surface (Joiner et al., 1982), 
inhibition of classical pathway activation via C1q/C1s binding molecules (Stemmer and Loos, 
1985) and prevention of C9 polymerisation (Heffernan et al., 1992). Clay et al. (2008) 
reported that Francisella tularensis LPS O-antigen is also involved in evasion of 
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complement-mediated lysis. In this work, I found that the ?STM0029 strain showed higher 
sensitivities against human and mouse sera challenges (Fig. 13), which suggests that 
STM20029 should be required for Salmonella defense host innate immune system. However, 
the mechanism in which STM0029 involved to interfere with the function of the host 
complement system still needs to be investigated.  
A number of genes involved in peptidoglycan (PG) biosynthesis were found to be 
affected in the ΔSTM0029 mutant in this study as well, including lppB (STM1376) (Sha et al. 
2004) and mrcA (STM3493) (Meberg et al., 2001). Braun (murein) lipoprotein (Lpp) is also 
one of the major components used to establish the outer membrane of Gram-negative enteric 
bacteria in addition to LPS. Lpp functions as a potent stimulator of inflammatory and immune 
responses. Functions of LppB, which is a functional copy of Lpp, has been demonstrated by 
Sha et al. (2004). LppB causes not only an increase of the expression level of TNF-? and 
IL-6, but also greater tissue damage in the liver and the spleen (Fadl et al., 2005). The mrcA 
(STM3493) gene product, which has a predicted function of bifunctional murein 
transglycosylase/murein transpeptidase, is involved in the synthesis of cross-linked 
peptidoglycan from the lipid intermediates during the cell wall formation. 
 
5.4. Current model and perspectives  
Based on the results observed in this study, I propose a model in which STM0029 acts as a 
regulator involved in the expression of genes required for Salmonella intracellular survival 
within host cells (Fig. 15; see page 96). Although the signal(s) involved in the expression of 
STM0029 remain unknown, I believe that the signal(s) could be involved in many aspects of 
changes in environmental conditions (intracellular niches), e.g. acid, concentration of 
intracellular ions and/or host bactericidal compounds. As shown in Fig. 15B, once the activity 
of STM0029 is triggered, the expression of gene products involved in LPS O-antigen 
biosynthesis and modifications are further directly and/or indirectly activated by STM0029, 
contributing to Salmonella resistance against host antimicrobial peptides challenges and to 
survival within the unfavourable intracellular niche. 
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Fig. 15. Current model for the possible role of STM0029 in regulation of genes involved in LPS 
O-antigen biosynthesis and modifications. (A) Before the uptake by host cells, expression of 
STM0029 is repressed by the pmrA/B two component system. (B) Once Salmonella infects host cells, 
expression of STM0029 is activated. Therefore, the STM0029 gene product is able to control 
expressions of downstream genes involved in LPS O-Antigen biosynthesis and modifications. Red 
blunted lines represent the repression of target genes and green lines with arrows represent the 
activation of target gene.
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 In the present investigation I have shown that expression of STM0029 is repressed by 
the PmrA/B TCS; in the absence of the PmrA/B TCS, expression of STM0029 is strongly 
activated. However, it is remains unclear whether STM0029 is a part of the PmrA/B regulon 
or it acts as a connector and/or coactivator, which functions in crosstalk with different 
regulatory networks. Based on my microarray analyses (Fig. 12), 730 genes are co-regulated 
by STM0029 and the PmrA/B regulon (15.86 % of total genes), implying that STM0029 
should be somehow strongly associated with the PmrA/B regulatory system. Furthermore, 
oafA was identified in this study as a specific STM0029-regulated gene. Fox et al. (2005) 
reported that OafA-encoded acetylation is essential for Haemophilus influenzae resistance to 
human serum killing; however, the regulatory system(s) and regulators involved in control of 
this mechanism in H. influenzae are also unknown. In this study, I have shown that STM0029 
contributes to both aspects of the LPS modifications and the resistance to host sera, which 
suggests that STM0029 may function to link both aspects. 
 To test this hypothesis, a plasmid-encoded oafA will be introduced into the 
ΔSTM0029 strain and investigate whether this experimental strain is capable to compensate 
for a defect against AMP challenges. Moreover, a plasmid-encoded STM0029 will be 
transducted into strains harboring transcriptional lacZ fusions with STM0029 to elucidate 
whether STM0029 serves as an autoregulator. Additionally, in vitro and/or in vivo signals 
involved in activation of expression of STM0029 should be further investigated.  
 In this study, the function of STM0029 has been shown to contribute to Salmonella 
resistance against AMP challenges. Antimicrobial peptides are one of the major mechanisms 
to eliminate invasive pathogens within host cells, which implys that alterations of 
environmental conditions and/or Salmonella intracellular niche (Salmonella-containing 
vacuole; SCV) are possible signal sources, which are able to stimulate expression of 
STM0029, e.g. acidification of Salmonella-containing vacuole, the alteration of intracellular 
ionic concentrations and encountering host antimicrobial peptides and host complement. 
 In addition to genes involved in LPS O-antigen biosynthesis and modifications, the 
roles of other possible STM0029-regulated genes which are not involved in Salmonella 
virulence and the LPS/bacterial cell wall biosynthesis are of interest. Based on the results 
shown in Fig. 12, expression of numerous genes involved in the category of “carbohydrate 
transport and metabolism” (8.0%; light blue), “post-translational modification, protein 
turnover and chaperones” (7.1%; brown) and “intracellular trafficking, secretion and vesicular 
transport” (6.3%; light purple) are affected by loss of STM0029 as well. In the future, 
Chromatin Immunoprecipitation-on-Chip (ChIP-on-chip) methods and deep sequencing might 
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be carried out to aid to identify possible candidate genes, which directly interact with 
STM0029 in order to provide us a more comprehensive picture of the STM0029-regulated 
network. 
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7. SUPPLEMENT 
Supplement I. Laboratory equipments and materials  
Laboratory equipments   
Agarose gel electrophoresis tank B1A and GE-B2, AGS, Heidelberg 
Agilent 2100 Bioanalyzer Agilent Technologies, UK 
Aspirator Vacuboy, neolab, heidelberg 
Autoclave GTA16, Gössner, Hamburg 
Axon GenePix 4000AScanner Axon Instruments, USA 
Centrifuges Rotina 46R, Hettich Zentrifugen, Tuttlingen 
  3K30, Sigma Laborzentrifugen, Osterode 
  5415D, eppendorf Zentrifugen, Engelsdorf 
  Avanti J-25, Beckmann Coulter, Krefeld 
Contrast microscope Telaval 31, Zeiss, Jena 
Nanodrop peqLab, Erlangen 
Electronic balance BL3100, Sartorius, Göttingen 
Electronic precision weighing instrument BP210S, Sartorius, Göttingen 
Electroporator  EasyjecT Prima, peqLab, Erlangen 
Electrophoresis power supply PS 250, Hybaid, Lexington, USA 
Freezer -20  Liebherr comfort GS1313, Ochsenhausen 
Freezer -70 Advantage, Nunc, Wiesbaden 
Heating block Thermomixer compact, Eppendorf, Hamburg 
Hybridisation chambers Anachem, UK 
Image-Dokumentation instrument UV-Transilluminator UVT 28 MP, Camera 
  E.A.S.Y. 429 K, Documentationssystem RM6, 
Herolab,  
Wiesloch 
Image-Dokumentation photo printer Incubators P93E, Mitsubishi Electric, Ratigen 
  CB150, Binder, Tuttlingen 
  VT 5042 EK/N2, Heraeus, Hanau 
LABMATE Precision pipettes ABIMED GmbH, Langenfeld 
Magnetic stirrer IKWAG RET, Th. Karow, Berlin 
pH-Meter Mikroprozessor pH-Meter 740, Knick, Berlin 
Pipetting aid Pipetus-akku, Hirschmann, Eberstadt 
Refrigerator Privileg 4873, Quelle, Fürth 
Scanner  DUOSCAN T1200, AGFA, Köln 
SDS-PAGE-apparatus Biorad, USA 
Shaking incubator GFL3031, GFL, Burgwedel 
Spectrophotometer Ultrospec 3000 pro, Amerscham, Freiburg 
Sterile work bench LaminAir HB 2448 and LB-48-C, Heraeus, Hanau 
Stratalinker Stratagene, UK 
Thermocycler T3 Thermocycler, Biometra, Göttingen 
Vaccum pump N735 AN18, KNF Neuberger, Freiburg 
Vortexer MS2 Minishaker, IKA, Staufen 
Waterbath Grant OLS 200, CLF Laborgeräte, Burgwedel 
  E-5, Julabo, Seelbach 
    
Consumables   
Amicon ultra centrifugal filters Millipore, Germany 
Cell culture flasks Corning, Schiphol-Rijk, Netherland 
Cell scraper Corning, Schiphol-Rijk, Netherland 
Nunc Cryotubes Laborversand, Würzburg 
Disposable cuvettes MBT, Giessen 
Disposable pipettes Costar, Bodenheim 
Electroporation cuvettes 2 mm, peqLab, Erlangen 
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Filter paper Whatmanpaper 3MM, Schleicher and Schüll, 
Dassel 
Pasteur pipettes Roth, Karlsruhe 
Petriplates Sarstedt, Nürnbrecht 
Sterile filters Rotilabo-Spritzzenfilter 0.45 µM and 0.22 µµ pore 
size, 
  Roth, Karlsruhe 
12-well cell culture plates CellBIND, Corning, Schiphol-Rijk, Netherland 
    
Reagents   
Acetic acid Roth, Karlsruhe 
Acrylamide-Bisacrylamide-Solution, 
Rotiphorese Gel 30 
Roth, Karlsruhe 
Agar Roth, Karlsruhe 
Agarose Roth, Karlsruhe 
Alizarin yellow Sigma-Aldrich, München 
Ammoniumpersulfate (APS) Sigma-Aldrich, München 
Anhydrous 1,2-dichloroethane (DCE) Sigma-Aldrich, UK 
Anhydrous succinic anhydride Sigma-Aldrich, UK 
Antibiotics Sigma-Aldrich, München 
L-Arabinose Roth, Karlsruhe 
Boric acid Roth, Karlsruhe 
Bovine serum albumin (BSA) Sigma-Aldrich, München 
Bromophenol blue Serva, Heidelberg 
5-Bromo-4-chloro-3-indolyl-D-galactoside (X-
Gal) 
Sigma-Aldrich, München 
Calcium chloride Roth, Karlsruhe 
Chloroform Merck, Darmstadt 
Coomassie brilliant blue R250 Serva, Heidelberg 
Cy3 GE Healthcare Lifesciences, UK 
Cy5 GE Healthcare Lifesciences, UK 
Diethylpyrocarbonate (DEPC) Sigma-Aldrich, München 
Dimethylsulfoxide (DMSO) Roth, Karlsruhe 
Dithiothreitol (DTT) Sigma-Aldrich, München 
DMEM/Ham‘s F-12 salts medium Biochrom, Berlin 
dNTPs Roth, Karlsruhe 
Ethanol pure Merck, Darmstadt 
Ethylenedinitrotetraacetic acid (EDTA) Roth, Karlsruhe 
Ethylene-glycol-bis-tetraacetic acid (EGTA) Roth, Karlsruhe 
Fetal calf serum PAN Biotech, Germany 
Gentamycin Biochrom, Berlin 
Glucose Sigma-Aldrich, München 
Glycerin Roth, Karlsruhe 
Isopropyl-ß-D-thiogalactopyranoside (IPTG) Roth, Karlsruhe 
Magnesium chloride  Roth, Karlsruhe 
Magnesium sulphate Roth, Karlsruhe 
Methanol Roth, Karlsruhe 
n-Methylimidazole Sigma-Aldrich, UK 
o-Nitrophenyl-ß-D-galactopyranoside (ONPG) Sigma-Aldrich, München 
PBS Biochrom, Berlin 
Phenol Roth, Karlsruhe 
Phenylmethylsulfonylfluoride (PMSF) Roth, Karlsruhe 
Potassium chloride Roth, Karlsruhe 
Random hexamers Invitrogen, UK 
Sodium carbonate Merck, Darmstadt 
Sodium chloride Roth, Karlsruhe 
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Sodium citrate Sigma-Aldrich, München 
Sodium dihydrogen phosphate Roth, Karlsruhe 
di-Sodium hydrogen phosphate Roth, Karlsruhe 
Sodiumdodecyl sulfate (SDS) Roth, Karlsruhe 
TEMED Biorad, USA 
Tris Base Sigma-Aldrich, München 
Triton X-100 Sigma-Aldrich, München 
Trypsin-EDTA Biochrom, Berlin 
Tryptone Roth, Karlsruhe 
Ultra-pure water Sigma-Aldrich, UK 
Wasserblau / Anilin blue Fluka-Riedel-de Haen, Seelze 
Xylene cyanol Fluka-Riedel-de Haen, Seelze 
Yeast extract Roth, Karlsruhe 
    
Commercial Kits   
Abgene Extensor Hi-Fidelity PCR master mix Thermo Scientific, UK 
BCA Protein Assay Kit Pierce, USA 
BioPrime DNA labeling system Invitrogen, UK 
100 bp-DNA Ladder Roth, Karlsruhe 
Lambda HindIII marker Roth, Karlsruhe 
Protein molecular weight marker Vll-L Sigma-Aldrich, München 
Protein Ni-TED column Machery-Nagel, Düren 
QIAGEN Plasmid Midi Kit Qiagen, Hilden 
QIAGEN Genomic DNA preparation kit Qiagen, Hilden 
Qia-quick PCR purification kit Qiagen, UK 
    
Enzymes   
Affinity Script multi-temperature Reverse 
Transcriptase 
Stratagene, UK 
Bio Therm Taq-Polymerase Rapidozym, Berlin 
DNA-Restriction enzymes Promega, Mannheim 
Lysozyme Roth, Karlsruhe 
RNase free DNase Promega, UK 
T4 DNA-Ligase Promega, Mannheim 
    
Solutions, Media and Buffers   
Agarose gel electrophoresis buffers   
6 x Agarose-Loading buffer 40% Sucrose 
  0.25% Bromphenolblue 
  0.25% Xylene cyanol 
    
Ethidiumbromide solution 1% in sterile H2O 
    
10X TBE-buffer  890 mM Tris-base 
  890 mM Boric acid 
  20 mM EDTA 
    
Bacterial culture medium   
IPTG stock solution 0.1 M IPTG in dest. H2O 
    
L-broth 0.5% NaCl 
  1% Trypton 
  0.5% Yeast extract in H2O, autoclaved 
    
1X M9 minimal medium 50.0 ml 10X M9 salts 
  5.0 ml 20 % Glucose 
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  0.5 ml 1 M MgSO4 
  0.5 ml 10 mg/ml Ca2+-Pantothenate 
  0.5 ml 10 mg/ml Thiamine 
  0.5 M CaCl2 
  in 445ml of H2O, autoclaved 
    
PCN defined medium 100 ml 10 X MOPS Mixture 
  10 ml 0.132 M K2HPO4 
  in 580 ml sterile H2O, filter  
    
LB agar L-broth 
  1.5% Agar, autoclaved 
    
Top Agar L-broth 
  0.7% Agar, autoclaved 
    
X-Gal 25 mg/ml in Dimethylformamide in cultures: 50 
µg/ml 
    
Green plates 0.8% Tryptone 
  0.1% Yeast extract 
  0.5% NaCl 
  1.5% Agar, autoclaved 
  16.8 ml of 40% Glucose in 1000 ml 
  0.0625% Alizarin yellow 
  0.0067% Water bleu 
    
Antibiotics   
Carbenicillin 10 mg/ml in H2O 
  In cultures: 100 µg/ml 
    
Chloramphenicol 10 mg/ml in H2O 
  In cultures: 20 µg/ml 
    
Kanamycin 10 mg/ml in H2O 
  In cultures: 50 µg/ml 
    
Tetracyclin 10 mg/ml in 70 % Ethanol 
  In cultures: 20 µg/ml 
    
Beta-Galactosidase assay   
2X Z buffer 0.12 M Na2HPO4·7H2O 
  0.08 M NaH2PO4·H2O 
  0.02 M KCl 
  0.002 M MgSO4·7H2O 
  in 1000 ml ddH2O, filter sterilzed 
ß-mercaptoethanol is added immediately before 
the assay with a concentration of 0.1 M (stock: 
14.3 - 14.4 M) 
  
    
RNA preparation   
Stop solution  95% absolute ethanol 
  5% phenol 
    
Resuspension buffer 25 mM Tris (pH 7.0 -7.2) 
  1 mM EDTA 
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  in DEPC-treated water 
    
Lysis solution 0.6 M NaOAc (pH ≈ 5.0) 
  4.0 mM EDTA 
  3.0% SDS 
    
RNA resuspension buffer 0.1 mM EDTA 
    
RT-PCR fomula   
ddH2O 32.3 µl 
10X reaction buffer 5.0 µl 
dNTP 5.0 µl 
MgCl2 1.5 µl 
Probe DANN 5.0 µl 
Forward primer 2.0 µl 
Reverse primer 2.0 µl 
Taq polymerase 0.2 µl 
    
PR-PCR program   
step 1 94ºC, 3 minutes 
step 2 94ºC, 1 minute 
step 3 50ºC, 1 minute 
step 4 72ºC, 1 minute and repeat from step 2 for 34 cycles 
step 5 72ºC, 10 minutes 
step 6 4ºC, pause 
    
Microarray atudies   
50X dNTPs 25 mM dATP 
  25 mM dGTP 
  25 mM dTTP 
  10 mM  dCTP 
    
10X dNTPs 1.2 mM each of dATP, dTTP, dGTP 
  0.6 mM dCTP 
  10 mM Tris pH 8.0 
  1 mM EDTA 
    
RT reaction mix 2 µl of 10X RT buffer 
  2 µl of 0.1 M DTT 
  0.6 µl of 50X dNTPs 
    
20X SSC buffer 3 M NaCl 
  0.3 M sodium citrate, pH 7.0 
    
50X Denhardt‘s solution 1% Ficoll 
  1% polyvinylpyrrolidone 
   
    
Hybridisation buffer 1.5 µl of 50X Denhardt‘s solution 
  2.25 µl of 20X SSC 
  1.125 µl of E. coli RNA (10µg/µl) 
  0.375 µl of 1 M HEPES, pH 7.0 
    
Softwares   
Genespring microarray analysis software silicon Genetics, UK 
Sigma plotⓇ 10 Systat software, USA 
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         Supplement II. Relative transcript levels in ?STM0029 compared to the wildtypea 
                      (rel. expression level [?STM0029/wildtype])b 
No. Gene   Predicted functions   Fold Change 
(log) 
  Reference 
PhoP/Q-
regulated genesc 
        L-
broth PCN
d    
STM0628 pagP   Catalyzes the transfer of 
palmitate to lipid A 
   0.03  0.26   Bishop et al., 
2000 
STM1246 pagC   Outer membrane protein 
with sequence sililarity 
to Enterobacter OmpX 
  -0.02 -0.02   Gunn et al., 
1995 
STM1230 phoQ  Sensor protein PhoQ   0.38  0.08  Miller et al., 
1989 
STM1231 phoP  DNA-binding 
transcriptional regulator 
PhoP 
 -0.07  0.00  Fields et al., 
1989 
STM1465 pcgL   D-alanyl-D-alanine 
dipeptidase 
   0.17 -0.04   Hilbert et al., 
1999 
STM1601 ugtL   Putative membrane 
protein 
  -0.25  0.06   Shi et al., 
2004 
STM2080 pagA   UDP-D-glucose 
dehydrogenase 
  -0.14 -0.20   Morona et 
al., 1995 
STM2298 pmrF   Synthesis and/or 
incorporation of ?-
aminoarabinose into 
lipid A 
   0.26 -0.10   Gunn et al., 
1998 
STM2304 pmr
D 
 Polymyxin resistance 
protein B 
 -0.07 -0.10  Kox et al., 
2000 
STM2396 pgtE   Outer membrane protase; 
resistance to peptide 
C18G 
   0.24  0.10   Guina et al., 
2000 
Pietilä et al., 
2005 
STM2871 prgK  Needle complex inner 
membrane lipoprotein 
  0.05  0.31  Sukhan et al., 
2003 
STM2872 prgJ  Needle complex minor 
subunit 
  0.33  0.37  Sukhan et al., 
2003 
STM2873 prgI  Needle complex major 
subunit 
 -0.29  0.26  Sukhan et al., 
2003 
STM2874 prgH  Needle complex inner 
membrane protein 
  0.15  0.14  Sukhan et al., 
2003 
STM2876 hilA  Invasion protein 
regulator 
  0.10  0.10  Rodriguez et 
al., 2002 
STM3763 mgtB   Pathogenicity island 
encoded protein: SPI3; 
Mg2+ transport ATPase, 
P-type 2 
   0.08  0.03   Snavely et 
al., 1989  
STM3764 mgtC   Pathogenicity island 
encoded protein: SPI3; 
Mg2+ transport ATPase 
protein C  
   0.31 -0.13   Alix et al., 
2003 
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STM4291 pmrB  S. Typhimurium sensor 
protein BASS/PMRB 
  -0.44 -0.14   Merighi et 
al., 2005 
STM4292 pmrA  Putative RBS for BasR   -0.19 -0.15   Merighi et 
al., 2005 
pSLT039 spvB  Salmonella-encoded virulence plasmid gene 
 
0.18  -0.08  Fierer et al., 1993 
 
a Protein encode by differentially expresssed genes were identified by annotation or homology to 
known proteins (http://www.ncbi.nlm.nih.gov/sites/entrez?db=genome) and assigned to categories 
based on description in clusters of orthologous groups of proteins (COGs). 
b Genes, whose expressions showed the natural log of hybridization signal ratios (rel. expression level 
[?STM0029/wildtype]) ≥ 0.33 were selected. 
c PhoP/Q-related genes are selected according to the reference from Groisman, E.A. (2001). 
d PCN medium contains 0.4 mM Pi. 
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No. Gene   Predicted functions   Fold Change 
(log) 
  Reference 
PmrA/B-
regulated genesa 
        L-
broth 
PCNb      
STM0115 leuO   Probable activator 
protein in leuabcd 
operon 
   0.27 -0.05   Hernández-
Lucas et al., 
2008 
STM0195 stfA   Major fimbrial subunit 
StfA  
  -0.14 -0.44   Humphries et 
al., 2005 
STM0275 yafC   Hypothetical protein; 
putative cytoplasmic 
protein 
  -0.06 -0.36     
STM0304 sinR   S. Typhimurium SINR 
protein 
  -0.16  0.09   Fredrick et 
al., 1996 
STM0313 dinP   devoid of 
proofreading; 
Damage-inducible 
protein P; similar to E. 
coli damage-inducible 
protein P 
   0.02  0.19     
STM0605 ybdN   3'-phosphoadenosine 
5'-phosphosulfate 
sulfotransferase  
   0.00  0.12     
STM0606 ybdO   Putative LysR family 
transcriptional 
regulator 
   0.08  0.14     
STM0708 ybfA   Putative periplasmic 
protein 
   0.05  0.16     
STM0732 sdhC   Succinate 
dehydrogenase, 
cytochrome b556  
  -0.28 -0.04     
STM0865 ybjG   Putative permease   -0.35 -0.03     
STM0987 ycaR   Ortholog of E. coli orf, 
hypothetical protein  
   0.19  0.52     
STM1161 yceP   Putative cytoplasmic 
protein 
   0.23  0.07     
STM1444 slyA   MarR family 
transcriptional 
regulator for 
hemolysin 
   0.01 -0.03   Song et al., 
2008 
STM1445 slyB   Outer membrane 
lipoprotein SLYB 
precursor 
  -0.18 -0.07   Song et al., 
2008 
STM1479 pntA   Pyridine nucleotide 
transhydrogenase, 
alpha subunit  
  -0.28 -0.08     
STM1631 sseJ   Regulated by SPI-2; 
secreted effector J SseJ 
(gi|9931614); 
Salmonella 
translocated effector 
   0.05  0.11   Freeman et 
al., 2003 
STM1801 ycgO   Ortholog of E. coli 
orf, hypothetical 
protein 
  -0.17  0.10     
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STM1852 yebW   Putative inner 
membrane lipoprotein  
   0.14  0.04     
STM1868A mig-3   Phage tail assembly 
protein  
   0.06  0.08     
STM2080 pagA 
(ugd/ 
pmrE) 
  S. Typhimurium UDP-
glucose 6-
dehydrogenase 
  -0.14 -0.20   Morona et 
al., 1995 
STM2119 yegH   Putative inner 
membrane protein 
   0.01  0.07     
STM2220 yejG       Putative RBS for yejG  -0.26  0.08   
STM2298 pmrF   Putative glycosyl 
transferase 
   0.26 -0.10    Gunn et al., 
1998 
STM2301 pqaB   PqaB; affects 
polymyxin B 
resistance and 
lipopolysaccharide 
synthesis; putative 
melittin resistance 
protein 
   0.01 -0.14   Baker et al., 
1999 
STM2304 pmrD   Polymyxin B 
resistance protein 
PMRD; polymyxin 
resistance protein B 
   0.25 -0.07   Perez et al., 
2007 
STM2395 pgtE   Phosphoglycerate 
transport; outer 
membrane protease E 
precursor 
   0.24  0.10   Pietilä et al., 
2005 
STM2396 pgtA   Phosphoglycerate 
transport; 
phosphoglycerate 
transport system 
transcriptional 
regulatory protein 
PGTA 
  -0.14 -0.05   Yang et al., 
1988 
STM2397 pgtB   Phosphoglycerate 
transport; 
phosphoglycerate 
transport system 
sensor protein PGTB 
   0.03  0.01   Niu et al., 
1995 Yang et 
al., 1988 
STM2398 pgtC   phosphoglycerate 
transport; 
Phosphoglycerate 
transport regulatory 
protein PGTC 
precursor 
   0.00 -0.17   Niu et al., 
1995 
STM2399 pgtP   Phosphoglycerate 
transport; 
phosphoglycerate 
transporter protein 
  -0.27  0.21   Niu et al., 
1995 
STM2400     Putative inner 
membrane protein 
   0.36 -0.25     
STM2826 csrA   Putative RBS for csrA    0.08  0.01    Altier et al., 
2000 
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STM2828 oraA   Similar to E. coli 
regulator, OraA 
protein  
   0.15  0.01     
STM2982 gcvA   LysR family;regulator 
of gcv operon 
  -0.39  0.10     
STM3029 stdA   Similar to E. coli 
putative fimbrial-like 
protein  
   0.31  0.06   Chessa et al., 
2008 
STM3313 yrbF   Putative ABC 
superfamily transport 
protein 
   0.15  0.02     
STM3361 yhcN   Putative outer 
membrane protein 
  -0.35  0.15     
STM3538 glgB   1,4-alpha-glucan 
branching enzyme  
  -0.22 -0.03   Steiner and 
Preiss., 1977 
STM3607 yhjC   Putative LysR family 
transcriptional 
regulator  
   0.12  0.16     
STM3640 ipfA   Long polar fimbria 
protein A precursor 
   0.26  0.08     
STM3707 yibD   Putative 
glycosyltransferase  
  -0.39 -0.16   Marchal et 
al., 2004 
Merighi et 
al., 2005 
STM3761 slsA   Pathogenicity island 
encoded protein: SPI3 
   0.23  0.25     
STM3869 atpF   Putative RBS for atpF   -0.06  0.08     
STM4118 cptA   Putative integral 
membrane protein 
  -0.14 -0.02   Tamayo et 
al., 2005 
STM4291 pmrB   S. Typhimurium 
sensor protein 
BASS/PMRB 
  -0.44 -0.14   Merighi et 
al., 2005 
STM4292 pmrA   Putative RBS for basR  -0.19 -0.15   Merighi et 
al., 2005 
STM4293 yjdB   Putative RBS for yjdB  -0.35 0.13   
STM4294 yjdE   Putative APC family 
Putrescine/ornithine 
transport protein 
   0.06  0.04    
STM4470 yjgD   Hypothetical 15.7 dda 
protein in argI-miaE 
intergenic region 
  -0.04 -0.05    
STM4600 lasT  Putative RNA methyltransferase 
  0.15 -0.04    
 
a PmrA/B-related genes are selected according to the result obtained from Marchal et al. (2004).  
b PCN medium contains 0.4 mM Pi. 
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No. Gene   Predicted functions   Fold Change  (log)   Reference 
LPS, PG and 
cell wall-
associated genes 
        L-broth PCN
a 
  
STM0048 slpA   
Ortholog of E. coli probable 
FKBX-type 16KD peptidyl-
prolyl cis-trans isomerase (a 
rotamase)  
  -0.30 -0.03     
STM0049 lytB   
Similar to E. coli control of 
stringent response; involved 
in penicillin tolerance 
(AAC73140.1) 
  -0.25  0.03   Begley et al., 2002 
STM0123 murE   
UDP-N-
acetylmuramoylalanyl-D-
glutamate 2,6-
diaminopimelate ligase  
  -0.25 -0.12     
STM0124 murF   D-alanine:D-alanine-adding enzyme   -0.30 -0.04     
STM0125 mraY   Phospho-N-acetylmuramoyl-pentapeptide transferase   -0.18  0.03     
STM0126 murD   
Ortholog of E. coli UDP-N-
acetylmuramoylalanine-D-
glutamate ligase 
  -0.02 -0.01     
STM0127 ftsW   
Ortholog of E. coli cell 
division; membrane protein 
involved in shape 
determination 
   0.02  0.07     
STM0128 murG   
UDP-N-acetylglucosamine:N-
acetylmuramyl-(pentapeptide) 
pyrophosphoryl-undecaprenol 
N-acetylglucosamine 
transferase 
  -0.11  0.02     
STM0129 murC   
L-alanine adding enzyme; 
UDP-N-acetyl-
muramate:alanine ligase 
   0.22  0.04     
STM0130 ddlB   
Ortholog of E. coli D-alanine-
D-alanine ligase B, affects 
cell division  
  -0.20 -0.12   Zawadzke et al., 1991 
STM0134 lpxC   
UDP-3-O-acyl N-
acetylglucosamine 
deacetylase 
  -0.70 -0.06   
McClerren et al., 
2005 Langklotz 
et al., 2010  
STM0190 mrcB   
Ortholog of E. coli 
peptidoglycan synthetase; 
penicillin-binding protein 1B 
  -0.48 -0.05     
STM0226 lpxD  Transfer of ß-hydroxymyristic 
acid from ACP  
0.06 -0.01   
STM0228 lpxA  Transfer of ß-hydroxymyristic acid from ACP  
-0.24 0.06  Anderson et al., 
1987 
STM0375 ampH  Penicillin- binding protein  -0.01 0.04  Gantois et al., 2006 
STM0444 ampG  Muropeptide transporter  -0.21  0.05   Folkesson et al., 2005  
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STM0445 yajG   Putative lipoprotein    -0.51  0.02     
STM0446 bolA   Ortholog of E. coli possible 
regulator of murein genes  
  0.28 0.01     
STM0447 tig 
 
Ortholog of E. coli trigger 
factor; a molecular chaperone 
involved in cell division 
 
-0.45 -0.06 
  
STM0637 dacA   
Ortholog of E. coli D-alanyl-
D-alanine carboxypeptidase, 
fraction A; penicillin-binding 
protein 5 
  -0.13  0.17   Baquero et al., 1996 
STM0638 rlpA   Putative RBS for rlpA   -0.21  0.07     
STM0639 mrdB   Putative RBS for mrdB   -0.36  0.08     
STM0640 mrdA   
Similar to E. coli cell 
elongation, e phase; 
peptidoglycan synthetase; 
penicillin-binding protein 2 
   0.23  0.21     
STM0863 dacC   
Ortholog of E. coli D-alanyl-
D-alanine carboxypeptidase; 
penicillin-binding protein 6 
  -0.13 -0.11   Baquero et al., 1996 
STM0988 kdsB   Synthesis of CMP-KDO from KDO-8-phosphate     0.00  0.00     
STM1376 lppB   Putative methyl-accepting chemotaxis protein   -0.38 -0.30   Fadl et al., 2005 
STM1377 lpp   Murein lipoprotein   -0.07 -0.24   Fadl et al., 2005 
STM1518 marB   Putative RBS for marB    0.37 -0.56   Randall et al., 2001 
STM1519 marA   
AraC/XylS family 
transcriptional activator of 
defense systems; multiple 
antibiotic resistance protein 
   0.02 -0.24   Randall et al., 2001 
STM1520 marR   Multiple antibiotic resistance protein MARR    0.55  0.01   
Randall et al., 
2001; 
Sulavik et al., 
1997 
STM1521 marC   Multiple antibiotic resistance protein MARC   -0.11 -0.04     
STM1679 mppA   Periplasmic murein tripeptide transport protein   -0.22 -0.02   
Park and Uehara, 
2008 
STM1772 kdsA   Synthesis of KDO-8-phosphate     0.06   0.00     
STM1845 prc   Tail-specific protease   -0.42 -0.07   Bäumler et al., 1994 
STM2062 dacD   DD-carboxypeptidase   -0.02 -0.05   Baquero et al., 1996 
STM2082 rfbP   Initiates synthesis of LPS O 
unit 
  -0.12  0.01   Jiang et al., 
1991 
STM2083 rfbK   Synthesis of GDP-rhamnose 
from mannose-1-phosphate 
  -0.22  0.09   Jiang et al., 
1991 
STM2084 rfbM  Synthesis of GDP-rhamnose 
from mannose-1-phosphate 
 -0.49 -0.10  Jiang et al., 
1991 
STM2085 rfbN  Synthesis of LPS O unit  -0.33 -0.06  Reeves, 1993 
STM2086 rfbU  Synthesis of LPS O unit  -0.35 -0.01  Reeves, 1993 
STM2087 rfbV   Synthesis of LPS O unit   -0.06 -0.08   Reeves, 1993 
STM2088 rfbX  Assembly or transfer of LPS 
O unit 
 -0.49 -0.09  Reeves, 1993 
STM2089 rfbJ  Synthesis of CDP-abequose  -0.45 -0.08  Reeves, 1993 
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STM2090 rfbH 
 
Synthesis of CDP-4-keto-3,6,-
Dideoxyglucose from CDP-
glucose 
 
-0.08 0.09  Reeves, 1993 
STM2091 rfbG   
Synthesis of CDP-4-keto-3,6,-
dideoxyglucose from CDP-
glucose 
  -0.09  0.11   Reeves, 1993 
STM2092 rfbF   
Synthesis of CDP-4-keto-3,6,-
dideoxyglucose from CDP-
glucose 
  -0.37 -0.06   Reeves, 1993 
STM2093 rfbI   
Synthesis of CDP-4-keto-3,6,-
dideoxyglucose from CDP-
glucose 
  -0.38  0.04   Reeves, 1993 
STM2094 rfbC   Glucose-1-phosphate thymidylyltransferase   -0.39 -0.09   Jiang et al., 1991 
STM2095 rfbA   Glucose-1-phosphate thymidylyltransferase   -0.40  0.01   
Lindquist et al., 
1993 
Jiang et al., 1991 
STM2096 rfbD   
Glucose-1-phosphate 
thymidylyltransferase   -0.58  0.00   Jiang et al., 1991 
STM2097 rfbB   
Glucose-1-phosphate 
thymidylyltransferase   -0.03  0.07   Jiang et al., 1991 
STM2107 wcaH   
GDP-mannose mannosyl 
Hydrolase [Salmonella 
Typhimurium LT2]. 
  -0.47  0.00   
Domínguez-
Bernal et al., 
2004 
STM2108 wcaG   Bifunctional GDP fucose synthetase   -0.74 -0.24     
STM2109 gmd   GDP-D-mannose dehydratase   -0.11  0.03     
STM2110 wcaF   Putative acyltransferase    0.08 -0.94   
  
Ophir et al., 1994 
 
STM2111 wcaE   Putative RBS for wcaE    0.07 -0.38     
STM2112 wcaD   Putative RBS for wcaD    0.65  0.01     
STM2113 wcaC   Putative glycosyl transferase     0.06 -0.32     
STM2114 wcaB   Putative acyl transferase   -0.09  0.03     
STM2115 wcaA   Putative glycosyl transferase    -0.68  0.13     
STM2116 wzc   Putative RBS for wzc    0.10  0.16     
STM2117 wzb   Putative protein-tyrosine-phosphatase    0.03 -0.07     
STM2118 wza  Putative polysaccharide export protein   0.14  0.14  
Wehland et al., 
2000 
STM2188 mglC  Putative RBS for mglC  -0.28 -0.05  Müller et al., 1985 
STM2189 mglA  Putative RBS for mglA  -0.07 -0.10   Müller et al., 1985 
STM2190 mglB  Galactose transport protein  0.09 -0.05 
  Müller et al., 
1985 
STM2191 galS   GalR/LacI family 
Transcriptional repressor of 
mgl operon 
 
0.27 -0.06 
 
Yoshimura et al., 
2006 
STM2232 oafA   O-antigen five; acetylation of 
the O-antigen (LPS) 
  -0.20 -0.21 
  
Slauch et al., 
1995 
Slauch et al., 
1996 
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STM2383 mepA   Penicillin-insensitive murein DD-endopeptidase   -0.27 -0.06     
STM2439 yfeL   Putative membrane carboxypeptidase    0.06 -0.13     
STM3186 tolC   
Required for detergent 
resistance and LPS cross-
linking 
   0.06  0.10     
STM3197 glgS   RpoS dependent glycogen biosynthesis protein   -0.14 -0.17     
STM3200 rfaE   
putative sugar nucleotide 
Transferase domain of ADP-
L-glycero-D-manno-heptose 
synthase 
  -0.07 -0.15   Kim, 2003 
STM3300 dacB   
D-alanyl-D-alanine 
carboxypeptidase; penicillin-
binding protein 4  
  -0.18  0.15   Baquero et al., 1996 
STM3307 murA   UDP-N-acetylglucosamine 1-carboxyvinyltransferase   -0.20 -0.04   Kong et al., 2008 
STM3308 yrbA   Putative BolA family transcriptional regulator     0.22 -0.20     
STM3309 yrbB   Putative STAS domain   -0.26 -0.24     
STM3310 yrbC   putative ABC superfamily transport protein   -0.34 -0.17     
STM3311 yrbD   Putative RBS for yrbD   -0.30 -0.07     
STM3312 yrbE   Putative ABC superfamily transport protein    -0.01 -0.15     
STM3313 yrbF   Putative ABC superfamily transport protein     0.15  0.02     
STM3314 yrbG   Putative CacA family Na:Ca transport protein    0.14 -0.03     
STM3315 yrbH   Putative polysialic acid capsule expression protein   -0.37  0.02     
STM3316 yrbI   Putative protein of HAD superfamily   -0.38 -0.04     
STM3317 yrbK   Putative inner membrane protein   -0.35  0.00     
STM3318 yhbN   Putative ABC superfamily transport protein   -0.11 -0.05     
STM3319 yhbG   Putative ABC superfamily transport protein   -0.11 -0.02     
STM3372 mreD   Rod shape-determining 
protein 
  -0.14 -0.01   Costa et al., 
1993 
STM3373 mreC   Rod shape-determining 
protein  
  -0.32 -0.25   Costa et al., 
1993 
STM3374 mreB   Rod shape-determining 
protein 
  -0.22  0.03   Costa et al., 
1993 
STM3493 mrcA   Transpeptidase of penicillin-
Binding protein 1a; 
peptidoglycan synthetase 
  -0.15 -1.22     
STM3710 rfaD   ADP-L-glycero-D-
mannoheptose-6-epimerase 
  -0.03 -0.04   Sirisena et al., 
1994 
STM3711 rfaF   LPS heptosyltransferase 1   -0.28 -0.12   Chen et al., 1993 
STM3712 rfaC   Lipopolysaccharide heptosyltransferase-1    0.07 -0.13   Klena et al., 1992 
STM3713 rfaL   O-antigen ligase   -0.17 -0.03   Klena et al., 1992 
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STM3714 rfaK   Lipopolysaccharide core biosynthesis   -0.27  0.00   Klena et al., 1992 
STM3715 rfaZ   Lipopolysaccharide core biosynthesis protein     0.24  0.05   Klena et al., 1992 
STM3716 rfaY   Lipopolysaccharide core biosynthesis protein    0.38 -0.06   Klena et al., 1992 
STM3717 rfaJ  
UDP-D-
Glucose:(galactosyl)lipopolys
accharide glucosyltransferase 
  0.16  0.10   Pradel et al., 1992 
STM3718 rfaI   
UDP-D-
Galactose:(glucosyl)lipopolys
accharide-alpha-1, 3-D-
galactosyltransferase 
   0.31 -0.07   Pradel et al., 1992 
STM3719 rfaB   
UDP-D-
Galactose:(glucosyl)lipopolys
accharide-1, 6-D-
galactosyltransferase 
  -0.81  0.14   Pradel et al., 1992 
STM3720 yibR   Putative inner membrane protein   -0.07  0.05     
STM3721 rfaP   Lipopolysaccharide core biosynthesis protein   -0.18  0.02   
Parker et al., 
1992 
STM3722 rfaG   Glucosyltransferase I    -0.08 -0.12   Parker et al., 1992 
STM3723 rfaQ   Lipopolysaccharide core biosynthesis protein    -0.27 -0.01   
Parker et al., 
1992 
STM3724 kdtA   KDO transferase   -0.05 -0.01   Belunis et al., 1995 
STM3725 kdtB   Phosphopantetheine adenylyltransferase   -0.05 -0.15     
STM3918 rfe   Undecaprenyl-phosphate N-acetylglucosaminyltransferase   -0.10 -0.25   
  
Keenleyside et 
al., 1994 
 
STM3919 wzzE   Ortholog of E. coli putative transport protein  -0.46 -0.47  
Morona et al., 
1995 
STM3920 wecB  UDP-N-acetyl glucosamine-2-epimerase  
-0.28 -0.19  Barua et al., 2002 
STM3921 wecC 
 
Ortholog of E. coli UDP-N-
acetyl-D-mannosaminuronic 
acid dehydrogenase 
 
-0.12 -0.15 
 
Bulach et al., 
2000 
STM3924 wecD 
 
Lipopolysaccharide 
biosynthesis protein 
 -0.14 -0.21   Hung et al., 2006 
Ramos-Morales 
et al., 2003  
STM3925 wecE  TDP-4-oxo-6-deoxy-D-glucose transaminase 
 -0.09 -0.05   
STM3926 wzxE  O-antigen translocase in LPS biosyntesis  
  0.16 -0.26   
STM3927     putative inner membrane protein   -0.25 -0.31     
STM3928 wecF   S. Typhimurium probable 4-alpha-L-fucosyltransferase   -0.19 -0.33     
STM3929 wecG   
S. Typhimurium probable 
UDP-N-acetyl-D-
mannosaminuronic acid 
transferase 
  -0.08 -0.35     
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STM3977 rfaH   
Affecting biosynthesis of 
lipopolysaccharide core, F 
pilin, and haemolysin 
  -0.26 -0.20   
  
Kong et al., 2009 
 
STM4045 rhaD   Rhamnulose-1-phosphate aldolase    -0.42 -0.16   
Al-Zarban et al., 
1984 
STM4046 rhaA   L-rhamnose isomerase   -0.20  0.10   Al-Zarban et al., 1984 
STM4047 rhaB   Rhamnulokinase    0.29  0.02   Al-Zarban et al., 1984 
STM4048 rhaS   
AraC/XylS family; L-
rhamnose operon regulatory 
protein 
   0.20 -0.14   Al-Zarban et al., 1984 
STM4049 rhaR   
AraC/XylS family; L-
rhamnose operon 
transcriptional activator  
  -0.39  0.07   
Al-Zarban et al., 
1984; 
Tate et al., 1992 
STM4050 rhaT   
L-rhamnose-proton symport 
(L-rhamnose-H+ transport 
protein) 
  -0.13 -1.00   
Al-Zarban et al., 
1984; 
Tate et al., 1992 
STM4582 slt   Soluble lytic murein transglycosylase   -0.41 -0.03     
 
a PCN medium contains 0.4 mM Pi. 
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